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Commissioning for long-term conditions: hearing the voice
of and engaging users – a qualitative multiple case study
Stephen Peckham,1,2* Patricia Wilson,3 Lorraine Williams,2
Jane Smiddy,3 Sally Kendall,3 Fiona Brooks,3 Joanne Reay,4
Douglas Smallwood5 and Linda Bloomfield3
1Centre for Health Services Studies, University of Kent, Kent, UK
2Department of Health Services Research and Policy, London School of Hygiene &
Tropical Medicine, London, UK
3Centre for Research in Primary and Community Care, University of Hertfordshire, Hatfield, UK
4National Institute for Health Research Management Fellow, West Essex Primary Care Trust,
Epping, UK
5Patient and Public Engagement and Involvement Consultant, NHS East of England, UK
*Corresponding author s.peckham@kent.ac.uk
Background: Some 15 million people in England have a long-term condition (LTC) but there is concern
about whether or not the NHS meets their needs. To address this, consecutive governments have
developed policies aimed at improving service delivery and patient and public engagement and
involvement (PPEI). There has been little research that examines the impact or benefit of PPEI in
commissioning. This project explored the role and impact of PPEI in commissioning for people with LTCs.
The research was undertaken during a period of substantial change in the English NHS, which enabled us
to observe how the NHS reforms in England impacted on approaches to PPEI.
Aim: The aim was to examine how commissioners enable voice and engagement of people with LTCs and
identify what impact this has on the commissioning process and pattern of services. Our specific objectives
were to (1) critically analyse the relationship between the public/patient voice and the impact on the
commissioning process; (2) determine how changes in the commissioning process reshape local services;
(3) explore whether or not any such changes in services impact on the patient experience; (4) identify if
and how commissioners enable the voice and engagement of people with LTCs; and (5) identify how
patient groups/patient representatives get their voice heard and what mechanisms and processes patients
and the public use to make their voice heard.
Methods: We used a case study design examining the experience of PPEI in three LTC groups – diabetes,
rheumatoid arthritis and neurological conditions – through three in-depth case studies. Our approach
involved reviewing practice across the UK and then focusing on three geographical areas to examine
practices of commissioning health care for people with LTCs, approaches to PPEI, patterns of services for
people with LTCs and the activities of local patient and voluntary organisations for people with LTCs. The
research had five phases and involved participatory and interactive methods of data collection and analysis.
Findings: We identified two key areas where improvements to practice in relation to PPEI can be made.
The first relates to the framework or infrastructure arrangements for PPEI and how PPEI can be supported
in the NHS and other organisations. To combat short-termism and the fragility of PPEI activities, sufficient
resources need to be invested in developing shared understandings and sustaining relationships and
infrastructures. The second area of action relates to the process for PPEI and how it should be undertaken.
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Conclusion: Action needs to be taken by organisations at both national and local levels. PPEI is a circular
process and, in itself, extremely fragile. This circular process can be ‘virtuous’ – successful engagement
leads to improved involvement and outcomes. However, where involvement is tokenistic or ends, patients
and the public become disengaged and less involved and can be described as a ‘vicious circle’. In addition,
we identified a number of key methodological issues and areas for further research that should be
considered by research funders and researchers undertaking research in the area of PPEI, including a
need for research on PPEI with young people.
Funding: The National Institute for Health Research Health Services and Delivery Research programme.
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I t is estimated that some 15 million people have a long-term condition (LTC) in England and, whilethe number of people with LTCs is increasing, there have been concerns for a number of years about
whether or not the NHS meets their needs. In order to improve the way that the NHS provides services to
people with LTCs, successive governments have developed policies to improve the way that NHS plans
and organises services and also to strengthen the involvement of patients and the public in decisions
about local services. This project examined these developments in three areas of the country focusing on
the experience of people with diabetes, rheumatoid arthritis and neurological conditions. We found few
good examples of instances where NHS organisations involved patients and the public, but where there
was involvement and developments started by patients, these were beneficial for them. The main problems
were that the way people were involved was often tokenistic or good ideas were not followed through.
Many initiatives started by patients were short term and not sustained. Recent changes in the NHS also
meant that existing relationships between NHS organisations and patients were disrupted and people
were frustrated at having to start again to develop new relationships with NHS organisations. Essentially,
we found that involvement was more successful in places where it was supported and maintained, and
where patients could see that it made a difference. However, the process of involvement can be seen as
a delicate circle that might be easily broken, leading to people feeling frustrated and disconnected.
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It is estimated that some 15 million people in England have a long-term condition (LTC) and that this
number will continue to increase. People with a LTC have, to varying degrees, a long-standing relationship
with local health services. Concern about whether or not the NHS meets the needs of people with LTCs
emerged in the 1990s and consecutive governments have developed policies aimed at improving service
delivery and also patient and public engagement and involvement (PPEI). Both the current and the
previous government emphasised the need to improve commissioning for people with LTCs, and PPEI in
commissioning was seen as a key policy priority. However, there has been little research that examines the
impact or benefit of PPEI in commissioning. This project was designed to explore the role and impact of
PPEI in commissioning for people with LTCs. Our original focus was on the activities of primary care trusts
(PCTs) as commissioners of health care for people with LTCs. However, from the very beginning of the
research period, there were substantial changes to the commissioning structures in the English NHS,
with PCTs merging into clusters. With the change of government in 2010, the extent and rate of change
accelerated, with the abolition of PCTs and development of a new commissioning structure – initially
outlined in the White Paper Equity and Excellence: Liberating the NHS, published in July 2010. From
January 2011, new ‘Pathfinder’ general practitioner (GP)-led commissioning groups began to develop,
leading, eventually, to the establishment during 2012 of new Clinical Commissioning Groups (CCGs).
These CCGs took over statutory responsibility for some 60% of the NHS budget from April 2013
to commission local community and hospital services. At the same time, PCT clusters evolved into
commissioning support units and NHS England was established with responsibility for 40% of the NHS
budget, with a specific emphasis on specialist services, national GP, ophthalmic, pharmaceutical and dental
contracts, prison health, armed forces and a number of national public health programmes. Public health,
including the commissioning of public health services, moved from PCTs to local authorities. In addition,
new structures for PPEI were introduced. This presented challenges for the conduct of the research given
the organisational turbulence but provided an opportunity to observe the impact of these changes on PPEI
in relation to commissioning services for people with LTCs.
Aims
The project’s initial aim was to examine how commissioners enable the voice and engagement of people
with LTCs and identify what impact this has on the commissioning process and pattern of services. A key
outcome of the research was to provide guidance for commissioners on the skills and expertise needed by
different commissioners, what actions are most likely to lead to responsive services and the most effective
mechanisms and processes for active and engaged commissioning for people with LTCs. Our specific
objectives were to:
1. critically analyse the relationship between the public/patient voice and the impact on the
commissioning process
2. determine how changes in the commissioning process reshape local services
3. explore whether or not any such changes in services impact on the patient experience
4. identify if and how commissioners enable the voice and engagement of people with LTCs
5. identify how patient groups/patient representatives get their voice heard and what mechanisms and
processes patients and the public use to make their voice heard.
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The research was undertaken during a period of substantial change in the English NHS which enabled us
to observe how the NHS reforms in England impacted on approaches to PPEI. While this did not provide
an analysis of the position of PPEI in CCGs, once established in April 2013 it did provide useful indications
of how PPEI was being developed, and the priority being placed on PPEI, during the development and
authorisation stages of CCGs.
Methods
Given the complexity of studying PPEI in commissioning, we used a case study design in order to provide
an in-depth, rich analysis in selected areas. The research examined three experiences of PPEI in three LTC
groups – diabetes, rheumatoid arthritis and neurological conditions – through three in-depth case studies.
Our approach involved reviewing practice across the UK and then focusing on three geographical areas
to examine practices of commissioning and purchasing health care for people with LTCs, approaches
to patient and public involvement (PPI), patterns of services for people with LTCs and the activities of
local patient and voluntary organisations for people with LTCs. The research had five phases and
involved participatory and interactive methods of data collection. Methods of data collection comprised
documentary analysis, participant workshops, observation of meetings, focus groups and interviews, and
the collection of data on service use and patterns of services in the three localities. We were able to
involve a wide range of participants and respondents in our study from patient groups, statutory and
non-statutory health-care providers, health-care commissioners, clinicians, patient representatives and
carers and local authority officers and politicians. Following an initial analysis and synthesis of our data,
we presented our findings in a summative workshop and selected a number of exemplars which were
assessed for their potential to provide patient benefit by an expert reference group.
Results
The shift in guidance and policy from PPI to patient and public engagement (PPE) seems to be linked with
a periphilization of PPEI activity. We found a greater emphasis on concepts of communication rather
than active involvement within CCG developments. PPEI was generally not a key issue in authorisation,
the process by which CCGs are assessed against a series of criteria in order to become established
commissioning organisations. While many CCGs reported that PPEI was a key priority, there was little
evidence in authorisation documentation about PPEI and we did not observe a significant degree of PPEI
activity in CCGs. In general, we found that at a CCG level PPEI is also becoming a peripheral activity.
Despite this, respondents in our study also identified the development of CCGs as an opportunity to
innovate in relation to PPEI but we found little evidence to support such innovation, although at the time
of this research CCGs were very new organisations. In addition to changes in rhetoric, we found that there
were different understandings of involvement in terms of how it was understood and what is was for
between commissioners, providers, patients and the public. It is important that common understandings
are agreed if effective PPEI is to be developed.
Case study 1 had a strong pedigree of PPI initiatives but there were few notable examples of service user
voice having a major impact on service delivery. While a commitment to PPEI transferred to the CCG
board, this intent did not extend to all GPs. The employment of a dedicated project lead to develop the
PPEI strategy demonstrated a commitment, but there was a general feeling that the aims of the strategy
would take longer than anticipated to achieve. Within the time frame of this study, it was too early to be
able to fully evaluate whether or not the service user voice was being heard and responded to in the CCG
decision-making processes.
Case study 2 had a long-standing tradition of PPEI initiatives, with a strong emphasis on partnership
working. There were a number of examples of service user voice influencing service development
and delivery, but we were not able to determine the impact of such involvement. The development
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and expansion of patient participation groups was evident in general practice during the research period.
During the data collection period, the CCG had formulated only a PPEI draft plan, rather than a strategy,
with a GP-lead rather than a dedicated appointment. There were a number of potential PPEI vehicles
within the new organisation, such as a membership scheme and patient engagement panel, but it was
unclear how these structures would function within the organisation or how PPEI would feed into service
development and overall decision-making.
Case study 3 did not have a marked history of PPEI within the PCT, although there were a variety of
different methods used to involve and engage with their community. There was little evidence of much
meaningful engagement, particularly within primary care, an area of increasing significance for people
with LTCs. Some efforts were made to ensure that services were planned to meet the needs of particular
sections of the community but these failed, due, in part, to poor PPEI planning and execution. The CCG is
better placed to ensure that PPEI is firmly embedded in all areas of commissioning decisions in the future
and new staff and structures are planned to enable this to happen. There is a strong commitment and will
make a difference, but within the time frame of this project it was not possible to assess any impact.
Given the complexities and range of PPEI and health-care commissioning, it was not possible to
demonstrate whether or not PPEI was being done well in our case studies. In particular, assessment of
process was hampered by the continuing structural and organisational changes taking place within
the English NHS during the period of the research. We did identify some positive impacts in terms of
improvements in process and also to initiatives that would lead to patient benefit. However, our findings
suggest that the priorities for health care are predominantly driven by national and local policy priorities
and clinical priorities. PPEI tends to be framed by these priorities rather than patient and public voices
being able to influence the core concerns and priorities. It is interesting to note that the initiative that we
identified as being most strongly driven by lay people and also rated most highly by the expert reference
group was outside the health-care sector, although having substantial patient benefit. This initiative
struggled to gain and sustain relevant support.
The need for sustainability was a constant theme that emerged in our research. There was frustration
about constantly changing NHS structures which had an enormous negative impact on PPEI and the
contribution that patients and the public were making. In particular, there was a loss of organisational
memory with the organisational restructuring and staff changes, causing significant knowledge gaps and
disruption in relationships.
Future development of PPEI is dependent on training and development, which is likely to remain
under-resourced. Our research also demonstrates that young people and adults have different experiences
and perceptions. We found that, for adults, engagement and experience provide the key underpinning
for developing involvement in decision processes. For young people, however, the combination of
experience and engagement tend to lead to a withdrawal of interest. Further research is needed with
young people to understand the reasons for this and how young people’s involvement can be supported
and sustained.
We did find examples of effective PPEI that had positively influenced agencies. However, much PPEI
continues to be undertaken in silos, with little sharing of resources, processes or experience, and there is
a need for improved networking and sharing if PPEI is to be effective and beneficial.
Conclusions
The findings set out in this report identify some key areas where improvements to practice in relation
to PPEI can be made. In particular, these findings point to two broad areas of action. The first relates to
the framework or infrastructure arrangements for PPEI and how PPEI can be supported in the NHS and
other organisations. To combat short-termism and the fragility of PPEI activities, sufficient resources need
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to be invested in sustaining relationships and infrastructures – including training and sharing experience
across sectors. Developing a shared language and understanding is also important. The second area of
action relates to the process for PPEI and how it should be undertaken. These action areas are relevant to
national organisations (and the new regional structures and organisations developing within the reformed
English NHS) and to local commissioners (the CCGs) and service providers. PPEI is not a linear process.
There is a circular process and this is, in itself, extremely fragile. This circular process can be ‘virtuous’,
in that good engagement can lead to improved involvement if it is not tokenistic or has sustainability.
However, where involvement is tokenistic or ends, patients and the public become disengaged and less
involved, and this can be described as a ‘vicious circle’.
We identified three areas that frame approaches to PPEI and provide an analytical framework for evaluating
PPEI within the context of commissioning. Developing approaches to PPEI needs to be framed by asking
whether or not it is moral – PPEI as a right for the tax-paying citizen in a democracy, and the moral
argument of ‘nothing about me without me’; whether or not it is approached methodologically – PPEI
as a tool for quality improvement, improved patient safety and increased efficiency; and how the policy
imperative is enacted – PPEI undertaken as a policy imperative. This provides an approach that begins to
help shape a potential evaluative frame for PPEI by asking, for example, whether or not everyone has a
voice, if quality has been improved, or if PPEI has been implemented as per policy.
In addition, the research identified a number of key methodological issues and areas for further research
that should be considered by research funders and researchers undertaking research in the area of PPEI.
In particular, we identified key challenges for undertaking research on PPEI with young people and
recommend further specific projects with younger people on examining PPEI in health care.
Implications for national organisations
l National agencies should ensure that training and development programmes on PPEI for
commissioners, providers and patients and the public are implemented; these can be delivered
nationally or support local training and development initiatives.
l National organisations such as NHS England and National Healthwatch need to develop monitoring
criteria for PPEI.
l There needs to be clarity about terminology with agencies being specific about the meaning of terms
such as engagement and involvement. These terms carry different meanings to different people.
l National and regional agencies need to develop and support a sustainable environment for PPEI in
which local relationships can develop and flourish.
l At a regional level, organisations need to ensure that resources and structures for PPEI are shared,
for example supporting networks, sharing resources and jointly supporting infrastructures.
Implications for health-care commissioners and providers
l Commissioners need to embed PPEI throughout the commissioning cycle.
l Commissioners need to understand that strategies for engagement, while important, are not
substitutes for involvement; this is a contributing stage but does not constitute active participation.
l Commissioners and providers need to agree measurable outcomes of PPEI with patients and public,
and evaluate these annually.
l Commissioners and providers need to work together on PPEI as providers have more opportunities for
engaging with patients and carers.
l Commissioners, providers, patients and the public should work together to develop a shared vision
of PPEI.
l Agencies should participate in existing networks and forums, such as participation in a
neurological network.
l Agencies should co-operate on the mapping of local PPEI.
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l While PPEI requires an organisation-wide approach, organisations require dedicated resources
(staff, funding) for PPEI.
l Commissioners and providers should develop a shared framework for evaluating PPEI and its outcomes,
for example in relation to improved patient experience and safety.
l Indicative data should be collected to understand the local contextual enablers and barriers to
implementing PPEI.
l PPEI processes and structures should enable the voice of the public who are the most vulnerable, such
as people with long-term health conditions (mental health problems, dementia, learning disabilities) or
long-term socioeconomic conditions (homeless people, traveller groups, sex workers, refugees, asylum
seekers, prisoners/ex-offenders, people living with persistent poverty/lower levels of education), and
those from black and ethnic minority communities.
l A highly visible and accessible main point of contact for the public should be provided, focusing on
relational integration such as the fostering of relationships and trust, and consistently providing timely
and informative feedback.
Recommendations for future research
l Our research suggests that further research is urgently required to examine how PPEI is being
developed within the reformed English NHS. Our research has demonstrated the fragility of PPEI and
how reorganisation can impact negatively on PPEI processes and developments.
l Research on PPEI among young people and children requires dedicated research projects where all
resources and activity are focused on accessing, involving and supporting young people.
l This project has demonstrated the value of linking research between similar research projects – in this
case linking with the Department of Health Policy Research Unit in Commissioning and the Healthcare
System research on CCGs – and allowing the pooling of data.
l This project has demonstrated the value of participative and iterative methods for investigating PPEI
and researchers should be encouraged to utilise similar methods in future studies.
l There is still a need for research to measure the potential economic costs/benefits of PPEI.
Funding
Funding for this study was provided by the Health Services and Delivery Research programme of the
National Institute for Health Research.
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I t is estimated that some 15 million people in England have a long-term condition (LTC) and thatthis number will continue to increase. People with a LTC have, to varying degrees, a long-standing
relationship with local health services. Concern about whether or not the NHS meets the needs of
people with LTCs emerged in the 1990s.1 The previous Labour government emphasised the need for
better services developing a national strategy for people with LTCs, service developments, improved
patient and public involvement (PPI) and supporting new service developments.2,3 PPI was a key element
of policy responses to developing services for people with LTCs, with a particular emphasis on PPI
in commissioning.4
Importantly, however, the emphasis on PPI has been continued by the current government and the NHS
Mandate5 places a responsibility on the NHS to improve the co-ordination of care for people with LTCs.
In particular, NHS England and Clinical Commissioning Groups (CCGs) are required to improve services
and, in particular, develop commissioning strategies that address the needs of people with chronic LTCs,
support strategies for self-help and engage them in decisions about the services they receive.6 In Equity
and Excellence: Liberating the NHS,7 the coalition government explicitly set a key task for the new NHS
commissioning board (NHS England) to champion patient and carer involvement, and stated that the
Secretary of State would hold it to account for progress. This represents a significant challenge, not only
for NHS England but also for local CCGs. However, there has been an important change in language
and terminology. Equity and Excellence refers to engagement as a key route for clinical commissioners
to take rather than involvement, which was a term used previously in policy documents and guidance.
While such a change may, in reality, be semantic, meanings are quite important; as we shall discuss later
in this report, a problem exists of terms being used interchangeably while, at the same time, different
stakeholders and individuals confer different meanings to the same terms.8 Involvement and engagement
were terms used interchangeably in the data. We have used the term PPI where it was clear that it related
to PPI. Patient and public engagement and involvement (PPEI) has been used in this report as an
overarching term to describe activities involving engagement and involvement.
In 2007, government proposals for people with LTCs suggested that user groups were to be key to
increasing the devolution of decisions to practice-based commissioners (now abolished) and the
development of ‘strategic commissioning’ between health and social care agencies.9 Guidance for
commissioning agencies, published in 2007, placed great importance on how commissioners could procure
care that promoted the health and well-being of individuals in consultation with local people.10 These
were incorporated into the commissioning competencies, needs assessment frameworks and performance
regimes across health and social care, and there was a clear emphasis on increasing the role of the third
sector.11–13 The NHS Next Stage Review14 highlighted changing public expectations related to ‘control,
personalisation and connection’, and building partnerships with patients and LTC user groups.
While the policy direction for commissioning was clear, implementation was variable as primary care
trusts (PCTs) coped with a complex blend of incentives and regulatory arrangements. Practice-based
commissioning (PBC) was seen as integral to the success of commissioning strategies for LTCs but
remained underdeveloped, had little significant effect on the redesign of services and did not sufficiently
engage most general practitioners (GPs) in commissioning.15,16 Good commissioning for people with
LTCs requires not only developing a set of skills for commissioning responsive and appropriate patient
pathways that provide relevant choices for service users, but also developing approaches to sustaining user
engagement. Research on engaging users in the NHS and on user involvement in change management in
health services has demonstrated a willingness and commitment to engagement, but few, if any, concrete
examples of effective influence by users or evidence of change.17,18
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While the importance of PPI in commissioning has been recognised since the initial development of NHS
purchasing in the 1990s, there has not been any significant evidence that such engagement has influenced
commissioning decisions.8,17–19 In 2007, a Picker Institute survey found that, while PCTs had a number of
mechanisms and defined management responsibilities for PPI, ‘. . . there is a disconnect between these
activities and the relatively low expectation that patient, public and community groups will have significant
influence on commissioning decisions’ (p. 15).18 Key barriers identified were difficulties in reaching
marginalised, isolated or deprived groups, a lack of understanding among the public of ‘commissioning’
and a lack of reliable data about patients’ experiences. However, when respondents to the Picker survey
were asked what approaches PCTs were considering for future engagement, there was a continued
emphasis on methods such as formal consultations, patient panels, citizens’ juries and surveys.
It was in this context that our original proposal to the National Institute for Health Research (NIHR) was
developed. The research brief highlighted a number of areas for research relating to the organisation and
processes of commissioning, with particular reference made to commissioning for people with LTCs. Our
project responded to these general issues and explicitly focused on the question in the brief related to
PCTs and their PBCs to ensure that ‘voice’ and community engagement, as set out in both Our Health,
Our Care, Our Say White Paper and World Class Commissioning, are achieved.
Aims and objectives
The projects initial aim was, therefore, to examine how commissioners enable voice and engagement of
people with LTCs and identify what impact this has on the commissioning process and pattern of services.
A key outcome of the research will be guidance on the skills and expertise needed by different
commissioners, what actions are most likely to lead to responsive services and the most effective
mechanisms and processes for active and engaged commissioning for people with LTCs. Our specific
objectives were to:
1. critically analyse the relationship between the public/patient voice and the impact on the
commissioning process
2. determine how changes in the commissioning process reshape local services
3. explore whether or not any such changes in services impact on the patient experience
4. identify if and how commissioners enable the voice and engagement of people with LTCs
5. identify how patient groups/patient representatives get their voice heard and what mechanisms and
processes patients and the public use to make their voice heard.
While the specific aim of the research did not change, the specific focus on methods had to be adapted to
undertaking the research within a dynamic and rapidly changing context. However, this did provide the
opportunity to investigate how PPI developed at this time of transition and what specific processes and
structures for PPI were being developed within the new emerging commissioning architecture of the
English NHS. As such, the aims and objectives remained the same but we have adapted our research
protocol to address this changing context (see Chapter 3).
The study
Over the last 10–15 years, there has been an increasing recognition that the NHS needs to improve the
support and service that it provides to people with LTCs. The current context for this is within a framework
where commissioners are expected to develop stronger roles in shaping and planning local services that
are responsive to local needs. In relation to LTCs, policies of choice and PPI are key to how this will be
achieved. The key objectives of this study were to examine processes – how people were involved in local
commissioning decisions – and impact – what was the result of that involvement.
INTRODUCTION
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However, the study was undertaken during a period of extensive change within the English NHS. In
particular, the abolition of PCTs and development of CCGs created an ever-changing local context for our
case study research, but this was only part of a much wider and far-reaching reorganisation of the English
NHS introduced by the coalition government and enshrined in the Health and Social Care Act 2012
(discussed further in Chapter 2).20 This had a significant impact on the conduct of the research in terms of
both the activities we initially intended undertaking and conducting the case study research which was
designed to incorporate interviews with key informants on a regular basis.
In 2009, when the project commenced, PCTs were the main commissioning organisations within the NHS,
with practice-based commissioners having been developed in some areas. The original study design was
focused on case studies of PCTs and our case studies were selected to reflect differences between PCTs
(rural, urban, strong PBC presence, etc.). At this time it was clear that increasing emphasis was being
placed on the role of PBCs and, as a result of reduced management cost funding and stronger PBCs,
some PCTs were already merging into larger commissioning organisations.21 With the election of the new
coalition government in 2010 and publication of Equity and Excellence: Liberating the NHS,7 the pace of
change increased, with proposals for a major restructuring of the English NHS. In particular, commissioning
responsibilities, which had predominantly been invested in PCTs, were now redistributed across new
GP-led commissioning groups, NHS England and local authorities (see Appendix 11). The reforms led to
further PCT mergers into clusters and the development of new GP commissioning groups, with a formal
Pathfinder CCG programme launched at the end of 2010.22 By April 2012, all areas of the country had
emerging CCGs and PCT clusters were beginning to reform into commissioning support organisations.
During 2012–13, these groups then went through an authorisation process to become statutorily
responsible for NHS commissioning from April 2013.
Patient and public involvement has been a key theme in health policy in the UK since the introduction of
the internal market by the Conservative government in the early 1990s and continues to be prominent
in the current coalition government policy.7 The changes introduced by the Health and Social Care Bill
also involved further reorganisation of PPI structures. The government has dismantled much of the
PPI infrastructure of the previous Labour government, replacing it with new developments at the primary
care level and in the role of local authorities. The only aspect of previous PPI structures that has been
retained is the governance of NHS foundation trusts with the emphasis on membership from staff,
patients and the public. CCGs, which will be led by GPs, will be commissioning health care to meet
the needs of their local population. They ‘will need to engage patients and the public on an ongoing
basis as they undertake their commissioning responsibilities, and will have a duty of public and patient
involvement’ (p. 7).7 Key changes to the role of local authorities in health care aim to align PPI with the
‘democratic oversight’ role of councils.
We planned to undertake a scoping review of PCT PPI activities across England. We commenced this work
to plan in late 2009, drawing data from websites and then selecting a sample of PCTs to follow up in more
detail where we identified particular good practice (see Chapter 2 for details). However, with the abolition
of PCTs, this information has become redundant, and it was decided, and agreed with NIHR, that we would
not produce a scoping review report. We also faced problems in case study site recruitment and access,
given the extent of the reorganisation. During the research, many of the NHS staff we initially interviewed
left their jobs, and new staff, in new organisations, took over responsibilities. This created a number
of difficulties tracking developments in case study areas. While the research was being undertaken,
we had the opportunity to collaborate with research being undertaken by the Policy Research Unit in
Commissioning and the Healthcare System (PRUComm). This involved surveys of all CCGs (in December
2011 and May 2012) and case study research in eight CCGs. We negotiated and discussed questions on
PPI in order to enrich our data collection. We discussed this and agreed the change with NIHR.
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However, the delays in case study recruitment meant that we needed further time for data collection.
The team also felt that it would be most useful if we could have sufficient time to explore changes being
introduced by the new CCGs. We approached NIHR to ask for an extension to July 2013. This would allow
us to undertake an analysis of CCG approaches to PPI in authorisation plans and draw on the PRUComm
data. This was agreed and the end date for the research was changed from November 2012 to July 2013.
As an integral element of our study, we responded to a call to apply for funding for a management fellow
to work with the project team. We were successful in being awarded funding for a NHS manager from
one of our case study sites to work part-time with the research team and who undertook further
research training.
Thus, the study draws on data from a literature of commissioning and PPI as well as PPI related to LTCs,
case study data collected as part of this research, survey and case study findings from the PRUComm
research (see Chapters 4–7) and an analysis of CCG authorisation plans.
Structure of this report
This report presents the key findings of the research and sets these within the context of the recent
changes to the organisation and structure of the English NHS and key conceptual frameworks relating to
PPEI. Chapter 2 discusses the background to the project and a summary of the key NHS changes that
occurred during the period within which the research was undertaken. In Chapter 3, we set out the
methods used, and challenges faced, in the process of undertaking the research. Chapters 4–6 present
the findings from our three case studies. Chapter 7 discusses the organisational changes in the NHS in
more detail, focusing on the development of CCGs and the extent to which PPI has been prioritised and
embedded in practice. This chapter draws on data from surveys and case study research undertaken by
PRUComm (directed by Peckham) and undertaken at the same time as the research in this study, as well
as an analysis of authorisation plans of a sample of CCGs. Chapter 8 discusses our findings. In Chapter 9,
we summarise the main conclusions of our research in relation to the key research objectives. In order to
provide some summative assessment of the impact of PPEI, we also include here the responses from an
expert reference group who independently reviewed three selected exemplars drawn from our case study
research. Drawing on the findings of the research, we then identify key guidance points for national and
local organisations and make recommendations for future research.
INTRODUCTION




The treatment and management of LTCs is one of the greatest challenges facing health systems around
the world today and is recognised as being of particular importance within the UK NHS.23 The strategies
used by health professionals to engage, support and empower people with LTCs have an important role
in improving health outcomes.24–26 However, there is continued recognition that the NHS has not provided
sufficient support for people with LTCs or managed their care to their, or the NHS’s, benefit.
It is suggested that there are around 15 million (almost one in three) people who have one or more LTCs
in England and this accounts for in excess of 70% of the total health and social care budget.27 This relates
to around 50% of all GP visits, 64% of all hospital outpatient appointments and 70% of all inpatient
bed-days.28 People with LTCs experience poor co-ordination of care, leading to adverse events and
increased hospitalisations. International comparisons suggest that the UK lags behind other countries in
supporting people with LTCs.29,30 While it is difficult to identify exact numbers of people with specific
conditions given the rise in multimorbidity, the numbers of people with diabetes, neurological problems or
rheumatoid arthritis (RA) do differ, with the first of these three conditions comprising the largest number
of patients. It is currently estimated that 2.5 million people in England are living with diabetes, and a
further 850,000 people in the UK have diabetes but either are unaware or have no confirmed diagnosis.31
The NHS spends approximately £10B per annum on treating diabetes and 80% of NHS spending on
diabetes goes into managing avoidable complications. People with diabetes account for around 19% of
hospital inpatients at any one time, and have a 3-day-longer stay on average than people without
diabetes. Most type 2 diabetes costs are due to hospitalisation.31
Taken together, neurological conditions are common. For example, 8 million people in the UK suffer from
migraine.32 Altogether, approximately 10 million people across the UK have a neurological condition.33
These account for 20% of acute hospital admissions and are the third most common reason for seeing
a GP. Around 17 people in a population of 100,00034 are likely to develop Parkinson’s disease and
two people in a population of 100,000 experience a traumatic spinal injury every year.32 An estimated
350,000 people across the UK need help with daily living because of a neurological condition and
850,000 people care for someone with a neurological condition.33
Rheumatoid arthritis affects some 580,000 people in England. There are around 12,000 children under
the age of 16 with the juvenile form of the disease. The total cost to the UK (including indirect costs
and work-related disability) are estimated to be between £3.8B and £4.75B per year.35 Uncontrolled RA
increases mortality through an increased risk of cardiovascular disease such as heart attacks and strokes;
thus, early detection and treatment and good management of the disease are important.35
Government policy on long-term conditions
Since the NHS Plan, the government has been committed to improving support for people with LTCs and
set public service agreements in 2005 to reduce emergency bed use and introduce case management for
high intensive service users.1,36–38
The Department of Health policy Your Health, Your Way39 identified five key outcomes for people with
LTCs: an improved quality of life, health and well-being and more independence; better supported
self-care; more choice and control, with services built around their needs; influence over the design of
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services that would be more integrated, proactive and responsive; and high-quality, efficient and
sustainable services.
This builds on the quality requirements for people with LTCs set out in the National Service Framework for
Long-Term Conditions38 that provided a framework for commissioning and service delivery.
A key policy theme has been enabling ‘person-centred’ or ‘personalised’ care.2 Commissioning is
central to this process and to the achievement of policy on LTCs.9 Yet commissioning for health, and
in particular, commissioning in the NHS has received much criticism.40–42 Research highlights the need for
substantial management investment and a range of needs assessment, clinical, contracting and relationship
management skills.40,41,43,44
Commissioning for long-term conditions
When the study commenced, it was already clear that additional investment in expanding commissioning
management was unlikely, given concerns about whether or not the additional cost would produce
sufficient gains in productivity.42 In fact, in 2009, it was already identified that savings would need to be
made in management costs in the NHS as part of a package of measures to address future NHS funding
shortfalls.45,46 With the introduction of changes outlined in Equity and Excellence: Liberating the NHS7
and enacted in the Health and Social Care Act 2012, the challenges facing commissioners have intensified.
In particular, reductions in the overall management allowance mean that there are fewer resources
available to support commissioning activities, including PPI. In addition, the proposals, which involved the
largest restructuring of the NHS since its inception, created a more complex commissioning structure than
that which existed prior to 2010, with responsibilities now spread between a number of local and national
agencies (see Appendix 13).
Equity and Excellence set out the rationale behind the proposed changes to commissioning, arguing that
the closer involvement of GPs in the commissioning of care would ensure more effective dialogue between
primary and secondary care; decision-making ‘closer to the patient’; and increased efficiency.7 The White
Paper argued explicitly that ‘we will learn from the past’ (p. 28)7 and claimed that the government had
built upon lessons learned from previous clinically-led commissioning initiatives, including GP Fundholding
and Total Purchasing Pilots from the 1990s.47,48 The reforms were set out in the Health and Social Care Bill
which became the 2012 Act following a controversial passage through parliament with a substantial
number of amendments.22 With the Health and Social Care Act 2012 passed by parliament, additional
guidance was published by the Department of Health (and subsequently by the shadow NHS
Commissioning Board) (Box 1). A timetable was set out for CCGs to apply for full ‘authorisation’ as
statutory bodies from July 2012, with the first CCGs taking full responsibility for commissioning from
April 2013.
BOX 1 Department of Health guidance on CCGs
1. Developing Clinical Commissioning Groups: Towards Authorisation.49
2. The Functions of GP Commissioning Consortia. A Working Document.50
3. Commissioning Support: Clinical Commissioning Group Running Costs Tool. A ‘Ready Reckoner’.51
4. Towards Establishment: Creating Responsive and Accountable Clinical Commissioning Groups.52
5. Developing Commissioning Support: Towards Service Excellence.53
6. Clinical Commissioning Group Governing Body: Roles Outlines, Attributes and Skills, in April 2012.54
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Two hundred and eleven CCGs worked towards becoming authorised by the National Commissioning
Body, NHS England, by the end of March 2013 (see Chapter 7 for a discussion of the authorisation
process). Since April 2013, they have been responsible for contracts with providers of health care in their
communities amounting to around £65B per annum.
In relation to commissioning services for people with LTCs, commissioners need to demonstrate how they
can achieve maximum benefit within existing resource levels by focusing activities on those that bring most
patient benefit. This approach is central to the Quality, Innovation, Productivity and Prevention (QIPP)
agenda for LTCs.55 One approach currently under discussion is greater integration of health services along
the lines of the USA’s integrated purchaser/provider models or making greater use of soft methods of
persuasion.1,42 The previous government placed an emphasis on developing choices by engaging local users
and organisations for people with LTCs, rather than individual patients, to ensure an appropriate range of
services that meet people’s needs. The 2007 Department of Health consultation on choices for people with
LTCs focused on shifting away from a ‘one size fits all’ model to one maintaining independence and
providing people with more choice and control over their care with benefits for patients and the NHS.4
With regard to people with LTCs, the emphasis was on developing clinical pathways and care
management programmes.1,42 However, evidence of the effectiveness of such approaches in many chronic
conditions is limited,56–59 and there is no evidence of significant service user input influencing the
development of such pathways.60,61 The development of pathways may also create tensions with policies
on choice and it would seem critical that to develop responsive pathways that provide meaningful choices
will require significant service user input as well as collaboration with health-care commissioners and
providers.4,62,63 Current policies focus more on individual management through approaches such as the
Year of Care model with flexible commissioning and self-management programmes.4,31
The current emphasis on developing integrated pathways for managing LTCs reflects the need to address
issues of comorbidity and fragmented service models. Recent policy, together with the structural reforms
introduced in the Health and Social Care Act 2012, have also highlighted the need for more generic,
integrated pathways for LTCs, as these might prove more successful in generating cost savings.64 However,
the evidence is not conclusive and it could take a number of years to show any meaningful impact.65,66
This changing context in which commissioners have to operate is a complex and turbulent environment
presenting significant challenges for health-care commissioners.55 Prior to April 2013, the NHS LTCs QIPP
work stream managed by local PCTs promoted a holistic model for management of LTCs – and was
focused not just on specific diseases but also on providing support for patients to co-manage multiple
conditions. This programme of work has now been taken over by NHS England and it is not clear how
they will be taking forward this work or what direction they will be headed, as they were still in the
process of developing their work programme during our study. Outcomes from the QIPP work stream
included risk stratification, integrated teams and co-managed care for people with LTCs. It also introduced
the Year of Care model as an alternative to Payment by Results.
Despite the large consultation undertaken in 2012 to develop a cross government LTC strategy, the new
government has placed the responsibility for developing a strategy around LTCs5 with the new national
commissioning board, NHS England. The strategy67 will seek to see a change in the quality of life for
people with LTCs (NHS outcome framework domain 2). However, the final output from this has not been
published and is now part of the work of NHS England – who may, or may not, develop their own strategy
for LTCs. This is interesting as there was a long consultation in 2012 with a number of user groups and
organisations but at the present time it is not clear what is being done with this information.64 Elements
of the LTC model (risk stratification/integrated pathway/maximising numbers with co-managed care) are
being used to develop Quality and Outcomes Framework (QOF) for general practice to place an emphasis
on ‘patient-centred care’. However, there are criticisms of QOF regarding both patient-centred care and
how it relates to quality of care.68,69
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Patient and public involvement: variety of organisations
While there have been numerous changes to structures and processes for PPI in the NHS, there have been
no formal mechanisms for PPI established since the 1970s.8,62,69,70 Recent changes to the English NHS
have reformed many previous structures but continue to emphasise the importance of engagement and
involvement.22 At a local level, there are a wide variety of patient and user organisations.71 Patients,
users and carers with a collective illness identity have long organised themselves, often independently of
government, but these organisations are diverse and hence difficult to categorise and analyse.72 Research
suggests that local organisations are often patchy in coverage,71,72 although at a national level, groups
such as Carers UK, National Voices [formerly the Long Term Medical Conditions Alliance (LMCA)] and
the Patients Forum [replaced by the Local Involvement Networks (LINks) and recently replaced by local
Healthwatch] are closely involved in the policy process and some support local group engagement with
the NHS and social services.72,73 Specific case studies of HIV (human immunodeficiency virus)/AIDS (acquired
immunodeficiency syndrome) groups, maternity, physical disability and mental health users suggest
that local groups do get engaged in policy and service issues and that patient/advocacy and voluntary
organisations are important in promoting PPI with the NHS.74–77 Such investigations have, however, paid
relatively little attention to the outcomes of PPI.17
Recent policy on patient and public involvement
Recent policy (since 2001) identifies that the NHS needs to be responsible to patients and service users and
more accountable to citizens who fund it.20 This rhetoric is further played out within the recent NHS reforms
of the coalition. The Health White Paper7 detailed intentions around shared decision-making – ‘nothing
about me without me’ – through choice and increased voice of local people, service users and patients.
Responses from consultations suggested that there needed to be a stronger voice of the public78 and
recent NHS reform planning echoes this ambition.79
The 2012 Health and Social Care Act made clear the duties of the new organisations established under
the Act, such as the NHS Commissioning Board and CCGs, around implementing proposals to give
patients and the public more say and greater involvement in care and treatment decisions within the new
health-care system, holding the board to account for delivery through its NHS mandate.5 However, much
of the recent policy vocabulary on involvement or engagement is patient centred and individual, with a
focus on empowerment in decisions about own care rather than about patients and the public having
a strategic role, either collectively or individually, in helping to shape health care.49 Examples of this
approach can be seen in the emphases on embedding care planning, shared decision-making and support
for people to manage their own conditions – including a pledge to care planning written into the NHS
constitution, roll-out of personal health budgets and support for telehealth/telecare, as well as producing
a compendium of information to support commissioning LTC care, aimed at commissioners. It appears
to be more about patient engagement (in own care) rather than public involvement in commissioning
health care.
Patient and public involvement/engagement in commissioning
health care
The recent health reforms present a new set of issues and challenges for PPI in commissioning health
care. The majority of health-care services in England will now be commissioned by CCGs led by GPs. This is
not the first approach to primary care-led commissioning in the UK, with GP fundholding introduced in 1991
and followed by a number of variants of engaging GPs in health-care commissioning.80 Research suggests
that in these previous approaches to primary care-led commissioning there has been little involvement of
patients and the public.80
BACKGROUND
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Patient and public: there is little evidence to suggest that practices engaged patients and public in their
commissioning activities in a meaningful way. Across the different schemes since 1990, GPs believed that,
by definition, they had an excellent understanding of patient needs and could act as reliable proxies for
their patients; as a result, they did not think of formal PPI as a priority.81–83 Where efforts to consult
patients were made, this was often seen as a box-ticking exercise.82 In primary care groups, where
approaches to involve patients and public had been initiated, this was more at the informing rather than at
the participatory level. It has been suggested that PPI is relatively underdeveloped in primary care and GPs
need to be educated about its value.84
Clinical Commissioning Groups are held accountable by a National Commissioning Board, NHS England,
which formally authorises CCGs. Currently, there are 211 CCGs authorised to commission NHS services
as of April 2013. Despite a number of policy levers and local incentives to develop PPI,49,67,85 it is unclear
whether or not CCGs will be able to fully embrace PPI within their culture. Given the lack of evidence of
effective models of PPI in commissioning, as well as a lack of reliable data on patient involvement18,86 and
the fact that many CCGs are likely to buy in commissioning support services from ex-PCT personnel,
this lack of a creative PPI culture looks likely to continue. Many do not have the skills, time or resources.
A recent study of CCG leaders for patient and public engagement87 revealed that, although CCG
leads were keen to engage with patients and public, there was some lack of understanding of what
engagement was and how it might be used within the whole commissioning cycle, particularly for
procurement and monitoring. Commissioning, particularly for LTCs, is resource intensive.88 However, the
new health-care landscape involves CCGs developing strategic alliances and partnerships with existing and
new organisations such as the Health and Well-Being Board (HWBB) and Healthwatch, which, in the case
of the HWBB, requires the development of joint strategies with their local authority, who have a culture of
public/community engagement, thereby providing some direction and potential for cross-learning.
Patient and public involvement influencing commissioning
decisions: is it working?
The importance of PPI in commissioning has been recognised since the initial development of NHS
purchasing in the 1990s. However, there has been no significant evidence that such engagement has
influenced commissioning decisions.8,17–19 In 2007 the Picker Institute published the results of a survey of
PCTs examining PPI in commissioning. They found that while PCTs had a number of mechanisms and
defined management responsibilities for PPI, there was a disconnect between the emphasis on processes
and structures for PPI and the relatively low expectation that patient, public and community groups would
have any significant influence on commissioning decisions.18 Key barriers identified were difficulties in
reaching marginalised, isolated or deprived groups, a lack of understanding among the public of
‘commissioning’ and a lack of reliable data about patients’ experiences. However, when asked what
approaches PCTs were considering for future engagement, there was a continued emphasis on methods
such as formal consultations, patient panels, citizens’ juries and surveys. These approaches did not identify
engagement or involvement of user and patient groups for people with LTCs, despite this approach being
promoted by the government’s policy on choice for people with LTCs.4,9 Guidance for commissioning
agencies placed great importance on how care that promotes the health and well-being of individuals in
consultation with local people was procured10 forming the basis for commissioning competencies, needs
assessment frameworks and performance regimes across health and social care.10,12 There was also a
clear emphasis on increasing the role of the third sector.13 The NHS Next Stage Review also highlighted
changing public expectations related to ‘control, personalisation and connection’, and building
partnerships with patients and LTC user groups.14 At the start of this research project (November 2009),
we undertook an extensive scoping exercise of national changes in commissioning for LTCs. The project
protocol highlighted a number of key areas for investigation: Department of Health pilot sites and
demonstrators, website analysis [PCTs, strategic health authorities (SHAs) and national patient
organisations] and documentary analysis (associated policies, budgets, commissioning power and choice
sets). Websites were traversed using key words (identified via project objectives, research questions,
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literature review, health policy, commissioning models) with a search for key documents associated with
LTCs/PPI and/or commissioning. Key documents were identified as Joint Strategic Needs Assessment
(JSNA); World Class Commissioning Panel reports; LTC strategies; commissioning strategy; communication
and engagement strategies; PPI strategies; and a 5-year strategic plan.
We found that many PCTs recognised the need to improve data collection, knowledge management and
address intelligence gaps in relation to needs assessment. PPI within this context was variable; methods
included the use of existing PPI mechanisms, steering group membership, workshops, stakeholder events
and facilitation by social enterprise organisations. LTCs were addressed in all JSNAs reviewed and was
referenced, either explicitly or implicitly, in all key documents. Correlations between an ageing population
and LTCs were highlighted, with such conditions often described as a disease burden. Emphasis was
placed on effective management; this included care closer to home, patient education, self-care, capacity
building in general practice, targeted risk assessment, the reduction of emergency admissions and
exploiting new technologies. As such, we found that in general the localised strategic viewpoint mirrored
Department of Health-related documentation and LTC models. Of particular relevance – especially given
the changes to commissioning that occurred during the period of research – was that PBC was seen as a
key vehicle for LTC commissioning; however, organisational development at this time was variable, with
limited PPI evident.
Generally, PCT PPI strategy focused on well-recognised methods, with one-third of the PCTs having a
panel or membership schemes in operation and otherwise an emphasis on expert patient programmes,
volunteering, Patient Advocacy Liaison Service (PALS) and reader panels. However, specific involvement in
relation to LTCs was more limited.
A lack of innovative approaches could explain World Class Commissioning panel report results for
competency 3 (influence on local health opinions, PPI, improvement in patient experience). In 2008–9, no
PCT (n= 114) had obtained the highest level 3 competency (67% operating at level 2 and 33% at level 1).
In 2009, assessments of the quality of commissioning published on the NHS Choices website showed
that only 2% of PCTs were coded as excellent, the majority gaining ‘good’ at 51%. PPI in specialised
commissioning groups was even less well developed, with 50% having no visible ‘involvement’ section on
their website. Data collection and analysis were terminated in August 2010 following changes in health
policy and the planned abolition of PCTs.
A search for recent evidence of impact of PPEI within LTCs health care revealed limited literature,
particularly in relation to the specific LTCs relating to this project, as well as a lack of robust evaluative
data. This reflects Sullivan and Skelcher’s89 view that lay representatives may be marginalised and have
less influence than senior executives and NHS decision-makers. Nevertheless, from the small number
of varied qualitative studies appraised (n= 9), a number of themes emerged. Involvement initiatives
led to some positive outcomes for the service users involved: increasing knowledge, self-confidence
and self-esteem,90–92 with a resulting increased capacity to become involved with decision-making.92,93
Much of involvement or engagement was limited to sharing information, through helping the
development or design of patient information material or commenting on experience of a service,
rather than helping to actively plan and shape services,91,93,94 and were largely professional rather than
service-user led or codesigned. Service users also demonstrated broader ‘critical awareness’ but were
unlikely to be involved at a strategic or active level, such as that of service development.95 As most studies
lacked robust evaluative data, it was difficult to attribute service improvements to PPEI specifically, even
though many reported positive outcomes in some areas. In addition, levels of involvement varied between
studies; while some showed that there was involvement at a limited, consultation level,94,96 others were
more in-depth,95,97 and this made between-study comparisons meaningless.
Our findings reflected those of the Picker Survey as well as contemporary research on PBC which also
highlighted its integral role for the success of commissioning strategies for LTCs, although these remained
underdeveloped and ‘yet to have a significant effect on the redesign of services’ and that ‘the incentives
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and infrastructure to support PBC are not currently sufficient to engage most GPs in commissioning’, a
finding supported by research on PBC.15,16 While PBC provided much of the stimulus for the development
of CCGs, early research on their development does not suggest significant differences in their approach to
PPI – as is discussed later in this report.
The challenges for PPI in the NHS are well discussed in the wider literature. Research has identified key
contextual factors that pose challenges for effective PPI such as lack of time and resources, lack of interest
among professionals and the public, and lack of knowledge of how to translate PPI into changes in health
services.98 Tritter and McCallum’s99 analysis of the state of play in user involvement suggested three areas
of weakness: time and expertise for developing trust, capacity to participate effectively, and a lack of
consensus on agenda and goals. Commissioners may also face the problem of who exactly to involve
(e.g. patient groups or the general public), how to achieve proper representation, and the difficulty of
reconciling different agendas (e.g. between organisational and professional interests and the variety
of interests of the public). Some researchers draw attention to the importance of clinical champions for
successful PPI.100 Past research indicates that it is unlikely that new commissioning groups will have the
required skills, resources, time or inclination to develop PPI.81
Patient and public involvement can employ a variety of mechanisms of involvement depending on the
degree of actual power invested in the public.101 Direct/indirect involvement refers to the absence or
presence of mediating agents (e.g. GPs in health care are mediating agents for patients). Passive/active
involvement refers to whether it is health professionals or the public who are setting the agenda or are
being instrumental in actual decision-making.72,100,102 Deliberative/non-deliberative involvement refers to
the presence or absence of face-to-face interaction with the public. Examples of deliberative mechanisms
are focus groups, health panels and citizens’ juries, while non-deliberative approaches include postal
questionnaires and public consultations through postal or electronic voting.
Research has yielded scant evidence about concrete outcomes achieved by PPI in commissioning.
The impact of PPI on services is often not clear, acting potentially as a disincentive to engage. Limited
tools exist for measuring or assessing patient involvement.103 When evaluating impact of user involvement
strategies we should look at indicators of success that include both process and outcomes including
economic evaluation.104 Evaluating outcomes, however, is not easy, as it may take years before the
outcomes of PPI can be measured. Equally, outcomes of PPI may be difficult to disentangle from other
interventions. Some benefits are easier to prove, such as user satisfaction, opportunities of meeting others
in a similar situation and increased knowledge about the availability of services related to their condition.94
Gibson et al.105 identify a series of key questions to be addressed in assessing the impact of PPEI:
l Does the new system allow a plurality of public arenas where the service user voice can be heard?
l Which areas of decision-making will be open to influence by PPI and which will not?
l Which proposed solutions will be acceptable and unacceptable to the various stakeholders?
l Is the host organisation prepared to change to accommodate some of these solutions?
These also link to what Barnes106 and others106–110 refer to as emotional and figurative deliberation based
on experiential knowledge. They argue that patient and public experience is as important as more
purposive-rational deliberations.
It is not surprising, therefore, that PPI has often remained a ‘window dressing’ exercise, with actual
implementation of policy by local managers being rather lukewarm and unsuccessful. Involvement, if it
happens, tends to be passive.111,112 When it is active, it tends to relate more to existing service users than
to members of the broader community.100,113 One review concluded that ‘primary care-led commissioning
organisations have struggled to engage patients and the public in a meaningful way’ (p. 3).114 Despite
some guidance available on skills development, such as in the Smart Series guide for commissioning,115
there would appear to still be a need to develop the required culture for PPI, and, until there is
evidence available about what is working/effective etc., it is going to be difficult to create that culture.86
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The previous World Class Commissioning and central guidance on commissioning was not specific for
GP practice which may explain why, in the past, there has not been enough work or guidance on skills
development around PPI for GPs. This is gradually being developed and the Royal College of General
Practitioners (RCGP) Centre of Commissioning competencies for clinically led commissioning (August 2011)
include engaging the public.116
Conclusion
Good commissioning for people with LTCs requires not only developing a set of skills for commissioning
responsive and appropriate care that provides relevant choices for service users, but also developing
approaches to sustaining user engagement. While previous research on engaging users in the NHS and
on user involvement in change management in health services has demonstrated a willingness and
commitment to engagement, there are few concrete examples of effective influence by users or evidence
of change.17
It was against this background that this study was developed. As described in the previous chapter, the
study was undertaken at a time of substantial change in the NHS which commenced in 2009 with moves
to reduce NHS management costs through PCT mergers,46 an increasing focus on integrated care and
approaches to self-management2,14 and substantial organisational reform introduced by the coalition
government in 2010 which developed from the end of 2010 and formally came into practice in April 2013.
With agreement from NIHR, the research period was extended to enable the research team to explore
some of the early impacts of this changing commissioning environment during 2012 and early 2013
(reported in Chapter 7). However, the key aim of the study remained an examination of how
commissioners enable voice and engagement of people with LTCs, and to identify what impact this
has on the commissioning process and pattern of services. Our key research questions were:
1. What kinds of relationships existed, and were developing, between the public/patients
and commissioners?
2. What impact did the public/patient voice have on the commissioning process and decisions made
by commissioners?
3. To what extent did any changes in the commissioning process reshape local services?
4. Did any such changes in services impact on the patient experience?
5. How did, if at all, commissioners enable the voice and engagement of people with LTCs in the
commissioning process?
6. How did patient groups/patient representatives get their voice heard and what mechanisms and
processes did patients and the public use to make their voice heard?
The findings of this project will contribute to supporting the development of relevant skills and
mechanisms for engagement for commissioners and service users and representatives within this new
health-care landscape.
BACKGROUND




The aim of this project was to develop an understanding of some of the complex issues of involving
patients and the public in commissioning health care. In order to investigate this phenomenon, a case
study design was adopted in order to develop an in-depth analysis of the processes, structures and context
of PPI. Case study methods are a recognised and well-established approach to conducting research in a
variety of ‘real life’ settings including health care.117 Yin defines case study research as ‘an empirical study
that investigates contemporary phenomena within a real-life context, when the boundaries between the
phenomena and context are not clearly evident and which multiple sources of evidence are used’ (p. 18).118
This approach allowed us to employ a range of social science research techniques and designs, mainly
qualitative, to gain some in-depth understanding of the nature of engagement between service users, the
public and local NHS organisations within their specific organisations. It also provided the methodological
flexibility to generate some theoretical insights from our results.119 We were thereby able to adopt an
interactive approach to data collection and analysis, allowing theory development grounded in empirical
evidence, a main strength of this design.120,121
A multilayered approach was used, combining mapping of activity at national and local levels, analysis
of local context and detailed case studies in three locations. Specific methods were employed including
interviews, focus groups and workshops with a range of stakeholders, observation of key commissioning
and PPEI meetings, and analysing documentary data, as well as using an adapted Likert Scale ‘Star Chart’
to measure perceptions of engagement and involvement over time.
Recruitment
As this study was undertaken during a period of great change within the NHS, recruiting NHS personnel
became a challenge. This was particularly significant during the tracking phase of the study, as
respondents moved on to different organisations and roles and responsibilities were not always clearly
defined during the transition to CCG stage. We therefore had to adapt our methodology during the
tracking stage of the study to ensure that we collected relevant data from those who were in the
appropriate posts. In some cases, this meant interviewing new personnel in the latter stages of the study,
including some who had new PPEI roles and responsibilities in the new health-care structures. This is
explained more fully in our findings (see Chapter 3). To support the iterative process, and enable
comparisons between each site during the course of the study, the case study sites were recruited in
turn (Figure 1).
Ethics
This project had NHS approval [Research Ethics Committee (REC) reference 10/H0713/24] obtaining
favourable approval by the REC on 6 July 2010 with minor protocol changes agreed by ethics (Table 1).
The project was originally funded for 3 years and the main focus was to investigate PPEI within the PCT
commissioning structure. An extension of 9 months was granted to enable data collection within the
transition stages of the new commissioning environment. A revised research plan to reflect the extension
was written. All changes to the research protocol were also reported to, and agreed with, NIHR.
Methodology
The research was carried out in five distinct phases from October 2009 to July 2013. The project flowchart
(see Figure 1) illustrates the phases of the research and methods employed.
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Evaluation of potential impact of PPI in LTCs
FIGURE 1 Plan of research.
TABLE 1 Research Ethics Committee approval timeline
Protocol Detail of amendment
Date approved
by REC
Initial protocol 6 July 2010
Amendment 1 To allow young persons option of being interviewed face to face or by telephone or
within a focus group. Amendments to interview schedules, consent forms and
information for participant forms made to reflect changes
7 February 2011
Amendment 2 Amendment to age of consent for interview for young person to be reduced from
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Phase 1: scoping national changes in commissioning and case study selection
As referred to earlier in this report, we were unable to complete this phase of the study due to the
abolition of PCTs. However, we did look at public information available from PCTs and this was used to
inform case study selection and to initially draft the Star Chart tool (see Appendix 15) used in agreement
with Health Services and Delivery Research (HSDR).
Phase 2: contextualisation
Aim
This phase was to establish detailed information on the three local case study sites selected for the study.
The aim was to contextualise the specific range, type and actions of the three tracer condition based
groups that would be examined in more depth in phase 3.
Sampling strategy: selection of case study sites
Three case study areas (PCTs) were purposefully selected to provide a range of demographic and
geographical variation to include urban/rural, different cultural and ethnic populations as well as including
a range of local NHS agencies (see Table 2). During the course of the research, the PCT in case study 1
(CS1) merged with other adjacent PCTs into a larger cluster. However, the emerging single CCG within
CS1 covered the original PCT population. In case study 2 (CS2) and case study 3 (CS3), the PCT remained
a single entity and these were replaced during 2012 by single CCGs.
Table 2 lists the main characteristics of the three sites.
Sampling strategy: selection of tracer long-term conditions
Three LTCs, reflecting varying known relationships across the health and social care divide as well as
demand for services, were chosen for study in each location (Table 3). It was anticipated that by selecting
diverse populations and levels of engagement and involvement we would identify a range of different
levels of PPI. Previous studies suggest that people who participate in local health-care decision-making are
generally older, wealthier and better educated than the general population and are less likely to be from
black and minority ethnic (BME) communities or from other vulnerable communities.122,123 These patient
groups were specifically selected as they reflected a wide age range for study, including children and
young people with LTCs, who are less likely to have a voice in their care than adults with LTCs. In addition,
TABLE 2 Case study site characteristics
Case study Setting Population/ethnicity Secondary care provider PBC/CCGs
CS1 Mixed
urban/rural
Some ethnic minority groups,
but mainly white
District general hospital Single CCG
CS2 City based Average-size BME population Teaching hospital Well-developed PBC,
single CCG
CS3 Urban High BME population Foundation trust district
general hospital
Single CCG
BME, black and minority ethnic.
TABLE 3 Long-term conditions: characteristics
LTCs Characteristics
Diabetes Vocal patient groups, large population, established services
RA Less established patient groups and services
Neurological conditions Variety of patient groups and services with substantial local variation in services
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we purposively selected one case study with an ethnically diverse and large BME population (see CS3).
The research design was structured to avoid only examining decision-making and service changes where
the process was framed by the health service and its approach to engaging patient or user involvement.124
Sampling
Purposeful sampling was employed to target practice-based and PCT commissioners and public
involvement staff, provider organisations and patient representatives for each of the tracer conditions.
Interview targets were set, with each site aiming to recruit up to seven PCT, PBC and PPEI leads, one
provider from each tracer condition and around five patient and public representatives, including adults as
well as young people and carers, from each tracer condition. In order to address problems of recruiting
only patient representatives who were already involved with local health agencies, we recruited
participants via local voluntary groups and support groups as well as through advertising in clinics and
practices and identifying participants who were not in formal groups.123,124 For example, in one case study,
site participants with RA were not involved in any group or health-care organisation approaches to PPI.
Theoretical data saturation also guided sampling, in that sampling relevant cases would continue until no
new theoretical insights emerged from the data. One case study site exceeded the target sample due to
staff reorganisation as a result of the health reforms, necessitating targeting the new ‘PPEI’ staff and
patient/public leads. A total of 102 participants were interviewed for the study across phases 2 and 3.
Table 4 shows the total number and range of participants interviewed in each site. Table 5 shows the full
range of roles.
In addition to the people interviewed, the local workshops involved other service users and their
representatives, providers and commissioners. For example, initial workshops were attended by between
30 and 40 people in each case study, with service users from a wide variety of age ranges and
backgrounds. In the second workshops, 76 people attended across the three case study sites and
30 people attended focus groups structured to address the tracer topics, with two of these being with
people from BME communities. There was some overlap between those attending initial workshops in
phase 1, the follow-up workshops in phase 2, focus groups and interviewees.
Inclusion and exclusion criteria
We set out to include as many local service users and their representatives as possible through running
local workshops which were advertised to as many people and organisations in each of the three tracer
groups, proactive work to recruit young people and use of snowballing techniques to reach as wide a
population as possible. Overall, in the study we included:
l service users and representatives from age 12 (no upper age limit), with diabetes or RA or a
neurological LTC receiving services in the case study site (PCT)
l informal carers
l parents of children 0–16 years old.





CCG/LA and PPEI leads) Providers
Total number of
interviews
CS1 33 11 4 48
CS2 11 9 5 25
CS3 11 13 5 29
Total interviewed
in range
55 33 14 102
LA, local authority.
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We excluded:
l younger people whose parents/guardians did not consent to their participation
l service users and informal carers who were unable to speak or read English and for whom translation
services within the research team or locally were unavailable
l informal carers of adult patients who had not consented for the carer to be approached.
Data collection
Initial meeting and workshop
An initial set-up meeting was organised by the research team with key stakeholders from the PCT in each
case study site. This was carried out with those leading on commissioning and providing services for
people with LTCs. The aim of this meeting (alongside providing information about the study and an
invitation to participate) was to discuss local provision for the three tracer conditions and how patients
and the public are currently involved. Information gathered from this meeting, along with additional local
scoping of patient and public groups, was used to identify and map the key organisations and groups, as
well as the institutional structures for local commissioning of health care for the three tracer conditions.
Representatives from these organisations and groups, including primary, community and secondary
providers, health-care commissioners as well as patient and public representatives, were purposefully
selected to represent the tracer conditions and to reach as many people with an interest in the research
topic as possible; they were invited to attend an initial workshop, or information meeting, within each case
study site. We specifically mapped as many relevant patient groups and organisations, voluntary groups
related to people with diabetes, neurological conditions and RA in each area as possible (including support
TABLE 5 Roles of participants
Role CS1 CS2 CS3
PCT commissioners 2 1 2
PCT PPEI leads 1
GP commissioners 1 2
GP practice managers 1 2
PCT/CCG transition PPEI project leads 3 1 1
CCG PPEI executive leads 1
CCG PPEI representatives 8 1
CCG medical director 1
Local Healthwatch 1
HWBB 1
Service providers 3 3 3
Service users and representatives 12 10 9
PCT/LA diversity lead 1
CCG clinical lead (diabetes) 1
Local authority PPEI executive 1 1
GP commissioning support (SHA) 1
PCT/LA commissioning (YP) 1
Provider PPEI lead 1
LA, local authority; YP, young people.
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groups run by services, local groups of national organisations), as well as contacting some specific
individuals identified through a snowballing technique to ensure that we reached as wider patient/user
community as we could.122–124 The aim of this meeting was to map the terrain of local PPEI to understand
the contextual features impacting on each case study. It was also used to identify any key issues, projects
or mechanisms for PPEI, which we aimed to follow up in more depth in the next phase.
Interviews
Following the initial workshop, a series of mainly individual in-depth semistructured interviews were carried
out with a purposive selection of commissioners, providers and service users and representatives for each
site (see Table 5 for total numbers interviewed in each site). Data saturation guided the sample limit.
The interview aimed to elicit views on the issues, processes and current activity relating to commissioning
health care for people with LTCs across the three tracer conditions. Interviews were carried out face to
face, normally at the participant’s place of work or leisure, or by telephone if requested, following the
researcher’s obtaining of full consent. The interview schedule, information on interview and consent forms
are attached at Appendices 3–6. Following interview, the participant was asked to complete the Star Chart
tool to obtain some assessment of the individual’s understanding and experience of PPEI.
Data from young people
It was planned to hold a series of focus groups with young people to obtain their perspectives on
involvement during this phase of the research. The research team consulted guidelines for the operation of
research with young people125–127 and these were taken into account, especially to ensure that the
principles of how to conduct fieldwork with young people with age-appropriate sensitivity were adhered
to.128,129 However, the project represented an attempt to include young people within a project adopting
an inclusive approach across the life course and in a new area, that of patient-led commissioning.
Moreover, we encountered a number of gatekeeper issues that were unanticipated. The team had
difficulty recruiting young people to a focus group (see Chapter 8, Power and control). In discussions with
our young person reference group, it was agreed that individual telephone interviews might result in more
success in recruitment. Following approval of this revision to the protocol by the REC and NIHR, a total of
10 young people and their carers were interviewed in this phase of the study.
Follow-up workshop
Focused, or follow-up, workshops (one in each case study site) were held at the end of phase 2 to explore
local issues and approaches to commissioning people with LTCs in more depth. Examples or issues around
PPEI, identified during earlier interviews and discussions with stakeholders, were used to guide some of the
discussion. PCT, local authority and practice-based commissioners as well as clinical leads (commissioner,
provider) and representatives from user groups and patient organisations from the three tracer conditions,
plus key representatives from consumer and patient organisations, were invited to attend. In total,
76 participants attended these workshops across the three sites. These represented a mix of commissioners,
service users/representatives and providers. The workshop also served to identify specific exemplars of PPEI
practice suitable for follow up as ongoing in-depth analysis over time in phase 3 of the project. For CS1, this
was identified as a third-sector targeted approach to support local commissioning of neurological conditions
and a schools-based diabetes project, for CS2 an integrated diabetes service with PPEI input and for CS3 a
proposed community diabetes service for the local BME population.
Dissemination of findings
It was originally intended that we would share results and outcomes of these workshops with participants
through a shared website. We developed a project-specific website at the beginning of the project.
This was a secure site in order to share documents, resources and findings within the project team, who
had intended to use this as a method of dissemination with participants. However, following discussions
with participants during workshops and interviews, a process of e-mailing workshop reports out to
participants was considered preferable to requiring people to engage with another ‘internet site’,
particularly in the current climate of change and turmoil.
METHODS
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Phase 3: evaluation of the impact of involvement on local health
policy processes
Aim
In this phase, we aimed to identify the impact of involvement on local health policy processes such as
service reconfiguration, service delivery and service development. This was through an exploration of
public/patient views and perceptions of how the public voice is heard and if/how it impacts on change.
Processes relating to the potential exemplars of PPEI practice identified in phase 2 were focused on, with
the aim of exploring the extent to which participants felt that they were able to successfully influence
local health policy processes in the past year, as well as issues that they were currently trying to place on
local policy agenda or attempts to influence current commissioning policy/strategies on LTCs. Their
development was tracked during this phase. (See Appendices 6–8 for exemplars.)
Methods of data collection
Interviews (phase 3 interviews and telephone tracking)
A purposive sample of three key informants (service user representative, commissioner and service
provider) were selected for each case study site. They were interviewed soon after the exploratory focused
workshop in phase 2. The original plan was to carry out a series of short tracking telephone calls as well
as a further two interviews (one in the middle of the 18-month tracking and one at the end), with the
purpose of tracking case study site activity and to explore any impact of PPEI on local health policy process.
At the end of each interview, measurement of the interviewee’s perception of changes in user involvement
was to be made through the Star Chart tool. However, staff changes (with key commissioning informants
lost from all three of the sites at varying stages of the study) meant that tracking could not be undertaken
in the manner it was intended and the Star Chart tool was of limited use. Tracking was, nevertheless,
carried out with those who were still in place and further interviews were undertaken with some of the
new commissioning and PPEI personnel where available. (See the case study site findings in Chapters 4–6
for further information.)
Focus groups
Aims and rationale A number of focus groups were held with a selection of service users within this
phase to complement the data collected from interviews and observation. Focus groups are group
discussions that are carried out to examine a specific set of topics.130 This was done in order to hear issues
which may not readily emerge from interviews or observations alone, and to capture the shared, lived
experience with the possibility, through the synergy of conversation, of developing unique data or ideas.131
As Ivanhoff and Hultberg suggest, the strength of the focus group method is that researchers are provided
with an opportunity to appreciate the way people perceive their own reality and get ‘closer to the data’
(p. 126).132 Focus groups also provide a safe environment for some individuals or groups, such as those
from similar socioeconomic or ethnic backgrounds, who might find interviews intimidating, and can serve
to provide a voice from seldom-heard or marginalised groups. We had originally planned to carry out focus
groups with young people in phase 2 but had to adapt our plans, as emerging data from interviews
indicated that this would not be the preferred option for this group and we had to amend our protocol
to include interviews as an option. No focus groups were held with young people in phase 2 or 3 of
this project.
A selection of service users were recruited using convenience or snowball sampling methods to ensure
adequate coverage of a range of patient groups.
Four focus groups with service users were carried out in this phase, with a total number of 30 participants
(Table 6 gives a breakdown of numbers and characteristics of participants). The focus groups were
facilitated by two members of the research team, with one acting as main facilitator and the other
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taking notes. The focus group discussions were recorded with consent and transcribed verbatim. Notes
taken during the focus group were used to clarify the discussion and aid analysis.
Some of the issues or findings emerging from the initial workshop and interviews were used to explore
further in the focus group. As previously discussed earlier, many of the statements contained within the
Star Chart tool were no longer valid as commissioning had changed so much. However, the statements
that were still meaningful in the new context were used to guide some of the discussion within the focus
groups. In two of the focus groups, vignettes developed from phase 2 interviews were used to trigger
discussion on their involvement in LTC service commissioning. In one of the case study sites, focus
groups were carried out with groups with very little or no spoken English and were therefore conducted
through a translator. (See Appendices 9 and 10 for focus group topic guides and information provided
to participants.)
Observation of meetings In total, 10 key commissioning and PPEI meetings were observed across all the
case study sites and relevant documents collected for analysis during phases 2 and 3. The central aim was
to observe the nature of PPEI within these meetings, how and in what way the lay voice is heard and acted
upon. Field notes of the meetings were recorded and used as appropriate for analysis.
National data on patient and public engagement and involvement in new Clinical Commissioning
Groups In order to better understand the position of PPI within the emerging new health structures, data
were obtained on PPEI processes and structures from a national survey on emergent CCGs (via PRUComm)
as well as from a selection of CCGs undergoing authorisation (refer to Checkland et al.22 for details of
methods in the PRUComm study). (See Chapter 7 for further information and findings.)
Phase 4: confirmation of outcome measures
Aim
Following an initial analysis of data in phases 2 and 3, the aim of this phase was to identify outcome
measures related to commissioning including direct evidence of service change, changes in investment,
satisfaction with changes and processes of engagement.
Methods of data collection
An expert reference group was formed, consisting of a number of external key people with a wide variety
of expertise and experience relating to patient involvement, clinical skills and knowledge and clinical
practice around LTCs in general and/or specific to the tracked tracer conditions. These acted as a virtual
panel to provide comments on the identified exemplars of PPEI practice tracked in phase 3. The aim was
to bring some external verification of whether or not the interventions, services or processes, developed
through PPEI, were likely to lead to improvements and benefits for patients. (See Appendix 9 for expert
reference group list.)
TABLE 6 Focus groups
Case study Number of participants and focus groups Characteristics of focus group
CS1 Six participants in one focus group Service users (adult) with neurological LTCs
CS2 Four participants in one focus group Service users (adult) with RA
CS3 Twenty participants in two focus groups Service users (adult BME) with diabetes
METHODS
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We had originally planned to carry out a number of summative focus groups with a purposive sample of
commissioners, providers and service users to discuss outcomes of commissioning. However, in the rapidly
shifting staff turnover, focus groups were not possible and individual as well as small group interviews (as
in CS1) were carried out instead. These were conducted with a purposive sample of commissioners, service
users, providers and PPEI staff to discuss changes in services and process of engagement. This was also
supplemented by participant and non-participant observation of specific related commissioning meetings
where field notes were made about evidence of service changes, including changes in investment,
processes of PPEI as well as any perceived satisfaction with any changes.
Phase 5: summative workshop
Aim
The aim of this phase was to present the findings from the study to date to a range of stakeholders, assess
the current situation and discuss the way forward. The summative workshop formed part of the initial
analysis and synthesis stages of the research and was used for both the presentation of findings and also
to explore the validity of our preliminary analysis of the data.
Methods
A summative workshop, with patient and public representatives, commissioners, PPEI executive/lay leads
and providers from all three case study sites, was held in London in April 2013. Over 40 stakeholders
attended this meeting. Preliminary analysis was presented to the audience for discussion and clarification.
The workshop was chaired by the chair of the Engagement and Voice in Commissioning (EVOC) advisory
group and facilitated by a lay representative who had experience in supporting emerging CCGs on PPEI at
the SHA level and was involved in assessing the PPEI part of the CCG authorisation process for a number
of CCGs. Data obtained from this workshop was used to refine the analysis. A report from the workshop
was written and circulated as a project output (see Appendix 10).
Analysis and synthesis
Comparative case study analysis was used to identify and explain patterns across and within organisations
and case study sites. The strategy for analysis was to:
l observe, describe and explain the interaction between commissioning approaches identified and the
way that patients and the public are engaged in these processes
l identify and explain patterns of commissioning LTC services in each case study
l examine the relative influence of patient and public views on LTC commissioning processes to identify
lessons for future development of policy and practice.
Extensive notes were made of workshops and workshop material collected and analysed by the research
team. Interviews and focus groups were transcribed verbatim and explored to uncover main themes.
Transcripts were analysed using qualitative software (NVivo, QSR International, Warrington, UK) to enable
thematic coding. Documents were coded to identify key themes and decisions were made. Framework
matrices were developed using coded themes to summarise and condense data sources by codes and
themes. Visual Star Charts were translated into Likert scale measurements and interpreted numerically.
National and local contextual information was obtained from undertaking a discourse analysis of key policy
documents and data from a range of national patient and public organisations. Data from a national
survey of emerging CCGs were extracted to provide further information on the direction of travel for PPEI
within the new health structures, and a selection of first wave CCGs undergoing authorisation were
analysed thematically in relation to the evidence supplied around PPEI.
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The analysis was structured around Ritchie and Spencer’s ‘Framework’ for applied policy research.133
An iterative approach to data collection and analysis was employed throughout the project. Initial analysis
was discussed between the team and Advisory Group to inform data collection and results. Interviews and
focus group transcripts were read by at least two team members, their content being organised into a
priori and emergent themes. To ensure that findings were empirically grounded, pairs of transcripts
were exchanged to compare inter-related reliability, any differences in interpretation discussed at team
meetings and a common thematic list agreed. A comparison between and within themes, case studies
and organisational type, and over time, was conducted. This was aided by the use of NVivo software via
a shared server to promote consistency of analysis.
Analysis focused on identifying implications for local policy and practice as well as contributing to an
understanding of the process of local policy development, highlighting inter-relationships between context,
role of local organisations and the local policy agenda. By submitting our initial findings and analyses to
external critique via phase 4 interviews and group discussions, expert reference group and phase 5
summative workshop, we were able to validate our analyses and ensure that they were informed by a
number of stakeholder and theoretical perspectives.
Within the report discussion, we employ two explanatory frameworks to interrogate our findings further.
First, we draw upon the work of Barnes106–109 on public participation and synthesise this with the
theoretical framework suggested by Gibson et al.105 in order to map our findings against the ‘ideal’ PPEI
processes. Second, we use normalisation process theory to identify the work required to sustain PPEI as
normal practice within the new structures.134,135
Patient and public involvement in Engagement and Voice
in Commissioning
The acronym EVOC was employed as a working title for the duration of the project. EVOC was supported
by a project advisory group, the members of which are listed on the acknowledgements in this report.
The advisory group was chaired by a lay person who had a long history of PPEI and was former chair
of the external reference group for the Department of Health National Service Framework for LTCs.
Lay members of this group consisted of representatives from a range of national LTCs organisations as
well as patient representatives drawn from the Patient Involvement in Research Group (PIRG), an
established group of service users and members of the public supporting research within the Centre
for Research in Primary and Community Care (CRIPACC) at the University of Hertfordshire. Adequate
representation to this advisory group was informed through discussions with the PIRG during the early
stages of the study. The advisory group supported the conceptual and methodological approaches utilised
in the research, providing critical commentary during the development of the project. They also provided
advice and guidance on the development of research tools, such as interview schedules and contributed
to reviewing sections of this report, including help in the dissemination of findings.
A young persons’ group, comprising a number of young people either with or supporting people with a
LTC were involved in the development of supporting information relating to children and young people.
The expert reference group, described above and also listed in Appendix 9, also included a number of
patient representatives, providing critical feedback for the exemplars of PPEI practice described.
In addition to the interviews and focus groups carried out with a range of service users and patient
representatives, invitations were provided to local patients, services users and representatives to the two
workshops held in each case study site. The summative, or consensus workshop, held at the end of the
project, included a number of service users and their representatives from a variety of LTCs including diabetes,
osteoporosis, arthritis and neurological conditions (see Appendix 10 for the report from summative workshop).
METHODS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
22
Chapter 4 Research findings: case study 1
Background
Case study 1 was the first study site to be recruited, with an initial workshop held in May 2010.
Amalgamated from three smaller PCTs in 2006, CS1 was, at the start of the EVOC study, a PCT with an
active research agenda focused on patient involvement and engagement. Data collection in this site falls
into two eras, the first during a relatively stable period with well-established PCT structures, and the
second during transition to the CCG. Some respondents (including all service users and representatives)
participated in EVOC during its lifetime; however, inevitably, a number of PCT staff moved on during the
transition phase.
Case study setting
Case study 1 is located in the south east of England and is less ethnically diverse than the rest of England.
The main population centre is a new town; other population centres are mainly rural. The average life
expectancy is higher than the national average but there is a mixed picture of deprivation; one of the three
local authorities in CS1 is in the bottom 30% of most deprived local authorities, whereas another is in the
top 5% least deprived. CS1 commissions the majority of acute care from the local district general hospital
which includes an accident and emergency department. In case study 1, there are 39 GP practices in three
commissioning consortia, and compared with many areas of the country, PBC in CS1 was well established.
One district in CS1 has a lower prevalence of chronic diseases, while another district has a higher prevalence
for diabetes and hypertension. The third district has a higher prevalence than the national average for all
chronic diseases.
Processes and supporting structures for patient and
public involvement
When the study commenced, the PCT’s rhetoric suggested that PPI was an underpinning ethos within the
organisation. In the World Class Commissioning report in 2010, CS1 increased its competency rating and
the score for engaging with public and patients was increased to level 2. Level 3 was not attained as it was
unclear how patient experience data influenced commissioning and hence improvements in quality of care.
At the first workshop, an array of initiatives aimed at enhancing PPI or guided by the principles of PPI was
described by the participants (Table 7).
Early discussions and interviews suggested a strong ‘will’ for PPI. There was a close working relationship
with the local LINks organisation, and a history of locally based action groups and health forums which
were drawn upon by the PCT for service user representation. The PCT’s lead on patient experience
reported directly to the Director of Nursing and Quality who was the board lead for public engagement.
The patient experience lead used a combination of proactive view seeking (particularly via the Voluntary
Action groups and LINks) and gaining feedback from the Patient Experience survey and PALS. At that time,
there were some local issues around the perceived lack of interpretation services, and the lead was able to
improve accessibility through the use of the Voluntary Action Group’s newsletter.
A key initiative developed jointly between the PCT and local researchers was the Patient Experience Blog
project. This was a move away from reliance on the Patient Experience survey and sought to capture
patients’ stories and experiences as a continuous dialogue between service user and commissioner.
The blog allowed patients and the public to tell their stories anonymously via the internet. Once checked,
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TABLE 7 Patient and public involvement structures in CS1
PPI structures PPI activities
PPI projects Patient Experience Blog. An interactive online blog-based tool that seeks to gain patient narratives
on their experiences of local health services, and their views on local health services
Marie Curie Delivering Choice project. A 2-year project assessing end-of-life care provision and gaps
Service user-led
PPI structures
PINpoint. Recommendations from prostate cancer survivors are directly fed to commissioners
Networks. Neurological, stroke and diabetes led by voluntary sector
LINks
Local Voluntary Action Groups
Organisation-led
structures with PPI
Children’s Trust Board (includes younger service users)
Maternity services engage with service users
End-of-life preferred place of care
Personal Health Plans pilot
Long-term conditions Pathways
PALS
General practice health forums
these narratives then appeared on the website. Feedback to commissioners happened monthly as a
themed summary and also as targeted feedback if, for example, the story was about a particular GP
surgery. It was also possible for NHS staff to anonymously respond to the patient stories. Dissemination
about the blog initially happened via established service user groups [e.g. the prostate cancer support
group and local Multiple Sclerosis (MS) Society branch] and publicity material at GP surgeries. While, early
on, service users met the blog with enthusiasm, this became tempered by time as service users received no
feedback about any response to their postings. This was mirrored in the provider services, with staff
complaining that commissioners were not passing on the summaries to them:
. . . the PEBL [Patient Experience Blog] site is obviously a commissioner tool, it’s not a provider tool but
actually, and that’s I think again an issue because commissioners are collecting, we collect and
whether the two match up and marry up and whether the service users really understand that who are
providing feedback, because I suspect that a lot of service users who put stuff on to PEBL think that
that information’s coming directly through to the provider unit.
CS1 neurological provider
When data collection commenced in 2010, the recent split between commissioner and provider of services
was also reflected in the way in which PPEI was defined and understood by the different stakeholders. For
providers, PPEI was about ‘fine-tuning services’ and being used as leverage on commissioners:
I think that in terms of advantages certainly in terms of sort of informing our commissioner, informing
our partner organisations, to have feedback from service users is absolutely crucial in terms of service
redesign, in terms of how the service is delivered.
CS1 neurological manager
Providers also felt that they were often left to deal with service user representatives who, because of
their sense of ownership of a service, may not respond well to a major service redesign. Service user
representatives also had to engage with a new cadre of people – the commissioners. This often resulted
in well-established relationships with providers being seen as less useful at a strategic level, but for the
‘grass root’ service user the provider service was the only tangible organisation to engage with.
RESEARCH FINDINGS: CASE STUDY 1
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Involvement of service users with long-term conditions
Although targeted at the whole PCT population, the blog was particularly taken up by people with LTCs.
The PCT had a number of other structures in which service users with LTCs were involved. At board
level, the PCT had lay representation on its LTCs programme board and there was service user involvement
in the development of the diabetes pathway. In most condition-specific development work, providers had,
traditionally, been asked to suggest suitable patients to be involved. As the diabetes pathway was
developed, an alternative approach to recruitment was taken:
. . . we tried to take a different approach to avoid that and we advertised in the local newspaper for
representatives on our network and then interviewed them, and what we got out of that is we ended
up with one retired gentleman who was a type 2, but we also ended up with the parent of a child
with diabetes and our type 1 lady, who is young and who works, but obviously we‘ve at least got an
input from a slightly different group of people.
CS1 PCT commissioner 1
There was also some involvement of younger people in a diabetes users group whose feedback helped to
reverse a PCT decision to supply a single model of glucometer:
. . . we had a younger girl there who had type 1 diabetes and she said ‘you know, when you’re
growing up, you know, you hate testing your blood glucose and if there’s a particular meter you like
because it looks cool or whatever it is, where it only takes five second or whatever, then you should
be giving people whatever they need which would kind of mean they’re more likely to test’ . . . and
we said ‘what about if we kind of promoted that as sort of the meter for choice but again didn’t
restrict if someone wanted a different one that was absolutely fine’. And she thought that would be
really useful so yeah, exactly we kind of adjusted our thoughts based on kind of the feedback that
we had.
CS1 PCT commissioner 2
The commissioners’ focus on diabetes resulted in the other two tracer conditions being less visible in
terms of PPI. Within CS1, RA service users engaged solely with providers and framed involvement purely at
the level of care (e.g. shared decision-making); this also appeared the case at a local patient group.
Similarly, providers of RA services had an equally narrow view limiting their definition of PPI as patient
complaints through the PALS. In contrast, service user representatives had a more strategic vision of the
potential for PPI, realised their low visibility to commissioners and actively strove to get their voice heard:
. . . we are relatively powerless, don’t really have much to lever any change with, you know, it’s not,
MS is not a media issue, we can’t really use that, you know, it’s not topical, it’s not sort of highlighted
in the press a lot, and I think compared to all the other services that the PCT look at I think those sort
of neurological conditions are pretty low down on the list . . .
CS1 service user MS 1
The MS Society, Parkinson’s UK and other smaller organisations for long-term neurological conditions had
formed a strategic alliance across the region to amplify their voice to commissioners. At meetings with
commissioners (e.g. neurological network, QIPP commissioning support events), these organisations
presented a united voice in an attempt to raise their constituents’ profile. Although this strategy was
clearly understood by the service user representatives and local service users engaged at branch level,
as pointed out by a service provider, reliance on voluntary organisations as the sole voice for a condition
resulted in a number of service users not being included in that voice. This was clear during the focus
group with service users and carers living with MS or Parkinson’s disease. Similarly to participants with RA,
these respondents viewed PPI as being limited to care level and feedback on services.
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Evidence of influence
Despite this limited view, the members of the focus group all benefited from a service improvement
influenced by the voluntary organisations. Both the MS Society and Parkinson’s UK had put a strong
case forward for a nurse specialist role in the respective conditions, and had provided some pump-prime
funding. Following focused lobbying, service user representatives were added to the appointment panel
and had a sense of continued ownership over this post. Although hard data are not available, both
commissioners and service user representatives reported that the appointment of these nurses had
improved quality of life and reduced avoidable hospital admissions.
However, while this example of service change demonstrated a partnership approach to meeting a need,
CS1 also provides another exemplar of influence and service change that was initiated by service users
themselves. A group of parents had approached the local LINks in order to address issues they were having
with local primary schools supporting their child with type 1 diabetes:
. . . they’re [parent] having trouble getting help for diabetic children, in their school. I took this through
to the county wide group . . . the LINk and we’ve ventured on a project which will, along with the
county education authority and the health group, it has resulted in a protocol being . . . how to treat
people who are youngsters in schools, it really is very important because if they can’t get . . . and this is
just about diabetes we’ve done this, but hopefully this will be adapted for other problems we’ve had
with children in schools.
CS1 LINks chairperson
The parents, LINks and PCT worked with the CS1 local education authority and Diabetes UK (regional
office), a paediatric diabetes specialist nurse from a local hospital and other interested parties to create a
protocol for implementation in CS1 schools. The protocol (see Appendix 16) was a set of guidelines to
ensure that school staff were supported and given the right equipment to support pupils with diabetes.
The protocol outlined recommendations on how schools can provide medical care and emotional support
to children who have diabetes. This included an individual care plan for each child and providing a place
for a child to test their blood glucose levels or administer their insulin injection, extra training for school
staff to prevent situations where children are unable to participate in day outings or residential trips, and
allowing children to eat snacks to regulate their blood glucose levels.
Clinics at some hospitals are very reluctant to put a child on a better regime because it might mean an
injection at lunchtime and so they don’t do it because of the issues surrounding schools. Well we’ve
now recently got a protocol up and running for schools to look at, of all the information that they
need regarding insurance, just the care of a child with diabetes, everything they need to know is in
this document that they can refer to and we’re hoping that it will be rolled out nationally.
CS1 parent 1
Feedback from the expert reference panel suggested that the protocol was highly likely to be adopted by
schools and lead to improved health outcomes of children with diabetes.
The voice of parents is strong and it is evident that involvement/representation on the working group
has highlighted key issues that are important to the lives of children with diabetes. If implemented
through discussion to develop tailored health plans, based on partnership working between the
PDSN [paediatric diabetic specialist nurse]/parents and school, it will improve health outcomes.
Diabetes charity representative
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I am of the opinion that the likelihood of the protocol leading to health improvement for children
with diabetes would be greatly increased. Schools need to have expert guidance in dealing with their
children with complex health needs and diabetes is one of these conditions. A robust protocol to
support the children, parents, carers and school staff is essential for the children to have good
experiences in school while living alongside their condition.
Specialist diabetes nurse
However, in tracking interviews, the parent above reported her disappointment in the slow uptake by local
schools, and a growing resignation that, unless a mandatory requirement, the protocol was unlikely to be
high on a school’s priority list. The need for a more mandatory approach was echoed by the expert panel
respondents, who expressed concern that insufficient attention was given to implementation.
The wider question about this policy and its development process is how it is delivered in practice and
monitoring/feedback processes. There does not appear to be a defined delivery or monitoring plan
involving the schools/teachers themselves.
Diabetes charity representative
While supportive, one panel member – a head teacher – also raised some concerns.
I have had only one child who developed Diabetes towards the end of her time with us and a
document like this would have been invaluable – but for non-medical people also a bit scary . . . Just
as a point, some staff may well not want any responsibility for a diabetic and in a small school this
could be an issue . . . I feel this is a sensible protocol which would be adopted in schools. Primary, and
secondary schools are now educating children with a wide range of illnesses, some are even life
limiting which cause emotional strain. We are doing it with very little support and so the protocol is a
HELPFUL document which can be our guidance. I particularly liked the Notification process . . . [but] . . .
Soon there will be very little LA [local authority] left to inform. FYI School Nurses are also very few and
far between nowadays.
Head teacher
As an alternative strategy, this parent then attempted to use the patient reference group (PRG) as a forum
to promote the protocol; this is discussed in later sections of this chapter.
Involvement of children and younger people
Despite the above parent-led initiative, it was acknowledged in CS1 that the involvement of younger
people and children was challenging:
. . . once we had a meeting, a day’s meeting, under the auspices of a Children and Young People’s
Strategic Partnership, and I can’t remember what we called it, it doesn’t matter what it was called, and
we did have a few young people along for that and then you know, they’d be peeling off into small
groups and that information would be fed back, but it is very, very difficult.
CS1 PCT lay representative and LINks member
Nevertheless, within CS1 we conducted interviews with three young people. One young person had set up
a school council for students with diabetes to meet and talk about their issues. This diabetes awareness
group was set up with the support of a teacher who had helped this young person through her struggles.
This young person described how she found clinic sessions to be a bad experience and that she received a
lot of support from her diabetes nurse outside the clinic on diet and insulin levels.
Yeah it was a big help, she answered a lot of questions that I’d had but couldn’t ask in the clinic, just
from being upset so it was nice to have them answered finally . . .
CS1 young person 1
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Her experience of the clinic was that no one responded to her attempts to make contact by telephone or
e-mail during a period where she needed support. She felt that within the school council there were
several voices who would like to be heard regarding service provision but she did not know who she
could go to or talk to with ideas and suggestions. Neither did she believe that they could make an impact.
Another young person had regular online activity with ‘diabetes support’ for peer support and to share
information and experiences but, again, she did not think that the group had any influence on services.
Her experience of care in school was not good and she felt that no support was offered to her. Examples
she gave were having to inject her insulin in the toilets rather than in the medical room, and not being
given appropriate facilities to eat during examination periods.
I did see a nurse [at school] because I had to go into hospital because I wasn’t very well, and when
I came out of that I went to see a nurse then, and she was like ‘is there anything we can do?’
and I, sort of, said the things but nothing become of it, they never did anything about it, so I did try.
CS1 young person 3
We also conducted interviews with five parents. Parents felt that support groups provided opportunities to
talk to other families in similar situations and share their experiences of accessing support, which enabled
them to question what they were being told by professionals and pinpoint where care was failing. One
parent felt that the support group had power to make changes through ‘campaigning and bombarding
people with e-mails’. This parent also sat on the CS1 diabetes network group as a representative for
meetings with the PCT; however, she felt that she had little influence:
Whenever I try and say something and put my point across, they all say, ‘oh yes, there – there’ and
take no notice.
CS1 parent 3
Another parent reported that her child’s school always responded appropriately to any care needed. The
parent is involved in training school staff to support her child to use her insulin pump. This parent also felt
that voluntary groups could provide examples of what has worked when writing to GPs and consultants
for service provision.
I feel you’re acting as an individual but you feel as if, supported, that you have the power of them
[the group] behind you even though the power doesn’t actually do anything.
CS1 parent 5
Patient and public involvement: embedded within the primary
care trust?
In the early phases of the research, there was a mixed picture of PPI within CS1. There was evidence that
the PCT as an organisation had ‘signed up’ to PPI, and, while acknowledging many of the challenges, was
undertaking some quite innovative work. The main issue was that many of these initiatives were ad hoc
and at the first workshop there was recognition of silo working and poor sharing of good practice in PPI
locally. Indeed, both workshops provided the opportunity for many participants to learn about each
other’s approaches.
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At board level, PPI was often interpreted in terms of patient experience, with feedback and complaints
used to illustrate methods of ‘PPI’. However, commissioners working at service design level were able to
describe the benefits of involving patients:
. . . you sometimes perceive it’ll be more difficult than it would be, sometimes you perhaps have an
anxiety that it might be a difficult meeting if you’ve got patients there. I have to say, my experience is
usually that it isn’t actually, and particularly if you’ve got consultants in the room they tend to behave
better actually if there are members of the public there, and they’re often more engaging . . .
CS1 PCT commissioner 1
The evidence of service change presented earlier suggests that PPI was not tokenistic on many occasions.
However, there were also a number of examples of reservations from commissioners and providers about a
potentially demanding public with a personal agenda. In contrast, many of the service users and their
representatives were aware of this perception and sought to allay it:
. . . a commissioner who achieved a lot, you know, was like, ‘Well there is no money, It’s no good
getting people coming in here and telling me all the stuff they want because I don’t want to raise
expectation, because there is no money’. And when we try to get these networks set up we have to
sort of reassure commissioners, . . . agree what we would like to see and then understanding that there
are certain realities and what can we do working together to maximise the resources that are available.
CS1 service user representative Parkinson’s disease
The impact of changing processes
The second workshop in CS1 coincided with a PCT board extraordinary meeting to discuss how the
transition to the new structures (in particular the clustering of PCTs as a first stage) would be managed.
There was a general anxiety that the current PPI infrastructure would be lost and that local GPs were
unlikely to have the experience or will to embrace the PPI agenda:
. . . the history of GP engagement with this sort of stuff isn’t good and it’s quite difficult really to see
the patients having much influence. I mean, I’m quite concerned, as a nurse by background, how
some of the other professions are represented, so I can’t imagine patients would find it easy to get
their voice heard.
CS1 PCT commissioner 1
This perceived GP antipathy towards PPI appeared evident in one interview:
. . . all they say is how they have got rights and how their rights should be, that they’ve looked it up
and they want it and they feel it is right for them and when they can afford to have it, despite being
aware of the costs and risks and everything and they’ve paid their taxes and why shouldn’t they
should have it and it all goes back to what they’re personally going to get and not get. I think they‘ve
just been too empowered with this idea of informed choice and rights.
CS1 GP commissioner
However, despite these rather negative perspectives, some key mechanisms played out in CS1 resulting in
a firmer embrace of the PPEI agenda than suggested above.
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Mechanisms for patient and public engagement and involvement
within the transitional structures
The PCT medical director was confirmed as medical director in the shadow and subsequently authorised
CCG. As a strong proponent of PPEI, she had undertaken an increasingly public facing role in the former
PCT, could describe how the PPEI agenda had developed in her own GP practice, and clearly articulated
her vision for PPEI within the new CCG:
PPEI in the CCG is absolutely right through, I’m absolutely clear about that. So and it’s a two way
process, it’s not just us hearing them, and one of the challenges is how do you create a public group
who have enough knowledge of the principles of healthcare without having been subverted into an
agenda that, you don’t want. You know, that’s actually the health agenda but are able to be critical
friends, critical partners and contribute, and have enough knowledge of the jargon and the processes
that they can feel confident as well to contribute and challenge.
CS1 CCG medical director
In contrast to the earlier data suggesting some silo working, PPEI was now envisaged as synergistic across
the health, local authority and voluntary sectors. The PPEI agenda had another prominent champion
within the CCG, the Director of Development and Strategy, whose portfolio included being the Public and
Patient Engagement Executive Lead. She described four key aims for PPI within the CCG:
1. to be different from how PPI was enacted pre CCG
2. to be present and embedded within all CCG decision-making processes
3. to have an active influence over CCG decision-making
4. to support people to make active changes over lifestyle, particularly those with diabetes type 2.
The first aim was a recurring theme with CCG and local authority respondents in the post PCT phase of
this study and will be explored further in Chapter 7. The executive lead offered the following evidence on
the CCG’s commitment to PPEI:
. . . we’ve got this strong will to do things differently but we’ve not been resourced to do so. So
what’s important to know is that we have just offered positions to Communication and Engagement
Managers within the CCG and we’re a bit different from other CCG’s because others are just buying it
from commissioning support . . . we interviewed two weeks ago and we had some exceptional
candidates and we have been a bit naughty [laughs] and now recruiting two managers.
CS1 CCG PPE [patient and public engagement] lead
In addition to the two CCG champions, a small project team headed by a lead bought in as a consultant
by the CCG cluster developed the PPEI strategy for the authorisation process; having a very experienced
and effective project team who role-modelled engagement during the development of the strategy
was an important mechanism within the CCG. The project lead highlighted the initial challenges as getting
the shadow CCG board to attend engagement events, and that these events had been too large and
were prone to being used as ‘an opportunity to have a moan and to complain about things’. Nevertheless,
a clear and coherent set of work streams resulted in a comprehensive strategy for PPEI. While the overall
PPEI structure is presented in Figure 2, this was supplemented by a number of tools. First, the close links
between the CCG and Public Health based in the local authority would provide the CCG with data for the
representative population and advice on what kind of engagement approach would suit this population.
Second, a database of existing PPI groups and service user representatives was being created:
. . . we’ve built up all our contacts and we’ve checked with our equality colleagues within (cluster) as to the
type of groups that we should be interacting with and making initial contacts with them and then once
you’ve got all those people and you’ve kind of identified them in this database that we’ve created, or
built up, you then can be very targeted about, approach about recruiting people in, so for example
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a clinical lead on a, one of their commissioning priorities, urgent care will say, ‘I actually need two or three
lay reps,’ so you can then say, ‘Right, for your area what coverage do you want there to be?’ and then you
write out to the people in that area and say ‘Here’s an opportunity for you, you’ve said you wanted to
either get involved at this level or you’ve said specifically you’re interested in A&E [accident and emergency]
issues, you know, what may be classified as urgent care, do you want to put yourself forward?
CS1 PPEI project lead
Third, the Patient Experience Blog described earlier took on a new importance in the eyes of the
commissioners and was seen as a key tool for PPEI. This represented a complete turnaround from
the rather ambivalent attitude of GPs to the Patient Experience Blog project in its early days. As one
of the original catalysts of Patient Experience Blog, the loss of enthusiastic PCT commissioners in the NHS
reorganisation had left the project floundering. Observation of a shadow CCG board meeting also
suggested that the GPs initially perceived Patient Experience Blog as being a ‘twitter like tool which was
just about patient’s [sic] having their say’ (field notes). However, specific championing by the PPEI project
lead and a SHA PPEI consultant resulted in the Patient Experience Blog being a key pillar of the CCG PPEI
strategy and, indeed, it was rolled out to other CCGs within the cluster.
The targeted approach to PPEI as articulated by the CCG PPEI project lead was mirrored by the project lead
for the shadow Healthwatch. He described focusing on areas where they could potentially have the most
influence: large budget holders and being the voice of the ‘ignored middle’, i.e. the everyday person who


































and younger people (2)
3−4-year tenure
Out-of-pocket expenses






FIGURE 2 Patient and public engagement and involvement structure in CS1. PPE, patient and public engagement.
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While strong links with the voluntary sector were integral to CS1 PPEI strategy, there were some
reservations from respondents representing these groups:
I haven’t had any links or contact with CS1 CCG, I don’t even know whether they have a neurology
lead, but I have been able to make contact with [a neighbouring CCG] and they were looking into
whether there was anybody leading in this area but they haven’t got back to me yet . . . [January 2013]
CS1 service user representative MS
This represented a more general view voiced by service users, that while the CCG was creating its
PPEI strategy it was a one-way ‘don’t call us, we’ll call you’ approach. However, there was some
acknowledgement, too, that CCGs were so focused on the authorisation exercise that there was less
capacity at that stage to operationalise PPEI in the spirit intended.
Concurrent to the PPEI development within the CCG, the Directed Enhanced Service (DES) payment was
resulting in the setting-up of local patient participation groups (PPGs) attached to general practices.
CS1 included some relatively affluent areas where there was some history of PPGs:
. . . at [xxx] Health Centre and that’s been going now for about 13 years, it was one of the originals . . .
our Chairman is an ex-partner of the practice, retired . . . he instigated it really, you see, and so we’re
very fortunate and the senior partner, you know, attends all our meetings so we‘re very lucky. What’s
the role of that particular group? Simply communication between the patients and the partners . . .
CS1 service user CCG reference group
However, the DES was encouraging more practices to set up these groups:
. . . other practice managers I’ve spoken to and said, well what does your do and how does yours work
and . . ? You know, and it was like well, you know, it’s very much about fundraising and they don’t
quite have as much involvement maybe and things like that. And then, of course, when the discussion
about the DES came out, we had a draft DES and thought well, you know, this probably gives us the
impetus to say let’s now do something about it . . .
CS1 practice manager
Nevertheless, while there was enthusiasm for PPGs from some local practices, in CS1 there was little
evidence on how they had been closely aligned to the overall CCG PPEI structure; as illustrated in
Figure 2, they appear at the periphery. In addition, there were proportionately fewer active PPGs than in
other case study sites and, of those active, there were more that were functioning as a virtual group rather
than face to face (Figure 3).
Termed Patient Reference or
Representative Group (PRG)
Adopting ‘virtual’ rather than actual
group (out of nine groups)
Groups with minutes/reports of PPG/PRG
published on website
Patient groups currently active
Information about patient group on
website (out of 33 with website)
Current GP practice website




FIGURE 3 General practitioner practice patient groups for CS1.
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Access
Within CS1, there was a real desire from the CCG and local authority to take a new approach to PPI and
recruit new people. In the earlier phase of the study, service user respondents in a PCT lay role or LINks
members described a long history of PPI often stretching back to community health councils. As described
by the project lead for the shadow HWBB, there was an initial assumption from LINks that there would be
an automatic transition into the new PPI structure. Indeed, in the early days of the shadow HWBB, this was
exactly what happened. However, the formal recruitment processes adopted by the CCG, HWBB and
Healthwatch ensured that a ‘refresh’ process occurred. Key lay positions on all three bodies were via a
formalised recruitment process. In the case of the HWBB, LINks had formally objected to this process and
so were invited to present their approach (open invitation) to the scrutiny committee which then voted for
the formalised approach. The Healthwatch project lead had also designed a recruitment process to
emulate the Olympics ‘Gamesmaker’ model in order to get the ‘right people’.
While the three lay positions on the CCG board were advertised within local media, the reality was that all
appointees were previously known to the CCG and were actively encouraged to apply. However, there
was an acknowledgement of the need not only for ‘new blood’, but also not to alienate those who had
undertaken years of lay involvement:
. . . it’s also not wanting to seem like an organisation that doesn’t value a group of the public because
that defeats what you’re trying to do. But it’s how to not alienate them, get them to feel involved but
allowing a wider range of comment. And you have the same thing with the lobby groups and it’s how
do you harness their energy and their knowledge without it railroading everybody else?
CS1 CCG medical director
The PRG was seen as the main forum to prevent alienation and continue the involvement of these
long-serving lay people. In contrast to lay appointments to the CCG board, the PRG had less of a formal
recruitment process and was generally offered to lay people serving in an existing role. Within CS1,
the PRG was chaired by the PPI lay non-executive CCG board member. Both she and the appointed
chairperson of Healthwatch were chief executives of local charities serving marginalised groups, and had a
long history of non-statutory service to the local population. The PRG chair was focused on moving the
PRG agenda on from a personal one:
I threw down a challenge at our first meeting and just said ‘I hear what you’re all saying, I really do
and I’ve got every sympathy’ . . . but we can all talk about that, we can all sit and nod and we can all
talk about it again next time and nothing will change. So my challenge to everybody around the table
is that our group will be solutions focused.
CS1 CCG board lay member 1
As data collection completed, the PRG had met only four times, and, as described by the PRG chair and
the CCG PPE lead, the group were still in the ‘storming’ phase of group development. It was also
acknowledged that the next steps were seen as focusing on engaging harder to reach groups, in particular
younger people.
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Agenda
When looking at access to the new PPEI structures in CS1, it appeared that the PRG was being used as a
‘holding area’ for patients and the public with a long history of health service involvement and lobbying
activities. There was also some evidence that the PRG chair was acknowledging that it would take time to
change the ‘personal agenda’ of many of the PRG members:
I had a sort of review meeting with the Chair and the Chief Accountable Officer last week and we had
quite a good and frank discussion, where I said ‘Look, this is my day job, but please don’t think I’ve
got a magic wand’, because to move forward there is a piece of work that we need to do with the
people that are currently engaged, because if you flip them off, instead of them being your
ambassadors and your advocates, they will become your enemies.
CS1 CCG board lay member 1
Interestingly, there was some evidence that service user-led initiatives, such as the schools diabetes
protocol discussed earlier, were being removed from the agenda by the PRG members themselves:
. . . someone started to talk about the diabetes pathway at the last meeting, legitimate issues, things
about. . . actually it boiled down to children, how people with a reliance on insulin need something
during the day, and they were talking about a programme that had been established . . . nobody
responded, nobody said ‘That’s really good, I can roll that out, I can take it back to my forum’, and the
end result was we came back to GP access . . . You know, the person that sat there [parent presenting
the protocol], what would be their incentive, what would be their ‘what’s in it for me to come back to
that sort of environment?’
CS1 CCG board lay member 1
It was too early to tell what impact the PRG was having on the CCG decision-making process, and, indeed,
the CCG lay board members felt that it was too early to assess their own impact on the agenda.
Agenda-setting within the new structures was understood as the role of the executive officers, with an
acknowledgement that lay representatives would have the opportunity to influence discussion of the items
on the agenda. For the CCG, key challenges were identified as occurring in 2014 with service restrictions,
and the CCG PPE lead described PPEI as a key tool in getting difficult decisions through. For the CS1
Healthwatch, the agenda was set around its self-definition of being ‘an evidence-based market research
organisation’. There was some evidence that the voluntary sector was trying to change or influence the
agenda. For example, the carer of someone living with MS was encouraged and helped by the MS Society
to successfully apply for Healthwatch in order to ensure that the MS population voice would be heard.
However, it was clear when interviewing this member that he perceived the importance of being able to
understand the health issues facing the broader population and being able to contribute more strategically.
Summary
Case study 1 had a strong pedigree of PPI initiatives; however, even with this history there were only a
few notable examples of service user voice having a major impact on service delivery. The will for PPEI
transferred over to the CCG board, although there was evidence that this intent did not extend to all GPs.
Nevertheless, the employment of a dedicated project lead to develop the PPEI strategy demonstrated a
commitment. However, when data collection completed there was a general feeling that the aims of
the strategy would take longer to achieve than anticipated, and that it was too early to be able to fully
evaluate whether or not the service user voice was being heard and responded to in the CCG
decision-making processes.
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Chapter 5 Research findings: case study 2
Background
Case study 2 was the second site to be recruited. Merged from four separate health organisations in 2006,
CS2 had a long-standing tradition of patient involvement and public engagement, with a PPI strategy that
focused on partnership working and active involvement.
Case study setting
Case study 2 is situated in an inner-city area in the north of England. It is culturally diverse, with a growing
BME population. Life expectancy is marginally below the national average and the site reflected high
levels of health inequalities, with areas and pockets of deprivation. Differences between life expectancy
between the best-off and worst-off neighbourhoods was marked (around 14 years in 2008) and
prevalence of chronic diseases showed a consistent and high relationship with indicators of deprivation
at ward level. CS2 commissions services from a variety of providers, including acute, community services
and specialist hospitals. Primary care is provided through 88 general practices, forming four locality-based,
practice-based, commissioning groups.
Processes and supporting structures for patient and
public involvement
Public and patient engagement and involvement appeared well established in CS2, primarily through
CS2’s relationship with the local authority. The city council was an active partner in health and social care,
with an established track record in community development, as well as increasing public involvement via
community assemblies. The voluntary sector was highly developed, with over 150 charities and voluntary
organisations operational. PPEI structures, such as a third sector assembly, brought together voluntary and
community organisations, faith groups and social enterprise organisations with statutory services.
The first workshop identified various PPI initiatives that were operating within the case study site.
Significantly, participants found the information exchange informative, and discussion identified that
many of the initiatives were not adequately or widely communicated. Sharing information was seen as
essential (Table 8).
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Interviews, discussions and documentary analysis showed a diversity of methods utilised within the case
study site in relation to PPEI (2010–13) (Table 9). The development of PPGs was evident at practice level.
Patient participation group recruitment was often via invitation, and involvement covered areas such as
practice environment, patient education and self-help, advocating access to services and involvement in
public events. Lay representation was identified in a number of working groups – this included areas such
as Partnership for Mental Health, Health Panels, commissioning/public/multidisciplinary meetings and
virtual groups. A focus group with local National Rheumatoid Arthritis Society (NRAS) members identified
the use of the press as a way of making their views heard.
Some of the examples focused on information exchange, with a strong emphasis on feedback. Data
collection tools such as survey, questionnaire and comment boxes were highlighted as well as a number
of public consultation events. Newsletters and practice leaflets were also identified, as well as the use of
consortium websites, with strong emphasis on providing patient information but also offering ways to
become involved. Discussion with LINk representatives highlighted the use of ‘enter and view’ at hospitals
and GP surgeries. There was PCT involvement (PPEI team) in citywide PPEI networks and expert patient
programme groups; in relation to tracer conditions, there were a number of consortia-led groups such as
diabetes planning and commissioning group/long-term neurological conditions forum.
A diabetes support group had been involved in service redesign and had the ability to work independently
of the practice, setting its own agenda and offering support and social networking. Patients were also
acting as champions at practice level, which involved supporting other patients and helping them to
access appropriate services. Patient involvement in educational programmes such as DESMOND
(Diabetes Education and Self-Management for Ongoing and Newly Diagnosed) had also led to increased
involvement, for example in changes made to adolescent services. In addition, there were some examples
where voluntary groups had been asked to run public consultation events; for example, the Royal National
Institute for Deaf People (RNID, now known as Action on Hearing Loss) was involved with hearing aid
TABLE 8 Patient and public involvement structures in CS2




Quality Improvement Academy – led by PCT chief executive, attended by LINk and service users,
focus on care pathways
Readers Panel
Health Inspectors – young people (11–19 group) inspecting children services re: fit for purpose
Patient Involvement in redesign of hospital car park
Lay involvement in steering groups
Patient stories
Big Health Conversation – public consultation for JSNA
Shadow Board for Coronary Heart Disease
PPI projects Experience-based design – the collection of real-time data focusing on how patients are feeling at
each stage of pathway
Person-centred planning – patient redesigned care pathway transition from child to adult learning




Local voluntary action groups
NRAS – directly approaching general practices to raise issues
NRAS, National Rheumatoid Arthritis Society.
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services redesign. In relation to tracer conditions, PPEI was evident in the redevelopment of musculoskeletal
services, with the PCT instigating a number of service provision reviews focusing on physiotherapy,
podiatry and chronic pain services. PPEI focused strongly on consultation, with the predominant use of
questionnaire and survey. Although there was a Long-term Neurological Conditions forum, with patient
and public representation, documentary analysis revealed no evidence in relation to the impact of
the forum.
Assessment of methods and approaches of PPI reviewed within the case study site (see Table 9)
highlighted a continuing focus on commissioner-led initiatives, with fewer examples of participatory
involvement. This would suggest that overall control of the agenda had rested within the PCT itself.
TABLE 9 Methods of involvement: CS2
Method of involvement Used or led by Level of involvement
Lobbying local press Service users Information exchange




Patients as champions Patients Participatory
Lay representation in commissioning meetings Commissioner Information exchange
Feedback
Lay representation in working groups Commissioner Information exchange
Feedback
Voluntary organisations facilitating public engagement events Service user representatives Participatory
Consultative
PPGs Initiated by practice personnel
User led
Participatory
Practice leaflets/letters Provider Information giving
Diabetes support group User led Participatory
Consortium/practice website Provider Information giving
Feedback
Comment box Provider Feedback
Lay representation in public meetings Commissioner Information exchange
Involvement network Commissioner/patients Participatory
Enter and view visits User led Feedback
Press releases Commissioner Information giving
Graffiti wall Commissioner Feedback
Public consultation exercises Commissioner Consultative
Questionnaire – patient satisfaction Commissioner/provider Feedback
Lay representation in forums Commissioner/local authority Information exchange
Survey Provider Feedback
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Local policy and embedding of patient and public engagement
and involvement
Consultation, partnership working and knowledge exchange had all impacted on the development of the
PCT PPI strategy, with three key priorities emerging:
1. focus resources on creative engagement of the seldom heard
2. maintain effective engagement through agreed approaches
3. patient involvement in the development, purchase of appropriate services and monitor their
effectiveness (ensuring that service users were part of the strategic procurement cycle).
Interview data from the evaluation suggested that creative engagement with seldom-heard groups was
linked to the restructuring of the Communications and Engagement Teams within the PCT. This involved
the abolition of the Engagement Team in 2010, with a social enterprise organisation contracted to run
8–10 consultations each year. The organisation had an established relation with the PCT with experience
of being involved in a number of consultations relating to ‘hard-to-reach’ communities. The rationale for
this significant move was explored and discussions identified a refocusing of PPI initiatives, moving
consultation out into specific communities, and bypassing established community meetings.
I mean the way that the Engagement Team before worked was that they, they used sort of traditional
methods like going through the voluntary sector organisations, going through established groups that
support some of those communities, but we felt we were probably getting opinions from the same
people through that route. Whereas using this company, they, I mean they’ll go and speak to people
within those communities, they don’t just attend the meetings that get attended by the same people if
you know what I mean, they’ll actually go out and speak to more people . . .
CS2 assistant director of PPI, PCT
Some informants thought that there was a broad range of representation within initiatives but also
saw that seeking a wider opinion was beneficial. However, some professionals still felt that the use of
proxy-users was acceptable. Furthermore, creating wider diversity was seen as problematic; one
commissioner highlighted the usual type of person who becomes involved as being too enthusiastic
or opinionated, and that there was a struggle to attract minority ethnic groups.
Documentary analysis revealed actual and potential examples of PPEI within the case study period
(2010–13) with emphasis on the use of advisory panels/forums, joint training initiatives (professional/
public), partnership working and consultation. A review of public consultations by the PCT (2008–12)
reflected a variety of health-related topics; however, none specifically related to the tracer conditions of the
research project. Website analysis identified a prominent place for patient stories; involvement initiatives
included health education programmes, volunteering and polls as well as the provision of links to other
involvement networks.
There was also evidence of PPEI as part of the strategic procurement cycle. Interviews with providers and
commissioners identified the importance of PPI both as a policy directive and within the commissioning
process. Discussion with commissioners highlighted the value and essential nature of PPI in ensuring that
services fit local patient need and facilitated service buy-in. The concept was also seen as an opportunity
to be involved in and informed about service provision.
Public involvement is trying to, for us or for me is about matching services to meet the needs of
patients and having them involved in that process as best as we can.
CS2 GP commissioner
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. . . effective commissioning is heavily dependent on good, constructive and meaningful patient
engagement in the development and redesign of services. Without it there’s a danger that we design
systems and care processes that patients, the public and service users don’t understand and don’t buy
into . . .
CS2 commissioner
Interviews with service providers identified that patients needed to be involved in any changes to services
and that such involvement was part of the effective shaping and development of service provision.
I think if you’re not careful a lot of well meaning people develop a service without necessarily the true
input of how someone actually on the receiving end of the service is actually going to feel about it . . .
CS2 NHS provider
Service user discussions identified lay involvement should be proactive, linked to improved patient care and
effective design or redesign.
Because we’re on the receiving end of all this care and so it’s important that you get the feedback on
how we are finding it and what we feel the hospital is doing well and what they could do better.
It just needs different peoples point of views, you know, not just the actual carers but the
patients themselves.
CS2 service user representative
Respondents gave examples of where PPI was discussed in specific service redesign contexts. This
highlighted that the concept of PPI was an essential element of the redesign process and that it was
embedded within the PCT operations and processes.
We did completely unpick the previous service model for community physiotherapy, and we ran a
series of engagement exercises, partly at practice level and partly at wider community level . . . we
actually had some very good constructive points of detail which helped develop the specification to a
level that was more productive, and that was as a result of, if you like, public input.
CS2 PCT commissioner
As with other the case study sites, public involvement was viewed as resource intensive; cost implications
were identified in relation to large-scale engagement events. Involvement was also seen as time-consuming
with the potential to slow down decision-making, with limited staff available for such work. Voluntary
organisation representatives identified difficulties with funding, recruitment and workload.
There was limited documentary evidence in relation to the place of PPI within PBC and general practice as
a whole, although PPGs and Patient Opinion work were operated by a number of practices.
Evidence of influence
There was some evidence of involvement leading to identifiable changes, although examples tended to
focus on small gains. Initiatives relating to the diabetes service gave a number of examples:
l patient retention of medication on admission to hospital
l redesign of leaflets
l development of exemptions to the standardisation of blood sugar meters
l accurate register of patients with diabetes
l use of patient-friendly letters
l greater localisation of eye-screening.
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The LINk was involved in the evaluation of a care home directory; following involvement, the directory was
redesigned to be more user-friendly. This organisation was also involved in challenging the planned closure
of two care homes; successful campaigning resulted in the care homes remaining open. Furthermore,
feedback from ‘enter and view’ initiatives at local hospitals had led to the implementation of an action
plan for change; however, it was unclear whether or not the suggested changes had been implemented.
Public involvement in relation to physiotherapy services had led to the rationing of such services,
i.e. six treatments only before review. Public involvement in hearing-aid service redesign had led to an
improvement in the quality of the specification and a service that was more cost-effective. PPGs had also
made a number of successful changes such as adjustment of practice opening times, patient confidentiality
at reception, changes in the waiting area layout, increased access to chiropody services and increased and
quicker access to physiotherapy services (identified within contractual arrangements).
However, the main exemplar of influence and service redesign related to the development and
implementation of a model of enhanced diabetes care within primary care settings in 2009. The transfer of
diabetes services from a predominantly secondary care-based service to a community-based model had a
number of drivers and this included disease projections, demands on secondary care, policy drives, service
gaps and stakeholder feedback. Public consultation events (n= 2200) had identified three public priorities
for diabetes services:
l improved communication
l care nearer home and at a single location
l better engagement with diabetic patients from BME groups.
I mean the diabetes community group hasn’t come out of just practitioners thinking this is a good
idea, this was from long-term listening to patients saying ‘actually, you know, why do we have to go
to the hospital for this, why can’t it be done at a GP surgery? Why do we have to traipse up there
when we can’t park?’
CS2 service user representative
A Clinical Commissioning Planning Group (CCPG) was activated to support the transition of this service;
although PCT-led, this group had lay membership in the form of Diabetes UK representatives. Interviews
with commissioner and service user representatives suggested active involvement and the valuing of
lay input. The new service was evaluated by patients at each stage (e.g. scoping, piloting and post
implementation). This included an additional evaluation by the social enterprise organisation (see exemplar).
With the evaluation that’s going on at the moment, what we determined was that we didn’t want it
just to be fed back to the patients, but we very much wanted them to be part of that evaluation.
So, we’ve looked at – we’ve got service data; we’ve got the effects on hospital spend, etc. going off;
we’ve got access. But what we also did do is put a strand in and we got a PR [public relations]
company doing some work for us that actually asked patients what they thought about the
new service.
CS2 PCT commissioner
However, assessment of the PPI initiative by the Expert Reference Panel identified a number of problems
with this exemplar. A diabetologist felt that there was insufficient attention paid to implementation
and outcomes.
We have a tripartite service with poor communication between primary, community and secondary
care and at least 3 different IT [information technology]/data collection systems. if not multiplicity and
delays in referral confusion in clinical responsibility. Have to demonstrate good governance/quality
of care.
Member of expert panel
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Similar concerns were echoed by the GP:
. . . possibility that the proposed new service configuration might be difficult to implement and lead to
problems during the transition phase (such as a disruption of care for patients).
Member of expert panel
In terms of the process, the representative from the national diabetes patient organisation felt that there
had clearly been some engagement with service users but was critical of the outcome measures:
The outcomes that are not described are the more intermediate outcomes of patient engagement in
their own individual care, confidence in the care delivered, increased capacity and confidence to
self-manage their diabetes. 95% of a person with diabetes life is spent managing their own condition
and only a maximum of 5% is spent in contact with the clinical system of care, therefore ability to
cope, understand, knowledge and engagement outcomes are important.
Member of expert panel
There was concern among the expert panel members that the overall focus of the exemplar was on
clinically defined outcomes which, while recognised as important, primarily focused on process outcomes
with little attention to issues related to the predominantly self-management of diabetes and clear
demonstration of a wider patient-focused engagement in process and outcome measures.
Involvement of children and younger people
Three interviews were conducted with three young people within CS2 and one interview with a parent;
as with other case study sites, gaining access to such interviewees proved time-consuming with
limited success.
A number of issues were highlighted within the interviews such as the importance of support. One young
person with complex conditions was not involved with any support group due to risk of infection. She
looked to her family and her consultant for support, and her experience was that the children’s hospital
was responsive to her needs.
Two young people interviewed had set up their own support and social group for local teenage girls with
type 1 diabetes. The group aims to provide a forum for social activities and for people to gain support,
information and advice from each other. The children’s hospital was encouraging in helping the group to
make contact with other young people and supportive to the needs of the group.
So I think they’re quite, you know, they‘re very supportive of us and I think if we did need an extra
service or more help the nurses and people would help us and back us up on that.
CS2 young person 1
One young person who had been involved in starting up the group said she felt that more members would
strengthen the group in terms of getting their ideas listened to.
I think it would just be a good idea to get other people but I think people do listen to us because you
know, obviously this is a long-term condition so it is something that you know probably would need
to be looked at if we did need another service.
CS2 young person 1
The parent interviewed had also been involved in the setting up of the young persons’ support group for
local teenage girls with type 1 diabetes. She has also attempted to set up a support group for families of
children who receive diabetes care at a local hospital. One of the challenges of reaching out to families
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who might want to participate in such a group was making contact. Advertising and word of mouth tends
to be how families find out about the group.
. . . we can’t be given people’s names and addresses.
CS2 parent 1
This parent had a good understanding of the commissioning process and organisational processes taking
place and she felt that young people should certainly be involved in decision-making but also that
young people’s views were not sought or represented.
But at the moment I don’t know, I don’t see anybody asking them for their opinion in terms of
commissioning I think there was a paper, I think it was about services for disabled people a few years
ago, which was entitled, sort of, ‘nothing about us without us’, and I do think that unless you involve
the people, i.e. the young people who this affects and their parents and carers who support them,
you won’t actually get the best solution, I think it needs everybody.
CS2 parent 1
She was happy with the services provided for her daughter at the children’s hospital, which she described
as flexible and person-centred, and she felt that she could easily approach the diabetes team to discuss
any additional services, if needed. She went on to say, however, that the service was responsive rather
than actively seeking user opinion.
So although the service is very good and they are responsive to you as an individual . . . I don’t recall in
7 years at . . . children’s hospital ever being asked, ‘What’s your opinion of the services?’
CS2 parent 1
The impact of changing processes
The data collection period for the study was extended until March 2013 to capture major health policy
changes, which included the abolition of the local PCT and LINk and the establishment of a CCG as well
as the development of the local Healthwatch and HWBB. The PCT communications team was incorporated
into a patient partnership group based at the NHS Teaching Hospitals Foundation Trust. It was expected
that there would be representation from Healthwatch on the Patient Partnership Committee. Some PCT
personnel transferred over to the newly developed commissioning support unit (CSU) in order to perform
an advisory role as well as have some responsibility for external public consultation on behalf of the
CCG. Although health policy had advocated a ‘smooth transition’ between organisational responsibilities,
interviews with PCT commissioners highlighted a number of issues regarding strategic development and
the implementation of services.
. . . in terms of the commissioning, contracting, that pushing, shoving, making happen, managing,
monitoring, implementation, managing performance, working with, you know, all that type of stuff I
can’t see where that actually is in the new organisation, which makes me really worried.
CS2 PCT commissioner
Officially we transferred, supposedly transferred, in August, but then we were transferred again
supposedly in October. But I don’t really know . . . I think for diabetes . . . we have made such
enormous strides forward that it’s – you just think well, where’s this going to go? What’s the future?
Will this progress?
CS2 PCT commissioner
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Discussions with lay representatives also identified frustration about what was seen as having to start again
with a new process of involvement.
And, you know, they often throw the baby out with the bath water. We had a very good system
going and it’s now gone. And I’m not sure that what’s going to be there instead will be any better.
CS2 service user representative
The PALS was split, with the CCG chief nurse having responsibility for the continuing care aspect of this
organisation; PALS in respect of GP-related issues remained independent of the CCG, resting within local
area team structure.
Getting heard
The restructuring of local services and organisations had impacted on PPI in several ways. Firstly, interviews
with service user representatives and commissioners highlighted a reduction in PPI activity. One example
of this was service user representation in relation to the community diabetes service (see exemplar).
A CCPG for this service, which had representation from Diabetes UK, had been disbanded following the
successful implementation of the new service into one locality. This left representatives feeling that they
had very little contact with the newly developing shadow CCG, affecting their ability to be heard.
Well, I can tell you that everything’s fallen apart completely . . . the commissioning group of the PCT
has been disbanded and the patient group that we were involved with, we haven’t met because
there’s been nothing to meet about. And they’re in a process of reorganisation into consortia, and
how it’s going to work, I don’t know.
CS2 service user representative
The CCPG was seen as a key vehicle for involvement, enabling a systematic ongoing dialogue between PCT
commissioners and service users. Importantly, it had acted as a feedback mechanism between clinicians,
managers and lay representatives. Dissolving the group had impacted on communication; for example, the
service user representative was unaware that the community service had been rolled out citywide.
. . . we had key people at the Primary Care Trust who we could contact as patients and keep the kettle
boiling, kind of thing. But now we don’t; I mean, we’re waiting and waiting for the new systems to
get into place. At the moment I have got the lead GP as a contact and that’s about it.
CS2 service user representative
[Re: community service] . . . I can’t tell you how it’s going really, ‘cause I don’t know . . . I know they
were planning for it to go city-wide, but I didn’t know it actually had.
CS2 service user representative
Communication had become more individualised rather than maintaining an organisational systematic
approach. Key members of staff had also resigned or been transferred, which had led to concerns over
the loss of expertise and organisational knowledge.
So like yesterday I was bouncing e-mails backwards and forwards to one of the ones of the group.
But that’s because I know this person and I keep her informed. But in terms of where’s the formal
route of doing this? I can’t see anything much happening.
CS2 PCT commissioner
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I think we’ve gone from having something really good and robust and we’re clinging hold of it and
determined we’re going to continue with getting patient involvement in there, but it feels as if we’re
doing that outside of now what is in place or what is supported by the organisation.
CS2 PCT commissioner
Discussions highlighted the importance of effective communication to increase the visibility of
voluntary organisations.
. . . the main problem is telling – is patients being told about Diabetes UK meetings and about services
it offers and you’re reliant on that . . . you can give people information, but they may not pass it on.
CS2 service user representative
The development of new processes had meant that voluntary groups had to be proactive to ensure that
they had a voice in the new structure; this included asking the GP lead for diabetes (shadow CCG) to
attend local voluntary meetings and leaving information regarding Diabetes UK at individual GP practices.
There were also concerns about a new approach to diabetes as a condition; with all LTCs having been
incorporated into an umbrella group (LTC committee), interviewees questioned whether or not specific
conditions would remain visible within this new structure. Acting as a specific group was seen as important
in relation to being heard:
I mean, some of the best engagement groups are where you’ve got people with the same condition
being involved together and then that voice can come from all of them, because they have all been
able to have a say.
CS2 LINk representative
The need to re-establish relationships was seen as unhelpful and time-consuming, demand for involvement
had dropped, difficulties with recruitment remained and fund-raising had halved.
Well, it’s not just getting representation, it’s getting any volunteers to do anything.
CS2 service user representative
For some interviewees, there was a loss of influence; however, for other groups this had never been
attained. Those with mainstream conditions, such as diabetes, cancer and heart disease, were seen as
groups more likely to have a voice. Focus group data analysis showed that groups such as the local NRAS
group did not feel that they were visible and it was difficult to get their voice heard – this may explain why
this group would tend to use the local press to air issues.
Other public involvement initiatives had stalled to some respect; specific consultation initiatives by the
social enterprise company had been operationalised but the report was delayed, perhaps suggesting loss
of organisational focus by the local PCT:
. . . this has been one of the things that has fallen a bit through the gap; that actually getting through
from them their end report or even a recent progress, hasn’t been there.
CS2 PCT commissioner
Access
Some stakeholders took advantage of the need to develop new structures. For example, the development
of Healthwatch was described as a coproduction between local citizens and local government, and
incorporated 18 months of stakeholder engagement focusing on the role and remit.
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. . . we wanted to take the approach that the citizens . . . sort of co-design and lead on the
development of our Healthwatch, you know, the scale of how do you get something that represents
what 500,000 very different sort of people might want.
CS2 city council representative
Selection of the organisation to run Healthwatch went through a robust tendering process; however,
difficulties were noted in relation to funding.
. . . I think some of the challenges for us have been that information from the Department of Health
has come out very late in the process and so for example we still don’t know what level of funding
settlements are that we’re going to get.
CS2 city council representative
The tendering process finished in January 2013, with the contract given to a consortium of local voluntary
organisations, leaving little time for organisational and partnership development before going live in April.
Within the case study, the 88 general practices formed one single CG, with practices divided into four
localities. The CCG board had two lay members, as well as a clinical executive team, with specific GPs
taking on portfolio specialities such as PPI and diabetes. The HWBB was seen as a useful vehicle in
supporting the development of PPI in the CCG, and there was GP membership at board level.
. . . I do also sit on the Health and Wellbeing Board for the city and that’s been very supportive, and
there’s similar conversations going on there about making sure that we’re doing what the public and
the patients want us to be doing to the best of our ability.
CS2 GP lead PPI CCG
There was also the development of a LTCs committee, an umbrella group for all LTCs. During the data
collection phase, it was unclear whether there was any patient or public representation on this committee.
Mechanisms for patient and public engagement and
involvement within the transitional structures
The PPI strategy for the CCG was at the stage of a draft plan by the end of data collection. Three main
involvement vehicles were advocated: CCG-wide membership scheme (open to all practice patients),
a patient engagement panel (PEP) and PPGs.
Both the membership scheme and the PEP were only at the stage of potential vehicles in March 2013.
The membership scheme, if implemented, would certainly have increased access to participation. The remit
of the PEP was unresolved at the end of data collection; however, there was some discussion that its
membership could potentially come from Healthwatch. One of the lay members on the CCG board was
also a member of an organisation within the consortium which had won the tender for Healthwatch,
and therefore had established links.
However, the development of PPGs was visible within the case study area. By March 2013, 65 out of
88 practices (74%) had established a PPG in some form; this included virtual and actual groups, with
Patient Opinion, again, increasing access to participation, with 81% of practices offering a publicly
accessible website.
DOI: 10.3310/hsdr02440 HEALTH SERVICES AND DELIVERY RESEARCH 2014 VOL. 2 NO. 44
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Peckham et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
45
The draft CCG PPEI plan (see Figure 4) did not clearly elaborate on how each element of the structure
would function, communicate or relate to each other; this could potentially lead to compartmentalisation,
with each operating as separate entities. This concern was also highlighted in discussion:
My worry is that information doesn’t find its way up and concerns don’t find their way up from the
shop floor, as it were.
CS2 GP PPI lead CCG
Agenda setting
A review of early CCG initiatives showed that initiatives such as the membership scheme and PEP had
been generated by CCG staff rather than through consultation with the local population. Discussion
identified the importance of the authorisation process, rather than a vision and strategy for PPI.
The CCG had taken a portfolio approach in relation to some of its roles and functions; such portfolios
were held by GPs, for example diabetes and PPI. The GP lead for PPI had developed the draft proposals,
in conjunction with other GPs and a lay board member, again suggesting that CCG personnel were setting
the agenda at this point in time.
When discussing the proposed PEP, the CCG PPI lead stated that ‘. . . I’ve got a meeting about that this
afternoon, where we’re going to decide about the terms of reference and the attendance of that panel . . .’
Summary
Case study 2 had a long-standing tradition of PPEI initiatives, with a strong emphasis on partnership
working. As can be seen from the findings, there were a number of examples of service user voice
influencing service development and delivery. However, there was limited documentation in relation to
impact of such involvement. The development and expansion of PPGs was evident in general practice
during the research period. During the data collection period, the CCG had only formulated a PPEI draft
plan, rather than a strategy, with a GP lead in this area rather than a stand-alone appointment. Discussions
and documentation identified a number of potential PPEI vehicles within the new organisation such as a
membership scheme and PEP; however, it was unclear, during this period of time, how these structures
would function within the organisation or how the service user voice would feed into service development
and, overall, decision-making.
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Chapter 6 Research findings: case study 3
Background
Case study 3 was the last of the three case study sites to be recruited to the project (April 2011). CS3 was,
at the time of recruitment, in the process of a major restructure, which included divesting its community
provider services. For the past 2 years, the PCT, in addition to its role of commissioning health care for
its locality, has been working to support its emerging CCG, which received authority to function as a
commissioning organisation in April 2013. Hence much of the data collection for this site has taken place
in a climate of major organisational change with its resultant confusion and uncertainty over futures
and services.
Case study setting
Case study 3 was located within a large urban town situated in the south of England, close to the capital,
London. It is an ethnically diverse town with a large BME population (over 40%) and a higher than
average birth rate and population of young people, as well as a rising rate of people within the older
age group. Health, in general, was poorer for the population of CS3 than the average for the people in
England. Life expectancy and infant mortality was considerably lower than national rates (in the bottom
quartile) and, like CS1, there was a mixed picture of deprivation, with a large proportion of CS3’s
population living within the top 10% most deprived areas of England. CS3 currently commissions most of
its acute services from one local acute trust, mental health services from its local mental health trust and
community services from its recently divested community provider, now located within a neighbouring
NHS community trust. CS3 comprises 32 GP practices with below-national density of GP to patient
(around 2000 patients to each GP). There were, until recently, two PBC consortia in CS3 which merged
into one in July 2011 and were functioning as a shadow CCG for the majority of this research project.
CS3, as a whole, had a higher than national average prevalence of diabetes and a higher than national
average mortality rate for cardiovascular disease.
Processes and supporting structures for patient and
public involvement
Approaches and methods for patient and public involvement
During the time of data collection for this study, CS3 did not have a dedicated lead for PPI. Despite this,
CS3 had performed relatively well within the World Class Commissioning competencies for PPI in 2010,
having made some significant improvements for competencies 2 and 3 (working with community partners
and engaging with public and patients). However, it was not clear how CS3 had involved patients,
including those with LTCs, in developing choices of services, and the organisation was focused on
improving this this through a variety of PPEI initiatives and activities (Table 10).
From data collected during workshops and interviews, it was evident that there was strong agreement
about the value of including service users in the process of commissioning.
Participants at the first workshop spoke about service users bringing local knowledge and expertise at
community, service and clinical level and of the importance this had in ensuring effective commissioning
of services. A list of PPEI structures and activities were described by the participants (see Table 10).
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However, it was also acknowledged that PPEI was not always effectively managed within the system, and
that they (the health service) were ‘not very good at it’. Evidence of good PPEI was particularly lacking for
LTCs as well as within GP practice in this site. There was no one leading PPEI at the helm and no
organisational strategy in place for user engagement.
Tensions around the proposed changes in health services certainly played a part in some of the comments
expressed at this workshop. Commissioners spoke about the current uncertainty on funding services and
how this impacted on their communication with service users and providers; ‘information can’t be passed
on because the commissioners don’t know whether the funding will be there one day to the next’ was
one comment expressed by a commissioner at the workshop. Service users and representatives spoke
about the need to build trust and relationships with those planning and organising health services and
that they were unsure at the time of what commissioners had planned for them. GPs were also generally
concerned or unsure about their new responsibilities, including those around PPEI, arising from the recent
White Paper.
Despite this climate of ambiguity and chaos, there was evidence that service users were actively involved or
engaged at some level, either individually or collectively, in health care. These approaches and methods of
engagement and involvement are summarised in Table 11.
However, much of this was through informal or ad hoc approaches and, prior to the formation of the new
CCG, there was a distinct lack of a strategic approach for PPEI within the organisation. There was also a
lack of evidence of PPEI within all stages of the commissioning cycle, particularly within the planning and
evaluating stages.
Despite this lack of evidence, there was a strong sense of commitment for PPEI in general across the site
and a determination, among those participating, to make improvements. This was expressed in interviews,
workshops and observation of meetings throughout the timeframe of the study.
Some viewed the recent NHS changes including the ‘Pause’ as an opportunity to make new inroads for
PPEI. Motivating factors varied from personal interest or altruism (service users) to viewing it as a necessary
part of their job role (commissioners, providers). Involving patients and public was seen as important not
only for effective service provision and improving staff morale but also for avoiding service user criticism
(commissioners, providers). As one NHS commissioner put it, ‘people are more likely to be critical if not
involved’. However, financial incentives such as the DES for PPEI were also viewed as a prime motivating
TABLE 10 Patient and public engagement and involvement structures in CS3
PPI structures PPI activities
Service user-led PPEI structures LINks






Children’s joint commissioning: You’re Welcome programme, young carers’ network
Equality Deliver System




COPD, chronic obstructive pulmonary disease; LA, local authority.
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factor within primary care practice. As one practice manager said, ‘I’d say that the PPG DES has probably
had more of an influence and raised, you know, sort of, the profile of patient participation more than any
of the commissioning documents, . . . in my opinion’. This is further illustrated in that GP practice PPGs
grew from only four prior to the introduction of DES, to 26 (out of a total of 31 practices) at the end of
data collection in the study.
For NHS commissioners, the focus of PPEI was more about obtaining patient feedback using patient
surveys or for providing information through community consultation events as well as through links with
a number of local patient groups, such as Diabetes UK or the LINk. However, not everyone agreed that this
was the best approach, as it was recognised that some groups might be missed and more of a targeted
approach was needed. One of the common themes emerging from the data at this site throughout the
project was whether or not there was adequate representation for PPEI. Patients and the public had
TABLE 11 Methods of involvement in CS3
Method of involvement Used or led by Reason(s)
Complaints systems (PALS) Service user groups
Individual service users
Commissioners (NHS)
To complain about local services
To inform services
Lobbying MP Service users To change services
Patient/user surveys Commissioners (NHS)
Providers
To inform/improve service provision/strategies
Patient representative on
health committee (LIG)
Service user(s) To provide information on experience
Public representative on
health/public committee(s)





To gain insight into quality of services
One to one with patients Clinical providers To get feedback on personal experience
Patient participant groups Practice manager To inform development/improve service provision
Website Service users To gain knowledge on condition/local services
Responding to consultations LINks representative To provide patient/public perspective to those
organising services
Meetings with commissioners Patient group
representative
To provide information to commissioners to help improve





To provide patient perspective to providers of services
Attend local disease-related
support group
Service users/carers Knowledge/understanding of condition/gain support from
others/raise public awareness/fundraise
Targeting and meeting local
community groups
Commissioners/providers To reach hard to reach communities/specific disease related/to
help commission/provide/improve services
Education groups Providers To provide information and guidance on services and
self-management
Workshops on services Commissioners (NHS) To consult and plan/feedback on services
LIG, local implementation group; MP, Member of Parliament.
The above list provided from those involved in study and is not necessarily meant to be exhaustive of methods used in case
study site.
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representation at both local and strategic levels of commissioning. At the local specific service organisation
and delivery level, patient representatives normally came through organisations such as the LINks,
the local voluntary organisations or representation through a local charity (often condition specific). Here,
commissioners felt that they were not always reaching the right groups and some (often minority ethnic)
groups were perceived as not having their voice heard. There was a reliance on the ‘same old faces’
for patient and public representation, the ‘usual suspects’ who volunteer their services as patient or
public representatives. They were often from the ‘white middle-class male population’. Getting the
‘hard-to-reach, minority’ audience was seen as important for take up of services, particularly for redesigning
or reorganising clinical services. As one PCT commissioner commented, ‘It’s pointless having a service if only
half the population is actually accessing it because they don’t understand it’. But it was also important to
have the ‘right’ representative, not only for representing the group but also in having knowledge and
experience of the specific condition and service. Most of those commissioning and providing services felt
that involving genuine local patients or carers, those who have ‘walked the journey’, rather than patient
representatives from an organisation such as LINks or a local charity, was an important factor for
commissioning services. One NHS commissioner spoke about her recent tactic of going out into the
community to reach minority or so called local ‘hard-to-reach’ groups in order to ensure that she would
have a representative voice to commission local diabetes services. There was also some discussion within
the shadow CCG about developing some guidance to GP practices on ensuring adequate representation
within the newly formed practice PPGs. However, in such a diverse population it was recognised that it
would be difficult to get good representation and that people might be missed if only vulnerable groups
were targeted.
From a service user perspective, apart from engaging with the health authority through the local LINk or
a patient group, normally organised through a voluntary organisation with a ‘disease’ focus, there were
limited opportunities to engage in commissioning local health care. However, where these were observed,
they often involved, at some level, the local authority, either singularly or through joint commissioning
with health. This was demonstrated in a consultation on reablement services, where patient and public
stakeholders were invited to provide their ideas, thoughts and feedback on the development of pathways
from hospital discharge into reablement. The outcomes from these workshops fed back directly into
the pathways. One (joint) commissioner pointed out ‘we’re already implementing some of their patient
experience and feeding that into development of pathways now, so we are utilising their feedback directly
into how we’re trying to improve the quality of pathways.’ Children’s health services, jointly commissioned,
also demonstrated some level of engagement. Young people were involved in designing and testing an
asthma log for the asthma pathway and there were plans to do a similar exercise for the child epilepsy
pathway. Another group of young people were involved in assessing a range of health services for being
‘young-person friendly’ through the ‘You’re Welcome’ local authority programme. The ‘You’re Welcome’
programme helps PCT and children’s trusts commissioners to transform the health services (NHS and
non-NHS providers) they commission by improving the acceptability, accessibility, quality and choice of
services for young people. The local authority had recently developed its community engagement
programme to consult with its local community on key priorities which include health, but these were
generally around public health with a focus on individual lifestyle. Within the provider arena, process and
methods of engagement and involvement existed primarily through feeding back experience through PALS.
Involvement of service users with long-term conditions
Although there was some discussion at PCT level about forming a LTC patient user group, there were
limited opportunities within the organisation for services users with LTCs to be involved in commissioning
services for LTCs. At the strategic level, patient representation was through patient representative
(single) on an area-health-level LTC clinical working group. At a local service level, there was service user
involvement in service redesign through membership of a committee set up for this purpose or through
taking part in a focus group, workshop or consultation exercise organised by one of the providers or
commissioner. Other opportunities existed outside the organisation, through membership of a local charity
or community group.
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Within the three tracer conditions, there was limited evidence of local PPEI activity for commissioning,
even within diabetes, which was, at the time, undergoing a redesign. The diabetes service redesign
committee included a patient representative with diabetes type 2 as a member. As previously mentioned,
the commissioning lead for LTCs was keen to engage with real patients who receive local services and
to reach out to ‘hard-to-reach’ service users who represented poor uptake of services. She was reluctant to
adopt an ‘in-house’ workshop approach, often used by other commissioners, to help to inform decisions.
Because to get the numbers of people to come in for a, sort of, workshop, which is the old way that
we’ve been doing it, again, you don’t necessarily get the right people, but if you take it out where
there are large numbers of patients that meet socially and support groups, then you’re going to get
much more honest answers about what is going on and what you’re proposing and how they think
that would work.
CS3 PCT commissioner 2
She was also reluctant to consult with focus groups of ‘patient representatives’, often organised through
the LINk, who she felt were not representative of local patients.
. . . LINk is a bit of a worry for me because it’s not the real people.
CS3 PCT commissioner 2
Involvement of children and younger people
As described in other chapters of this report, access to children and young people with LTCs was a
challenge and only one young person with epilepsy was recruited for interview for this site. This person
appeared quite informed about her own condition and of local support services, including engagement
forums for young people such as Epilepsy Action. However, motivating factors for engagement were
limited to personal needs for information, rather than wanting to become involved in supporting or
helping others:
I think I’ve got past all of that. I mean, I know it’d probably be good to go on there and help other
people, but I don’t, I don’t go on there, I don’t feel like I need to ask questions on there.
CS3 young person 1
Interviews with commissioners also revealed the existence of a specific young person’s group organised
through the paediatric department of the local acute services trust. The provider trust’s paediatric clinical
lead reported that this group met regularly and provided feedback to the trust on the quality of services
provided for young people with a variety of LTCs. However, despite a number of meetings, telephone and
e-mail correspondence with clinical and management personnel over a number of months, we were
unable to access this group for our research.
Evidence of influence
There was some feeling, specifically among some service users and representatives, that the balance of
service user power in commissioning rested with the voices of the larger, national charities as well as those
representing the conditions the commissioners are prioritising, for example those conditions perceived as
preventable and with a high cost to the NHS, such as diabetes. One exception was RA, which appeared to
have quite effective local patient support groups and a (self-)perception of some influence and autonomy.
Although examples were provided of PPI, it was not clear if very much of this was meaningful. In effect,
many of those interviewed (commissioners, providers and PPI leads) suggested that service users did not
have much power, that there was some engagement but only up to a certain level and they were not
having much influence on ‘real’ health decisions, including changing services. This is further illustrated by a
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comment provided by the lay representative on the diabetes reconfiguration local implementation group
(LIG), suggesting that agendas were set by the organisation and professionals.
I really came into that too late to say very much, because the pattern of what they were wanting to do
was really set, and I don’t think there was really very much likelihood that a layperson could affect the
pattern that they had laid down . . .
CS3 service user 2
In the case of primary care, a key area for people with LTCs, some patients involved in practice groups felt
that they had very little clout, as the group often lacked a clinical presence to take forward any issues or
concerns. Some saw this to be more of a tick-box exercise with service users or representatives not taken
seriously and a ‘done to’ rather than ‘done with’ approach to service delivery.
This was despite some innovative approaches to involvement, such as one patient representative
organisation targeting commissioners to present a business case for service development for people
with MS. Linked to a lack of power was a feeling of inequity which was mentioned by many of the service
users and representatives within the case study site. One service user said that he found it difficult to
understand the medical jargon at health meetings (diabetes) and felt reluctant to speak up.
. . . I think that’s very difficult for me to say they do listen, yes . . . absolutely no idea why. You know, I
think because there’s so many other people could be listened to and my opinion sometimes might not
matter to them, you know?
CS3 service user 3
This is further illustrated in this following dialogue at the same interview.
. . . when they talk about medical things, you know, me as a patient as a non-medical person it’s
very difficult to sometimes understand . . . I mean, when they talk about long-term conditions and
long-term patients’ problems; as a patient, you know, the medical jargon, it’s sometimes very
difficult to understand. [Interviewer: And do you tell them this?] If I don’t understand, I don’t speak
there and then. I probably will ask somebody in a little corner. Yeah, I would. I sometimes do it.
[Interviewer: Have they changed anything as a result of you saying something . . .?] No, not really.
CS3 service user 3
However, there were some exceptions. A large and well-attended patient group organised through the
NRAS argued for the appointment of two physiotherapists for RA, which was set up by the provider
following a meeting with clinicians. The service user felt empowered by the strength of the group voice.
. . . it was something the rheumatology consultants and nurses were pushing for, but I think, when he
was, sort of, confronted by . . . 50 people, 60 people and we were all saying ‘well, you know, we
really could do with this’, I think it was just all firmed up.
CS3 service user 4
In addition, within children’s services, the implementation of the ‘You’re Welcome’ initiative allowed young
people some say in local health services for children and young people. One PCT commissioner did feel
that things were changing, that it had been lip service in the past but now it was more meaningful as
commissioners and others involved in planning services were becoming much more aware of how useful
educated and well informed service users could be.
. . . I think the Health Service was guilty of just giving lip service to them [service users] and saw them
more as irritants. I think when they are powerful is if they can lobby MPs and what have you.
CS3 commissioner, joint PCT/local authority
RESEARCH FINDINGS: CASE STUDY 3
NIHR Journals Library www.journalslibrary.nihr.ac.uk
54
Despite the level of commitment to PPEI, there were few examples provided of PPEI initiating or effecting
change in health-care services for LTCs in the site. In fact, when asking for recent evidence of where PPI
initiated change, it was very difficult to get local current case site examples, many providing examples of
previous roles or roles in other organisations, suggesting that this might be more of a case site specific
or historical phenomena. Where examples were given, they usually centred around using PPEI for
developing service specs or for providing feedback on services already in place. These included examples
of meaningful public engagement for reablement and some children’s services and, through patient-led
organisations, services relating to RA and Parkinson’s disease. There were very few examples of having
service user input at every stage of the commissioning cycle.
This did have consequences in some areas. For instance, one example was provided where service users
were involved in the specs for new musculoskeletal services in the community and patients were involved
in choosing the specs and recruitment of the service provider but not in the procurement of the premises.
The premises ended up being situated on a busy roundabout with limited access for those the services
were aimed at. Had service users been involved in the discussions on location and access, this might well
have been avoided.
Negative outcomes from PPEI were also observed. As part of the diabetes redesign, local health-care
commissioners and providers have been consulting with the BME community about how it could best
meet its needs. A number of meetings and focus groups (facilitated by the EVOC research team) had
been undertaken with diabetic service users from the Bangladeshi community within their local community
centre, situated in one of the high prevalence of diabetes wards. Representatives from this community
have indicated, through a series of focus groups, interviews and surveys, that they would welcome diabetic
services, including advice and guidance on self-management, within their community, rather than through
their GP or general NHS community health centre (see Appendix 6 for a full account of this example). PPEI
in commissioning diabetes services for this community was tracked as part of the project for a period of
18 months. The project (plan to set up an integrated community-based diabetic and other LTCs service
clinic for this specific BME group situated ideally within their own community centre) was subject to a
series of delays due, in part, to NHS staff capacity and organisational restructure, including the loss of
the lead commissioner in December 2012. The new commissioner is currently in the process of reviewing
the business plan and it is not clear if this development will be on the agenda as initially envisaged as
service specs had not been defined and funding had not yet been agreed. One of the community providers
is now thinking of providing a community ‘drop-in service’ in the future where health promoting advice
and guidance would be offered, rather than the provision of integrated health and social care services as
originally considered.
Frustrated by the slow pace and delays/turnaround by the local NHS in developing the service, the director
of the BME community centre is now pursuing alternative funding (BIG Lottery) to help develop the
community centre as a diabetes advice and information centre.
Some of the feedback from the expert reference panel indicated that the failure was probably down to
poor PPEI planning and practice. Much of the PPEI was around needs assessment. As members of the
expert reference panel commented:
. . . This in itself is not ‘engaging’. Patients and communities will only see themselves as being
‘engaged’ if needs assessment is followed by continuing communication and further tangible action
such as involvement in planning and/or redesigning services. Neither appears to have been carried out
effectively here.
Policy officer for PPE national patient organisation
DOI: 10.3310/hsdr02440 HEALTH SERVICES AND DELIVERY RESEARCH 2014 VOL. 2 NO. 44
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Peckham et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
55
I have some criticisms of the process of PPE and some doubts about how they could know whether
the intervention will be successful or not. . . . The PPE is very basic and seems to me to be flawed
in at least 2 ways. It appears ad hoc and lacking in clear structure, without any clear sense of
representation at any of the decision points.
Representative from diabetes patient organisation
The expert panel also made specific reference to the way in which health agencies need to work with
BME communities.
With minority communities where information and communication may present significant barriers to
the success of such patient involvement (literacy in English, health literacy, culturally appropriate
information and information support, etc.) these interventions need to be located within the right
context of appropriately designed services and consultation. In my view this would be much more
likely within a genuine partnership between the statutory services and the community ‘hubs’
(community centre and mosque, for example), and probably requiring the training of a cohort of
Bengali health trainers or assistants who would then be capable of providing support to people’s self
care and self management. It would be much less likely with the ‘drop in’ health promotion service
that is now inferred.
Policy officer for PPE national patient organisation
This experience of having needs surveyed and then engagement which results in no action is not untypical
of the experience of minority communities with the NHS. Alternative models of involvement such as
experiential or coproduction might have proved more successful in this instance.
Other negative aspects of involvement, again in diabetes services, have resulted from the experience of the
service representative on the LIG, who felt ineffective as a result of being invited to the meeting at a late
stage, ‘once things had already been decided’, and did not feel able to contribute much due to the
technical nature of the meeting:
But at this moment, I am seriously wondering whether I can actually make much of a contribution
to what they’re going to be discussing. As I see it, and I haven’t seen any agenda yet for 2012,
they’re likely to be quite technical issues, medical issues which, really, I don’t have any impact.
CS3 service user 2
Attributing specific service-level outcomes to user input is always a challenge, as service users are only part
of the commissioning jigsaw. Much of the evidence provided within this study site was of the process and
actions of involvement rather than what impact this had on patient experience or service design. However,
there was one example provided of where positive outcomes (for both provider and user) were directly
attributed to service user input. A GP practice used feedback from people with LTCs (the PPG advised on
GP rota systems) to change booking appointment systems, which led to a true cost saving for the practice
and reduction in the did-not-attend rates for people with LTCs.
The impact of changing processes
As stated earlier, while there was a stated commitment or will for PPEI within the organisation, there was a
fragmented approach to its operation, little supportive infrastructure with no real strategy in place and no
one championing or leading it within the PCT (as stated earlier, the PPEI lead had left the organisation a
number of years earlier and was not replaced, and PPEI was thereafter taken up by the communications
team). In addition, despite a local authority with evidence of innovative community engagement activities,
evidence of a strong collective public voice for local health services was not apparent.
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This project commenced shortly after the new health reforms were announced and captured some of the
initial tensions and anxieties of a major change and restructure. It was acknowledged that GPs did not
have a history of good PPEI in the area, and there were issues of communication and trust between service
users, commissioners and providers. Uncertainty around budgets and resources, including staff capacity,
added to the unease. All of those interviewed within the NHS said that PPI was resource intensive and
that there was a lack of resources for this within the new commissioning arrangements. There was the
suggestion that by having PPEI you inevitably put up costs as patient suggestions often involve added costs
and PPI does ‘slow things down’. As the health service was engaged in making cost/efficiency savings,
with increasingly scarce resources, this presented its own challenge. The recent restructure placed an extra
strain on this agenda, specifically within the children’s services, who had recently lost their key member of
staff for PPEI, a health participation manager who acted as the local authority’s link with the NHS for
young people. Yet there was realisation that good engagement would lead to a cost saving in the long
run, particularly from the providers who viewed patient involvement as ‘becoming more aware of own
condition and taking more responsible for one’s own health, as well as family and friends’, thereby
reducing the NHS disease burden.
However, some saw this as a real opportunity to change things: to create an organisational strategy for
more effective and meaningful PPEI, and to create a CCG where PPEI is firmly embedded at every level of
CCG decision-making.
The new CCG structure, in theory, provides increased opportunities for patients and the public to be
engaged and involved in commissioning local health services, at both the strategic and the grass roots
level. Figure 5 shows a draft structure of PPEI governance within the CCG as described by the current
communications and engagement lead and local authority community engagement lead (note: a steering
group was established to develop new governance arrangements and was due to report in the summer of
2013 after the end of the research).
A new accountability officer has been appointed with a record of leading pioneering and award-winning
PPEI within a neighbouring urban multicultural PCT. The new mechanism for PPEI describes a partnership
approach between the local authority (the stronger partner for PPEI) and the health service within the
newly formed HWBB.
The CCG board currently comprises three lay representatives (only two were in place at the time of data
collection), with one leading on PPEI. Input from service users of primary care is direct to the board
through the PRG (one of six subcommittees of the board) where each GP practice is represented by up to
two service user representatives. Communication and Engagement is being contracted by the CCG. There
is also user representation through the HWBB, which has Healthwatch representation, and direct links
with the local forum’s community involvement strategy (the forum is a joint working forum of community
stakeholders including the PCT, local authority, fire and police services as well as academic and local
businesses) and neighbourhood governance programme (a CCG member sits on the local area boards) as
well through the equality and diversity strategy. There were also talks about having a Children and Young
People’s network feeding into the CCG board. At the time of writing the new Healthwatch had yet to be
officially launched, and the community and engagement strategy, submitted in draft form as part of the
CCG authorisation process, was still in discussion.
As the data collection for the study completed at the same time the new CCG was established, it was not
possible to follow up on how PPEI governance arrangements are working and how users are actively
influencing commissioning decisions. Perhaps the key distinction of this approach to PPEI is having primary
care strategically placed in the governance system through the PRG. This group is chaired by the lay
board member and membership comprises representatives of up to two members of local practice groups
(practice participation groups) as well as members from the communications and engagement team.
This did raise some questions about how representative this might be. One communication team member
observed that the meeting comprised mostly white men over 60 years. Further research revealed that these
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early meetings (only three had taken place during the data collection part of the study) included
representation from only nine of the 31 primary care practices, despite at least 26 having established
practice participation groups through the DES initiative. Plans were afoot to enlarge this group to include
other patient and public representatives, such as local patient and voluntary organisations.
Access
Some restrictions to being a lay representative in the new structures were observed in CS3. At the primary
care level, service users spoke about difficulties in accessing information from their GP, particularly about how
to become more involved outside their own health and care. Some were not aware that their local GP either
had or was recruiting for a practice participation group. Clarity and standardisation about what these groups
were and how they would be used was lacking from a number of practices. From a brief desktop scoping of
GP practice websites in CS3 (Figure 6), following the introduction of the DES payment for PPEI, only 17
out of the current active GP websites provided information about their PPGs and there was often varying
information about the aims and objectives as well as how to become involved. Many were indicating that
these were for providing feedback for the surgery for specific areas of practice. Some were asking for a virtual
group only, and only a few were indicating that these groups fed into the CCG’s strategy. Only a small
number published minutes of meetings and terms of references. However, some, probably four or five,
were implementing more meaningful/strategic PPI where patients had input into decision-making about
local health services. It was interesting to note that one of these four had a GP on the CCG board. Incentives
often drive practice and perhaps the reason for the variation in PPG practice was that much of this was not
required as a condition for payment for year 1. The DES has been extended for another year with more clear
outputs for quality which might have the effect of driving up standards as well as access.
Summary
Case study 3 did not have a marked history of PPEI within the PCT; nevertheless, they employed a variety
of different methods to involve and engage with their community. There was, however, little evidence of
much meaningful engagement particularly within primary care, an area of increasing significance for
people with LTCs. Some efforts were made to ensure that services were planned to meet the needs of
particular sections of the community but failed due, in part, to poor PPEI planning and execution. As a
consequence of the health reforms, the CCG is better placed to ensure that PPEI is firmly embedded in all
areas of commissioning decisions in the future and new staff and structures are planned to enable this to
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FIGURE 6 General practitioner practice patients groups in CS3.
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Chapter 7 Clinical Commissioning Groups and
patient and public engagement and involvement
Introduction
As discussed earlier in this report, this project was undertaken at a time of substantial change in the
English NHS following the election of the coalition government in 2010. Despite an initial promise that
there would be ‘no more top-down reorganisations of the National Health Service’,136 one of the first
actions of the coalition government was to propose a substantial reorganisation of the English NHS – so
large it is ‘visible from space’.137 In July 2010, the coalition government published a White Paper, Equity
and Excellence: Liberating the NHS,7 which had significant implications for arrangements within the NHS
for PPEI as well as for this research project. Box 2 sets out the main proposals contained in the White
Paper, Equity and Excellence.7
These changes represented a significant redistribution of responsibilities within the English NHS and,
ultimately, for the structures and processes developed for PPEI. For GPs, membership of what came to be
called CCG is compulsory via their practices, with some kind of quality payment available for those who
fulfil their commissioning responsibilities successfully. While initially the policy was deliberately permissive,
with, for example, the size and composition of CCGs not centrally specified, over time many aspects of
the development process became increasingly proscribed, leading to a formal authorisation process in
2012–13. In a letter to GPs in September 2010, Sir David Nicholson stated that:
We would want to enable new organisations, and particularly [CCGs], to have the maximum possible
choice of how they operate and who works for them. It is important that GP practices be given time
and space to develop their plans to form commissioning consortia. PCTs should provide support for
this process and empower consortia to take on new responsibilities quickly when they are ready to do
so, but it is important that solutions develop from the bottom up and are not imposed from above.
p. 5138
BOX 2 Main proposals
l PCTs to be abolished, with responsibility for commissioning (purchasing) services handed over to groups
of GPs.
l The abolition of regional SHAs.
l The creation of a new ‘arm’s length’ body to oversee the NHS called the NHS Commissioning
Board (NHSCB).
l The transfer of responsibility for public health to local authorities and the creation of a new national body,
Public Health England.
l The establishment of local authority-based Health and Wellbeing Boards, responsible for the development
of strategic assessment of local health and well-being needs.
l Changes to the role of Monitor (previously the body responsible for regulating foundation trusts) and its
establishment as an ‘economic regulator’.
l All NHS trusts to become foundation trusts.
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In October 2010, groups of GPs wishing to move ahead with setting up their local CCG were invited to
come forward to join a ‘Pathfinder programme’. The objective of this was to allow aspiring CCGs to begin
to work out the best way to organise themselves, facilitated by their local SHAs. The process gained
momentum quickly, and by June 2011, more than 90% of England was covered by a Pathfinder CCG. In
the summer of 2012, a formal authorisation process commenced in four waves to establish fully-fledged
CCGs from April 2013. The data presented in this chapter draw on an analysis of a sample of CCG
authorisation submissions and the findings from case study and survey research undertaken by the
Department of Health PRUComm.22
Background and context
Equity and Excellence set out the rationale behind the proposed changes, arguing that the closer
involvement of GPs in the commissioning of care would ensure more effective dialogue between primary
and secondary care; decision-making ‘closer to the patient’; and increased efficiency.7 It was argued
explicitly that ‘we will learn from the past’ (p. 28),7 claiming to have built upon lessons learned from
previous clinically-led commissioning initiatives including GP Fundholding and Total Purchasing Pilots
from the 1990s.47,139 As discussed in Chapters 1 and 2, the reforms were set out in the Health and Social
Care Bill which became the 2012 Act following a controversial passage through Parliament with a
substantial number of amendments.48 With the Health and Social Care Act 201220 passed by Parliament,
additional guidance was published by the Department of Health (and subsequently by the shadow NHS
Commissioning Board) (see Chapter 2). A timetable was set out for CCGs to apply for full ‘authorisation’
as statutory bodies from July 2012, with the first CCGs taking full responsibility for commissioning from
April 2013. The authorisation process was based on a number of key principles:
l A process ‘fit for purpose’ – sufficiently robust to enable a thorough and cost-effective assessment of
the CCG’s capacity and capability to carry out its functions.
l A process viewed by both the NHS Commissioning Board and CCGs as developmental and as
adding value and helping improve quality and overall patient experience and outcomes.
l Setting the tone for the future positive relationship between CCGs and the NHS
commissioning board.
l Minimising administrative demands for both emerging CCGs and the review team(s), and delivering
a process which is both rigorous and efficient.
l Evidence required should be a by-product of core business, as far as is possible.
l Recognising that this is a unique process – as ‘start-up’ bodies, CCGs will be building a track record of
performance; therefore, authorisation will focus on confidence in their potential to deliver,
drawing on their participation in, for example, improving LTC care, clinical care in general and other
aspects of QIPP, but will also draw on their track record to date as subcommittees of PCTs to whom
certain commissioning responsibilities have been delegated.
l A nationally consistent approach – so that all emerging CCGs can have confidence that the same
standards are being applied.
Authorisation was undertaken in four waves. The aim of the process was to enable the NHS
commissioning board (NHS England) to determine the level of commissioning responsibility and agree with
each emerging CCG the nature of the development support needed, or conditions to be placed upon the
CCG, in becoming established.
Two hundred and eleven CCGs worked towards becoming authorised by the National Commissioning
Body, NHS England, by the end of March 2013. From April 2013, they have been responsible for contracts
with providers of health care in their communities amounting to around £65B per annum. The first wave
of 34 CCGs were authorised in December 2012, having submitted evidence of their competence against
119 authorisation criteria across six domains.140 These required competence to be evidenced in clinical
focus, engagement, clear and credible plans, proper constitutional and governance arrangements,
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collaborative arrangements, and leadership (Figure 7). Domain 2 was headed ‘Meaningful engagement
with patients, carers and their communities’.
The challenge for CCGs is illustrated by the speed of the change in the expectations of government of
primary care health services to involve the public and patients in their decisions. In April 2011, a Patient
Participation DES scheme was introduced which provided GP practices with financial incentives ‘to ensure
that patients are involved in decisions about the range and quality of services provided’ by setting up and
supporting PPGs.141 There was no compulsion to participate. By contrast, domain 2 of the authorisation
process requires the CCG to ensure that ‘Arrangements are in place to ensure appropriate ongoing patient
Domain Description
Together, CCG leaders must be able to lead health commissioning for their population and drive
transformational change to deliver improved outcomes. These leaders need to demonstrate their
commitment to, and understanding of, partnership working in line with such senior public roles,
as well as the necessary skill set to take an oversight of public services. They need individual
clinical leaders who can drive change and a culture which distributes leadership throughout the
organisation. The accountable officer needs to be capable of steering such a significant
organisation and the chief finance officer must be both fully qualified and have sufficient
experience. All those on the governing body will need to have the right skills
Great leaders who
individually and collectively
can make a real difference
Collaborative
arrangements for
commissioning with other 
CCGs, local authorities
and the NHS Commissioning 
Board as well as the 
appropriate external 
commissioning support
CCGs need robust arrangements for working with other CCGs in order to commission key services
across wider geographies and play their part in major service reconfiguration. They also need
strong shared leadership with local authorities to develop joint health and well-being strategies,
and strong arrangements for joint commissioning with local authorities to commission services
where integration of health and social care is vital and the ability to secure expert public health
advice when this is needed. They also need to have credible commissioning support arrangements
in place to ensure robust commissioning and economies of scale. They need to be able to support
the NHS Commissioning Board in its role of commissioner of primary care and work with the
board as a partner to integrate commissioning where appropriate
Proper constitutional and 
governance capacity and 
capability to deliver all their 
duties and responses 
including financial control,
as well as effectively 
commission the services for 
which they are responsible
CCGs need the capacity and capability to carry out their corporate and commissioning responses. 
This means they must be properly constituted with all the right governance financial control
and probity, as well as driving quality, encouraging innovation and managing risk. They must
be committed to and capable of delivering on important agendas included the NHS Constitution
such as equality and diversity, safeguarding and choice. They must have appropriate
arrangements for day-to-day business, for example communications. They must also have all the
processes in place to commission effectively each and every one of those services for which they
are responsible, from the early health needs assessment through service design, planning and
reconfiguration to procurement, contract monitoring and quality control 
Clear and credible plans which
continue to deliver the QIPP 
challenge within financial
resources, in line with national
requirements (including
excellent outcomes), and local
joint health and well-being
strategies
CCGs should have a credible plan for how they will continue to deliver the local QIPP challenge
for their health system, and meet the NHS Constitution requirements. These plans will set out
how the CCG will take responsibility for service transformation that will improve outcomes,
quality and productivity, while reducing unwarranted variation and tackling inequalities, within
their financial allocation. They need a track record of delivery and progress against these plans,
within whole system working, and contracts in place to ensure future delivery. CCGs will need to
demonstrate how they will exercise important functions, such as the need to promote research
Meaningful engagement
with patients, carers and
their communities 
CCGs need to be able to show how they will ensure inclusion of patients, carers, public, 
communities of interest and geography, health and well-being boards and local authorities.
They should include mechanisms for gaining a broad range of views then analysing and acting
on these. It should be evident how the views of individual patients are translated and acted on.
CCGs need to promote shared decision-making with patients about their care
A strong clinical and
multiprofessional focus which
brings real added value 
A great CCG will have a clinical focus perspective threaded through everything it does, resulting
in having quality at its heart and a real focus on outcomes. It will have significant engagement
from its constituent practices as well as widespread involvement of all other clinical colleagues;
clinicians providing health services locally including secondary care, community and mental
health, those providing services to people with learning disabilities, public health experts, as well
as social care colleagues. It will communicate a clear vision of the improvements it is seeking to
make in the health of the locality, including population health
FIGURE 7 Clinical Commissioning Group authorisation: the six domains.
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and public involvement in CCG decision making’. While the requirement for CCGs is at a different level,
the shift from voluntary engagement/involvement to mandatory engagement/involvement demonstrates a
shift in policy focus. PPEI has become a clear requirement rather than an option.
In the first phase of research leading up to authorisation, the research demonstrated that PPE was not a
key priority for most CCGs. However, PPE did figure as an issue for discussion among CCGs although not
always with any priority:
I presented the proposed plan to the CCG in September which they noted, and I would stress the
word noted.
Manager, London CCG
However, there was a clear recognition that PPE was important and that it needed to be developed to
ensure real engagement. For example, in one CCG there had been discussion about strategy development,
with the board member lead arguing that:
What we have is we have a 1-year strategy, which is a strategy from now until next March, for the
CCG which is going to the next CCG board, um, this month, um, so it kind of sets the groundwork.
But my thoughts, what I want to do is over the next 6 months is as we go out and engage with
people on a range of CCG issues, strategy, and vision, and values, that actually we gather
information from that as well to prepare a three year engagement strategy ready for April 2013,
which is informed by the people that we’re engaging with. Because otherwise, you know, it’s a bit . . .
it would be ironic to produce an engagement strategy that we didn’t engage people in the
development of. It’s kind of not very good practice I think.
GP board member, south-west England CCG
In May 2012, a second survey of 211 (reduced from 253 following mergers) CCGs was undertaken.
The PRUComm survey asked CCGs about the membership of the main decision-making committee.
Figure 8 shows the type of membership by profession or background. When the survey was undertaken
(May 2012) there had been little guidance on membership. At that time, three broad groups of lay
members were identified: members of the public, LINk members and councillors.
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FIGURE 8 Clinical Commissioning Group governing body membership. GB, governing body.
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All of the case study sites in the PRUComm research expressed a commitment to genuine involvement of
patients and the public in their work. Many included such a commitment in their statement of their ‘vision’
or ‘mission’, and were keen to demonstrate a new approach:
No, absolutely. I mean, the other thing, probably, just the stress, because, it’s been a bit of a journey
for us, you know, us thinking that if we really want patients, at the heart of what we do, then, people
leading on, how do we reach out to the communities, the individuals, both, through the practices,
through any, you know, having that patient and public engagement, we felt that, in the PCT, it was,
almost, over here, as a, kind of, tick box part of the organisation, whereas, us, trying to bring that into
mainstream and whatever piece of work we do, putting it through the lens of, well, from your
perspective, how do we reach the customers we need to, has been really important.
Ex-PCT manager, central England
Engaging with patients and the public was seen as a ‘good’ in and of itself, but many respondents also
gave clear explanations of the value added by true public engagement. This manager had spent some time
considering the issue, and explained it thus:
Well, I think there’s four reasons you do public engagement, and that’s what I worked out in this
study. One is, you need to know whether things are happening, right. Secondly, you’ve got to be
aware of public needs, public feelings for the commissioning process that you decide what you’re
going to do. . . . Then you’ve got to . . . you’ve then got to, to some extent, have a two-way liaison
because you . . . sometimes if you’re trying to pursue policies that need people to change their
behaviour, you’ve got to take people with you . . . And the fourth one I think is long term caring,
long-term conditions. You’ve got to involve people much more in that, you know, supporting people
who have long-term conditions. So that’s four reasons, that’s it.
Manager, north-east England CCG
However, this suggests engaging through communication but not necessarily engaging in discussions
about decisions or involvement in decision-making. The importance placed on developing PPE is reflected
in one CCG’s approach to embed PPE in its founding principles (these draft principles were intended to
guide the shadow CCG through the delegation process and help it on the path to authorisation, in
advance of a communications and engagement strategy being developed):
1. Partnership approach to decision-making. The principle is for the CCG Communications and PPG to
have two-way communications. The CCG acknowledges that it is a membership organisation in which
practices are the members – not just board but also practices and population. Use this (membership
structure) as a core mechanism. The CCG will work with constituent practices to utilise the knowledge
and experiences of local stakeholders to assess needs, review existing service provision, decide priorities,
design services and develop its annual plan. Where this approach does not give a fully representative
view, additional mechanisms will be used to support disengaged communities.
2. Cross-boundary working – not only about diversity of population but also about common needs.
The CCG recognises that people living in different localities may often have different needs and require
different approaches. However, wherever possible, the CCG will adopt a cross-boundary approach to its
business while recognising the specific needs of localities.
3. Integrated engagement – between health and social care. The CCG recognises that working closely
with local stakeholders can add value to its work, but that fragmented engagement can result in
duplication. The CCG’s over-riding approach will be one of integrated engagement working through,
and within, existing structures.
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Concerns about PPE were also linked to questions about accountability and all CCGs in the PRUComm case
studies had spent time discussing the meaning, dimensions and importance of this.22 As one GP reflected:
I think what we haven’t done yet and what we’re trying to organise now in this locality is go one step
further and recognise that we are after all accountable to the public, we’re there to serve them, we
are paid by them, we’re there to provide their health needs. So actually it only makes sense to actually
be in discussion and contact with them and this has been a long sought after chalice to have, you get
public engagement made meaningful in the Health Service and no-one’s ever done it successfully in
my view.
GP, central England CCG
Similarly, in a CCG in the north-west the board were keen to embed PPE within the accountability
framework of the CCG:
We need to let the public know that their voice is valued. As time goes on the patient voice and
experience will be put more prominently into contracts with providers – quality measures. Also could
be linked to CQINS [Commissioning for Quality and Innovation]. This should be seen as ground
breaking and very positive.
GP
In the PRUComm research, CCGs identified a wide range of different approaches and initiatives to engage
with both patients and the public, some planned and some already established, with many sites planning
to use more than one approach. These included:
l Local patient forums – either generic or for specific patient groups.
l Patient participation groups at individual practice level. Many case study CCGs were looking at ways to
bring these groups together to provide wider intelligence about local services.
l Community involvement groups – bringing together representatives from carers’ organisations,
voluntary sector groups and patients. In some areas, these types of groups were constituted as a
subgroup of the CCG.
l Steering group – one CCG had set up a ‘steering group’ which brought together PCT Cluster
representatives with LINks members, carers’ representatives, voluntary groups, local clinical networks
etc. This group met periodically and offered advice and comment to the CCG governing body.
l Clinical reference groups – these are usually set up jointly with local acute trusts, and generally focus
upon particular service areas such as diabetes, etc.
l Stakeholder group – this is a group of local patients and the public who are asked to comment on
proposed major service changes.
l Public events – for example, one of our case study sites was planning a series of ‘road shows’ in
supermarket car parks which would offer health checks as well as providing information about the
development of the CCG.
l Citizens panel – this is a group of interested individuals specifically convened to discuss in depth a
proposed service development.
l Patient experience network – this is a network which focuses upon the collation of patient experiences
of different types of health care, including both primary and secondary care.
l Newsletter – at least one site was planning a public-facing newsletter.
l CCG board open public meeting – after authorisation, all CCGs will be required to hold some of their
governing body meetings in public. Many are starting to do this already, reasoning that it would be
good practice to begin to get used to this. Some were holding alternate monthly meetings in public,
using the other internal meetings to work on organisational development.
Many of these approaches were already in place as part of the local PCT’s work or the PBC group which
was in existence before. However, many CCGs reported that they were keen to develop more effective
public/patient engagement than had been achieved by PCTs in the past, but at the time of the PRUComm
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research (2011–12, i.e. pre authorisation), there were not any active initiatives that were significantly
different from those which had gone before. The issues identified in the PRUComm study reflect the
findings of the case study research undertaken within the EVOC study (see Chapters 4–6).
The authorisation process
Leading up to authorisation, CCGs adopted both structured and piecemeal approaches to PPE. The most
structured involve incorporating engagement into governance structures. For example, some CCGs have
established a patient committee reporting directly to the board. A more usual approach has been to
establish a PRG for the CCG, often drawn from the membership of PPGs within individual practices.
Sometimes this is very structured, including examples where every practice in the CCG has a PPG and has
a representative on the CCG PRG, such as identified in CS3 of the EVOC study (see Chapter 6). It is usual
for this to report to a board committee, often the Quality Committee, and for this to be reflected in the
terms of reference of the Quality Committee.
Another structured approach identified in authorisation plans was to provide an engagement and
involvement strategy together with evidence that it is being rigorously implemented. Some of these were
first class. One case was over 100 pages and demonstrated detailed understanding of the needs of its
patients, clear and substantial action plans to achieve engagement and demonstrable progress and
achievements against the plan. One of the strongest structures was a CCG for whom improving services
for those patients with LTCs was one of three strategic objectives. Their governance structure included
a Communications and Engagement Committee which sat alongside the Quality and Performance
Committee and reported directly to the board. There was also a Patient and Public Advisory Group and a
Practice Manager Forum, which informed the work of the Communications and Engagement Committee.
However, not all CCGs demonstrated such a structured approach. Part of the authorisation process
included a requirement to submit brief summaries of case study examples to illustrate their work. Many
CCGs used their response as an opportunity to demonstrate examples of engaging patients and the public.
In many cases, that supplemented an engagement strategy which was more a statement of intent than a
report of achievements to date. They included examples of proactive involvement in the redesign of
services as well as consultation about proposed service changes. This was reflected in the 10 case study
examples the NHS Commissioning Board supplied from the work of the first wave of CCGs when they
announced their authorisation. For example, NHS Warrington CCG described their transformation of the
service for LTC patients with lung conditions who are now looked after in the community wherever
possible and have a central contact point where they can request support without visiting hospital.
The chief clinical officer of the CCG is quoted as confirming the commitment to PPEI.
We’re keen to build on this success in other areas in the future and are working closely with partners
and engaging with the public to make sure health services are joined up and meet people’s needs.
p. 8142
However, there was also evidence in the PRUComm study of PPEI being managed in order to present the
right information for the authorisation process:
[A GP] said that she didn’t think the public were very concerned about the way that they run the
CCG – but that they should go public – it is good practice and we are ready. She felt that they should
do it sooner rather than later. She said that the press do not usually come, they use public minutes
and then phone up and ask questions. There was various discussion about this – someone said that
it will look good for authorisation.
Field notes from observation of CCG board, emphasis in original
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It might be expected that strategies for engagement would draw on acknowledged best practice to inform
them. For example, the authorisation criteria required CCGs to demonstrate how it would achieve shared
decision-making between health professional and patients and translate those views into commissioning
decisions. Applications as part of their strategies could have drawn on the evidence of what works,
including research from The King’s Fund.143 None of the applications for authorisation reviewed for this
study did so. Similarly, there was no reference to the leading research into the quality of the engagement
work in primary care, including notable practice.86
The impact of involvement
In their authorisation documents, some CCGs quoted case study examples of commissioning decisions that
have been influenced by individual patients and by public consultation.
These included the redesign of services for people with LTCs. Initiatives to deliver care across sectors and
disciplines in an integrated way featured largely in these examples. Fewer demonstrated how patient
feedback systematically informs their work and helped them achieve improved patient experience. A
minority did not provide any evidence but reported having a strategy for the future. In one case, the
minutes of a meeting held in July 2012 as part of an application submitted in October 2012 included the
statement ‘the detail around exactly how the CCG was going to engage with its communities was still
being worked on’. This reflects the findings of the PRUComm research, although some CCGs were more
engaged in thinking about both PPE and how this would be delivered post authorisation:
There’s two GPs leading for that, and myself as like the PCT cluster lead. Um, what we’ve done is
we‘ve set up a steering group made up of people within the PCT cluster and people from outside,
LINks and some of our voluntary sector organisations. Um, and we’re going to get some patients and
members of our public networks on there to help steer us through. So we have a work plan from the
authorisation, and we’re working through that to make sure that we’re delivering that. So we have
other people that are involved in that to help us and steer us.
GP, south-west CCG
The case study examples included in the NHS Commissioning Board’s announcement of the first wave of
authorised CCGs included examples relating to commissioning decisions including North Staffordshire
where the redesign took account of both the clinical perception and user experience to shape a new and
improved service – this is surely what clinical commissioning is all about.144
While there are many similar examples, not one of the 16 submissions assessed for this study was explicit
about the impact of the involvement of patients, i.e. how the outcome was different from what it would
have been if the involvement had not occurred. For example, in one case a CCG submitted a schedule
which described, in tabular form, the issue, who was involved, what feedback was forthcoming, what
decision was made and how the engagement influenced the decision. The content of the table, however,
comprised issues for which, in the main, evidence already exists about the views of patients. These
included issues relating to diabetes services where patients were asked about their views about self-care
programmes and what they would want included, when there is already no shortage of knowledge about
what diabetes patients want to support their self-management of their condition. It was, therefore, not
surprising that it was unclear how different decisions were taken as a result of the engagement.
There was a similar lack of compelling evidence that patient experience is informing other types of
decisions. For example, the role of the Quality Committee as part of the governance structure of a CCG
and its use of patient experience and feedback to establish indications of a failing service was often
contained in the CCGs Constitution, but it was rare to find examples of that working in practice. To some
extent, the lack of evidence of engagement in decision-making in practice was a reflection of the early
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stage of development of a CCG. It was not unusual for a Quality Committee to have been formed only
shortly before the CCG applied for authorisation.
Achieving impact is dependent in large part on the CCG leadership making it a priority in practice.
Again, the evidence is very varied. At one extreme were the organisations that had a long track record of
leadership championing engagement at practice level. For example, CCGs in Lincolnshire are building on
the excellent foundations of GP leadership in NHS Lincolnshire. This is illustrated by the handbook they
published in March 2011 ‘setting out 10 principles for GPs leading programmes of commissioning change
by working with their local population’.145 At the other extreme are those who seemed not to grasp the
distinction between communication, engagement and involvement. In one example, the chairperson of a
CCG referred in the foreword to their integrated plan to their commitment to keeping the public informed
about the decisions made by the CCG and made no reference to active involvement in the work of the
CCG. Similar differences were found in our three case study sites (see Chapters 4–6).
Proposals for voices to be heard after authorisation
It is pertinent to recognise that engagement has been regarded as an important but not urgent part of the
work of CCGs to date. The result is that delivering on engagement plans in the future is more significant
for the cause of engagement than the work to date.
It has been fundamental to the authorisation process to ensure that £65B of public money is safe in the
hands of the authorised CCGs. Governance, leadership, clinical competence and patient safety are
fundamental to this. The view that engagement, at least in the short term, is not a prerequisite is reflected
in the Draft Applicants Guide issued by the NHS Commissioning Board and the results of the first wave of
authorisation. The applicants guide states that the thresholds for authorisation reflect ‘coherence with
ongoing assurance and thresholds for early intervention in relation to failure. The criteria in relation to risk
on quality, safety and financial management and related governance, planning and capacity and capability
therefore have relatively high thresholds’.146 Note that engagement is not included in that list. This is also
suggested by the results of the first two waves of authorisations.
Of the 34 CCGs who were authorised, eight had no conditions attached to the approval. Twenty-six were
given ‘minor’ conditions because they did not meet fully the thresholds of one or more of the 119 criteria
in the six domains. A total of 96 conditions were listed, of which just eight related to domain 2. Only
six CCGs had conditions relating to domain 2. Fifteen of the 67 CCGs authorised in the second wave
were given conditions relating to domain 2, 11 of the 62 CCGs authorised in wave three and 13 of the
38 authorised in wave four. In all waves, the main areas of conditions were in respect of domain 3 and 4,
which address finance, governance and effective commissioning.
The process from the outset has emphasised that authorisation is the first stage of a process leading to
first-class commissioning groups. The Draft Applicants’ Guide includes a section for each domain on
‘potential beyond authorisation’. For domain 2, it includes a series of inspiring objectives including ‘CCGs
will recognise that communication and engagement drives transparency, accountability and ultimately
better services and outcomes . . . CCGs enable patients to make choices and shared decisions about their
care and treatment. They have clear plans to extend the potential for patients to exercise choice about
their care and treatment’ (p. 15).146
What is not yet clear, and what is crucial for delivering this vision, is how NHS England will ensure that
authorisation is the first part of a long-term process. A mechanism is needed for CCGs to be held to
account for the delivery of the engagement strategy they supplied as part of their application for
authorisation. A commitment is needed from NHS England to a methodology for giving assurance about
delivery post authorisation. Active dialogue with CCGs about progress in implementing strategies and
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plans is a practical step that would help to ensure an appropriate focus remains on engagement activity.
Other sectors demonstrate that service user engagement takes time to embed and can flourish.
One further key component for ensuring that intentions become reality will be that the work is adequately
resourced. Many CCGs believe that the management allowance is not adequate. There is a danger that
management and support services in practice become focused on issues which have short-term impact on
quality and safety as opposed to the longer-term development of engagement. Many CCGs are resourcing
at least some of management of their engagement work from CSUs, organisations which are being
established to provide management services to groups of CCGs. The challenge about securing appropriate
support specifically for engagement in these arrangements was illustrated by one application for
authorisation which stated that they were ‘insisting that a Communication and Engagement Manager is
based within the Clinical Commissioning Group for the majority of the time’.
Conclusion
Some CCGs have already delivered excellent examples of engagement which have impacted on decisions
about commissioning. Others can point to future plans. More can quote some case study examples
which demonstrate some good work but which fall short of a strategy being systematically implemented.
Some have put in place governance structures which facilitate engagement. Many of those are only now
being put into practice.
It is widely acknowledged that effective PPE is difficult to achieve. The findings from our case study sites,
the PRUComm research and our analysis of authorisation submissions suggest that CCGs are wrestling
with many of the issues that research into PPE have identified in the past. Firstly, while there is widespread
recognition that individual patient voices are important, it is also important that those appointed to forums
or engagement groups see themselves as representing the wider community as well as feeding in their
own experiences. Where wider engagement activities are attempted, it remains difficult to access those
whose voices are not usually heard. Some CCGs have tried to tackle this by engaging with existing patient
and voluntary groups. However, this can also be difficult, as there are a myriad of such groups, many of
which have diverging agendas. Secondly, in some sites we found some concern as to which different
aspects of the CCG’s work could most usefully seek engagement. While many remained committed to
engaging the public in all aspects of the CCGs work, others argued that commissioning and the strategic
aspects of service change were actually not of interest to the public.
Key to ensuring that voices are heard and acted upon will be the success of CCGs in delivering their plans
for engagement that they have all submitted as part of the authorisation process. Delivery will be partly
dependent on there being leadership from the CCG and also from service users in engagement so that the
work is championed, prioritised and resourced. There must be decision-making structures within the CCG
which enable patients and the public to engage, influence and, in the future, scrutinise. The NHS
commissioning board can also facilitate delivery through their future work. The potential beyond
authorisation that the commissioning board itself has articulated can become reality.
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Commissioners are required to procure care that promotes the health and well-being of individuals. Since
2007, consultation of local populations has been seen as key to this process,10 and this is particularly
important in LTCs where service users have extensive experience of local services and specific issues of
living with their condition. The EVOC study was focused on investigating PPEI in commissioning for LTCs.
However, the study was conducted during a time of unparalleled change for the NHS, and while this led
to challenges in conducting research in organisations undergoing the turmoil of transformation, it also
provided a unique opportunity to investigate how the policy imperative for PPI evolved within the
transitional structures. The need to adapt our protocol to the new structures enabled us to specifically
focus on how, in terms of PPEI, transition processes were managed, how the new patterns and structures
for PPEI varied from pre-organisation change and what evidence there was of the new structures being
embedded within the infrastructure. In order to illuminate this within the discussion, we draw on
normalisation process theory as an explanatory framework. During the transition processes we also sought
evidence on whether the patient and public voice was, or could potentially be, more easily heard and
responded to. To explore this further, we map our findings against the theoretical frameworks developed
by Gibson et al. and Barnes.105–109
Involvement or engagement?
When the project commenced in 2009, policy documents and local operational plans used the term
‘involvement’ to indicate that patients and the public should be part of the decision-making processes
in commissioning, service planning and care provision.2,7 However, Equity and Excellence7 highlighted
engagement as a key route for clinical commissioners to take. This change in language characterises the
move in emphasis from PPI at all levels of care from individual to strategic planning, to the bounding of
involvement just at care level as exemplified by the third edition of the LTC compendium.147
Our data, which were also supported by previous research,148,149 suggested that PPI was understood in
different ways by the main stakeholders. For commissioners, PPI was identified as being integral to a
rational approach to decision-making and a potentially useful tool for difficult decisions framed by the
need to ration resources. While providers identified PPI as being part of ‘fine-tuning’ services, they also
recognised that there was the potential for PPI to act as leverage on commissioners. Reflecting the variety
of roles they had at the time (e.g. LINks member, service user group member), service users and
representatives defined PPI in a number of different ways. These ranged from involvement in care to the
strategic long-term planning of services for a population. While variation in understanding PPI was
expected, the introduction of the term ‘engagement’ further compounded tensions in the different
understandings between stakeholders.150 Our data indicated that engagement and involvement were being
used as interchangeable terms, but were represented by markedly different levels of patient and public
participation. Engagement was limited to information giving (e.g. public engagement events) and
obtaining feedback on services (e.g. through a survey or public consultation meeting). Engagement was
not described in terms of active involvement in decision-making.
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Mapping the boundaries between engagement and involvement from our data, and supported by
definitions from National Voices151,152 and the Department of Health,79 involvement was the active response
to a combination of patient and public experience of living with the LTC and health and social care
services, and engagement which we define as a commitment to respond or interact (Figure 9). The
implications for CCGs and other organisations with a PPEI mandate is significant, for if patients and the
public are engaged but have no meaningful mechanism for involvement, this will inevitably lead to
frustration and a disengaged public. Our findings suggested that this particularly occurred with service user
groups who felt that their voice was not heard and that they were not being involved in decision-making.
For example, a service user group of people with RA in CS2 were clearly engaged with the health system
but, because they lacked any active involvement in decision-making processes, used complaints to the
press and MP as the first course of action in getting their voice heard. Equally, in CS3, engagement of a
service user group of people with diabetes and a BME background led to a breakdown in relationship
when this was not followed by involvement.
Although we have marked out the boundaries between engagement and involvement, guidance for CCGs
on engagement (e.g. InHealth Associates Engagement for commissioning success Smart Guides87) quite
clearly use the term to indicate the nature of the relationship between commissioner, service user and the
public.150 As discussed in Chapter 7, CCGs were required to state within the authorisation process how
they would ensure meaningful engagement with patients, carers and their communities. The PRUComm
survey, CCG authorisation review and the EVOC case studies suggests a continuum of strategies from
operationalising PPEI at a purely information-giving and feedback level, to participatory involvement of a
broad range of public and patients at all levels of commissioning. However, our findings also suggest that
engagement and involvement is not a linear process; rather, it is a circular process which is fragile and can
be broken – if involvement becomes tokenistic or ends then the service user becomes disengaged, and as
a prerequisite involvement cannot occur without engagement. During the transition period between PCT
and CCG, there was evidence that this cycle was often broken, sometimes as a deliberate cutting of ties




FIGURE 9 Engagement and involvement.
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Patient and public engagement and involvement: the transition
from primary care trust to Clinical Commissioning Group
Responses to plans for PPEI within the transition period can be characterised by anxiety from PCT
commissioners and service user representatives about loss of relationships and GPs’ lack of experience in
PPEI, counterbalanced by some respondents (particularly CCG shadow board members and local
authorities) seeing it as an opportunity for a more strategic approach and starting anew. However, our
findings indicate that PPEI processes and impact were being affected in the case studies by varying degrees
of organisational amnesia.153 As described in CS2 (see Chapter 5), an initiative underpinned by PPEI to
transfer diabetes care from the acute to primary care sector was seen by PCT commissioners as likely to
flounder during the transition phase. This was confirmed by service user representatives who felt that the
focus on this initiative had been lost and communication from commissioners had ceased, a situation
echoed in CS3 with the planned reconfiguration of diabetes services for the BME population.
In all our case studies, there was evidence that the speed of implementing the reforms153 and the sharp
focus on the CCG authorisation process resulted in a number of projects with PPEI being lost from the
radar. This was further compounded by the accompanying downsizing and loss of PCT staff who had
been leading these projects. In all case studies, our original PCT commissioners had moved onto other
organisations, indicative of the career-jumping that is suggested as one of the characteristics of a reformed
public sector organisation.154 Those staff who were still in post were working in great uncertainty about
their future position, and were negotiating continually changing short-term roles.154 In two of the three
case studies, there was outsourcing of Communication and Engagement, with only one of our case studies
retaining this in-house. This use of outside agencies may contribute to organisational amnesia by removing
PPEI from the central radar. Observation of meetings indicated that major decisions were being made
within a very short time frame (often as quickly as 24 hours), and supporting documentation was solely
electronic. This ‘time compression’ and change in mode of record-keeping154 inevitably made PPEI in the
decision-making process more challenging. There was evidence that there was insufficient time for lay
members of the shadow CCG boards to keep abreast and informed of changes, and, therefore,
meaningful involvement was lost.
However, the move to the CCG structure was seen as an opportunity to be innovative and move away
from the former PPEI models. The relative freedom allowed by Equity and Excellence7 to determine local
CCG structures resulted in a variety of structures, again indicative of recent reforms of public sector
organisations.154 While the PRUComm survey and EVOC case studies indicated the varied positioning of
PPEI in these structures, our case studies also suggested that there was an ongoing tension between
representatives of the previous PPEI structures and of the new.153 The innovators saw the previous model
of LINks as failing to be a conduit to harder-to-reach groups, and for perpetuating a very narrow
representation. In CS1, this tension was openly acknowledged and addressed and there was evidence of a
concerted effort to maintain a balance between change and continuity.155 However, in all case studies,
continuity in terms of service user representation appeared to be outweighing change. Although more
recently housed in different structures such as PRGs, the majority of our service user respondents remained
unchanged during the EVOC project. At the start of the project, many had been LINks or service user
group members, and all were committed to maintaining their local PPEI role. In many ways, they became
the organisational memory and were able to refer back to PPEI initiatives that had been successful in the
past. However, it was more of a challenge for them to have this memory acknowledged and listened
to during the frenetic period of reorganisation. The resourced project lead in CS1 enabled some
organisational memory to be retained through the development of an extensive database of service user
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groups and public involvement representatives. Nevertheless, this project lead was an outsider on a fixed
contract and there was some evidence towards the end of the data collection period that the achievability
of the PPEI strategy was being questioned. Within the other two case studies, the development of the
PPEI strategy was part of a shadow CCG board member’s workload, with an inevitable lack of focus
demonstrated by the comparatively late production of the PPEI strategy. It was also significant that both
leads were relatively inexperienced in PPEI, and much of this work was done alongside outsourced PPEI
resources (CS2) and complementary projects such as the Equality and Diversity Strategy (CS3). Having a
key project running in tandem both informed and shaped the PPEI strategy, and affected the way PPEI was
understood in this case study.153 The transition phase resulted in significant rehousing, with communication
and engagement teams and PALS being outsourced or moved to provider trusts or CSUs. Containing
PPEI within the overarching Communication and Engagement strategy made it vulnerable to being
overshadowed by the CCG’s organisational priorities around communication with staff and provider
services. Only one of the EVOC case studies had retained Communications and Engagement within the
CCG (CS1). There are questions of sustainability for the other case study sites – external organisations and
CSUs may be transitory.
Organisational memory is also stored through the norms and values of the organisational culture. In each
of our case studies, the data suggested that PPEI could be mapped onto an intersecting continuum
(Figure 10). The findings suggested a continuum of motivation for lay people to become involved ranging
from an individualistic perspective to collective.156 Our respondents included service users whose
involvement had been triggered by a personal health agenda, but more commonly were motivated
to undertake PPEI from a volunteerism perspective. Narratives from commissioners and providers also
indicated that organisations were undertaking PPEI because it underpinned the organisational ethos,
and (rather than a simple alternative view) because it was a statutory requirement or externally
incentivised. During the transition period, there was evidence of some shift, albeit relatively subtle, on the
continuum. This shift was influenced by the new structures, relationships within these structures and
changes in key stakeholders in each case study. Interestingly, we could find evidence in only one of the
case studies (CS1) of a shift towards an embedded ethos of PPEI. In the other two case studies, the sheer
pressure of change was evoking PPEI strategies and responses more attuned to the top-down requirement
of the reorganisation (see Figure 10).
Implementation of PPEI

























FIGURE 10 Continuum of PPEI.
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Changing patterns and structures of patient and public
engagement and involvement
When data collection commenced, there were different histories and leaders of PPEI in each case study
site. While all case study sites contained a local authority with strong pedigrees of PPEI activity, the PCTs
varied considerably in terms of PPEI history. Furthermore, even in the case studies with significant PPEI
activity, this tended to be fragmented with no overall joined-up strategy. Before the reorganisation, PPEI
had been housed within the PCT, service user groups, PALS, local authorities and LINks, and tended to be
focused within condition-specific pathway work, with an emphasis on service user feedback to proposed
developments. Tritter157 categorises gathering feedback from service user groups as indirect collective
involvement. Our findings also indicated that there were attempts, particularly by voluntary groups,
towards direct, collective and proactive involvement. We found examples in each case study site where
Diabetes UK, MS Society, Parkinson’s UK and the NRAS had actively influenced decision-making. In many
ways, having a pathway-focused structure was an enabling feature for these organisations to have
influence, and the shift away from this pattern resulted in a loss of relationships and concern over the
move towards a more generic landscape.
The CCG PPEI structures in the EVOC case studies (see Chapters 4–6) and the reflections from the
CCG authorisation review (see Chapter 7) indicated a significant movement towards integrated PPEI
between the CCG and social care. During the transition process, it was evident from our data that
clinical commissioners and local authorities were working more closely together to engage with
their local populations, not least because of the move of Public Health from the NHS to local authorities.
Models for involvement from the local authorities expanded the horizon of PPEI in the eyes of the clinical
commissioners. Our discussions with local authority informants suggested a real enthusiasm for this closer
joined-up working on PPEI. However, there was a significant difference between each case study site in
the relationship between local community involvement structures and the CCG board. In CS3, community
involvement was enacted through the Neighbourhood Governance Programme (see Figure 5) and reflected
the local authority’s rich tradition of engaging with a very diverse population. However, in the other two
case studies, community involvement appeared defined by the remit of the local Healthwatch and HWBBs
[see Figure 2 (CS1) and Figure 4 (CS2)] and evidence of community engagement programmes within these
two case study sites often had a public health focus.
While the closer linkage with local authorities and local populations significantly changed the landscape
of PPEI in each case study site, conversely the pull towards local authorities was mirrored by less linkage
with provider service PPEI groups. With the exception of the community diabetes service in CS2, we
experienced increasing difficulty in engaging provider services with the EVOC project, and found access to
any established provider service user group difficult. For example, in CS3 commissioners had alerted us
to an active young person user group at the local provider hospital, but despite research governance
approval we were prevented from making contact by the gatekeeper.
Although there appeared to be continued levels of silo working in PPEI, particularly between CCGs and
provider services, many of our service user respondents were acting as a bridge. It was unusual for a
service user or representative to be a member of just one committee or group. In reality, many of our
respondents were concurrent members of different PPEI forums including provider service user groups,
CCG-affiliated structures such as PRGs, and their local GP PPG. While the observation of different meetings
with varying health professionals and managers but the same service user representative may suggest a
range of arenas where the public voice can be heard,105 but a limited range of service user perspective, it
also suggests that these service users were acting as boundary spanners between the different constituent
parts of the whole structure. What is perhaps more important is whether or not they were enabled to
perform in this role, and particularly whether or not they were seen as credible and hence listened to in
this role (we will discuss this further in the following section).
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As mentioned above, many of our service user respondents were members of existing or developing
PPGs based at general practices. There was a marked difference between case study sites on where PPGs
sat in the overall PPEI structure and how important they were seen to be within the PPEI strategy. This
positioning alongside the relationship with local community involvement can be demonstrated in a matrix
illustrating the key differences in the emerging structures of PPEI during the transition period (Figure 11).
The mapping of the case studies onto this matrix contrasts with the direction of travel, as illustrated in
Figure 11. While the data on CS1 indicate that there was a subtle shift towards an embedded ethos of
PPEI, this may not be sustained in view of the more marked separation between the CCG board and the
voice of the ground roots patient and community. Equally, in CS3, which showed a direction of PPEI travel
directed by a top-down requirement, it will be interesting to explore whether or not the flatter, networked
structure creates a reversal of direction. As the positioning of PPGs within the new structures appears
emblematic of this paradox, they will be explored more in-depth.
Patient participation groups
General practitioner patient groups are not a new initiative. Historically, PPGs have existed in the UK since
1972, and have grown in number through support from a national member association [the National
Association for Patient Participation (NAPP)] and a joint campaign by NAPP, RCGP, the British Medical
Association (BMA) and NHS Alliance to establish PPGs in around 40% of all English GP practices in 2009,
and estimates of around 75% in 2012. However, research revealed that these groups exhibited a number
of concerns, including equity of access, unrepresentative membership, diversity of purpose, variation and
difficulties around assessing cost and benefit.158 A recent review86 found most of these groups
demonstrated little influence on practice management or service development, functioning primarily as a
provider of feedback on services with a subservient role within the practice. Nevertheless, within Equity
and Excellence,7 PPGs were seen as a potentially important tool for ensuring the patient voice was heard
within the proposed structures.159
To incentivise GP practices, a 2-year Patient Participation DES was implemented in 2011.141,160 There was
evidence from all our case studies that this had had a significant impact on developing these groups,
and was seen by some as the most important PPEI initiative at that time. Information on PPGs in each
case study is presented in Chapters 4–6. However, there are some interesting comparisons and points
to be made. Firstly, as with the confusions of terminology between PPE and PPI highlighted earlier,
GP practice-based PPGs also went through a blurring of titles. The DES required qualifying practices to
establish a ‘Patient Reference Group (PRG). This may be a formal Patient Participation Group (PPG) or a
similar group that is representative of the practice population . . .’ (p. 4).160 However, we found no
standard terminology in our case study sites, with around a half-and-half split in CS1 and CS3 of PPGs










FIGURE 11 Matrix of emerging structures of PPEI.
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versus PRGs, and in CS2 nearly all were termed PPGs. This confusion is further compounded as many
CCGs have a main PRG directly reporting or linking with the CCG and distinct from GP practice PRGs
(for clarity, we will continue to use PPG to denote GP practice PRG or PPG).
When we compared GP websites in each case study site, only 27% of CS1 websites had any mention of
an active PPG, in contrast to 58% in CS3 and 93% in CS2. This marked difference is reflected in each case
study site’s PPEI structure. In CS2, PPGs reported directly to the clinical executive team; in CS3, PPGs fed
into the CCG PRG committee which then reported to the CCG board. However, in CS1 where there was
the least evidence of active PPGs, these were remote from the CCG board and any viewpoint would need
to navigate the practice manager’s forum and then the clinical leads before reaching the CCG board.
Furthermore, CS1 had a much larger percentage of virtual rather than actual groups. While it was too early
to explore fully the consequences of these differences, our findings from the qualitative data and analysis
of documents such as PPG terms of reference do suggest a tentative typology that would merit further
exploration. The differences between PPGs could, to a certain extent, be differentiated in terms of who led
the group, and whether it was virtual or face to face (Figure 12).
There is evidence to suggest some implications from each quadrant. In quadrant 1, there may be a
selected customer feedback output, but it is questionable how representative this is, and how meaningful
this form of PPEI is. Quadrant 2 will ensure that the agenda is set by the GP practice, but this may not
include those issues most relevant for patients. Quadrant 3 may enable personal narratives (e.g. the Patient
Experience Blog project in CS1), but there is also the risk that these narratives will end up in a void. Finally,
quadrant 4 allows the agenda to be set by local patients, but may be at risk of focusing on personalised
single agendas.
As a number of respondents in case studies 2 and 3 quite clearly felt that PPGs were a key tool in ensuring
that the ‘grass roots’ voice was heard, and being a mechanism to engaging GPs with the reforms, their
operationalisation and route to the CCG board is important. Equally, PPGs’ ability to be an effective voice
for patient’s views and experiences is also important, as they are seen as a key source of information for
the Care Quality Commission to draw upon when regulating GP practices.161
While PPGs’ impact and future is uncertain, the DES payment was, quite clearly, a major incentive in the
establishment of PPGs. The financial incentives associated with PPGs were, however, not replicated within
the overall PPEI structure.




Virtual Face to face
FIGURE 12 Typology of PPGs in CCG structures.
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Resources for patient and public engagement and involvement
Although it was generally agreed that PPEI was resource intensive and had cost implications, resource
implications, interestingly, were rarely highlighted as a major barrier to PPEI during the interviews. However,
using resources on PPEI in the current financial climate was also highlighted by respondents to indicate their
level of commitment to PPEI. At our final stakeholder workshop, participants raised concerns that CCG
resources were unlikely to be adequate for PPEI and were currently targeted at communication rather than
at engagement and involvement. In acknowledging the potential for the CCG agenda to be dominated by
budgetary issues, many attendees suggested that PPEI work needed to show its impact on highlighting
potential cost savings. This fitted with our data from service user representatives, particularly those from
the condition-specific voluntary groups, who acknowledged the need to present potential cost savings
alongside PPEI initiatives and suggested development of new services. This balanced approach was linked
to being seen as rational and credible, a key criteria for shadow CCGs selection of lay representatives.
Power and control
Inevitably, PPEI brings with it questions of power and control. Earlier in this report, we mapped out the
policy direction in PPEI which aimed to change the relationship between service users, the public and
the NHS.157 Equity and Excellence7 sought to further challenge this relationship, and the EVOC study has
been in a position to watch any unfolding of a different dynamic during the transition process.
Specifications for lay representation: who did Clinical Commissioning
Groups want?
As the reforms began to be implemented, the emerging CCGs were reminded that they were not working
with a clean PPEI sheet and were encouraged to work on developing established relationships.78,162
The PRUComm survey also suggested that PPEI initiatives in the pre-authorisation CCGs tended to be a
continuation of work commenced by the PCT, and this was also reflected in some of the EVOC case
studies. However, there was also evidence that the shadow CCGs in our case studies had an agenda to
‘refresh’ PPEI and move away from a reliance on LINks members as the PPEI representatives. There was a
general concern that these members were of a particular background (white, middle class and retired), and
were not representative of those sections of the public the CCGs were most keen to have a conversation
with: the ‘harder-to-reach’ or seldom-heard groups. Prior to and during the transition process, our case
studies had tried to address this by outsourcing PPEI to a social enterprise organisation which worked with
these groups (CS2), by the appointment as CCG lay member of a chief executive officer running a local
charity working with vulnerable groups (CS1), and through commissioners going out into the community
to reach these seldom-heard groups in their own settings (CS3).
While there was some evidence of successful engagement within public health initiatives led jointly with
local authorities, if we take children and younger people as an example of a harder-to-reach group then
there was little evidence of successful engagement during the data collection period. Although we
contacted national voluntary organisations and local groups in each case study site, very few young people
were identified for interview. Despite following up potential contacts from organisations, in many instances
telephone calls and e-mails were not returned. In CS1, a meeting with community nurses for young people
with diabetes and juvenile arthritis resulted in only one interview, despite the enthusiastic efforts of the
nurses to make personal contact with and recruit each eligible young person. In contrast, direct contact via
LINks with a key member of a national advocacy group for children with diabetes resulted in several
interviews with parents and young people in CS1. However, despite a parent in CS2, who ran a young
person and family group for young people with arthritis, acting as an intermediary, we failed to recruit any
young people through that route. In CS2, we had mixed success via local support groups and in CS3 we
interviewed only one young person recruited via a diabetes nurse specialist.
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A lack of engagement with young people was evident in the interviews with parents and young people.
Parents said that there was little in the way of support groups for young people, and those parents who
had been involved in trying to set up groups come across many obstacles particularly in gaining access to
the young people themselves. This seemed to mirror the difficulties that we encountered with recruiting
and gate-keeping. Young people who used support forums tended to use them to look up information
rather than for contact with similar others sharing their condition.
As well as the difficulties in accessing young people, it was evident from those who were interviewed that
many did not want to talk about their condition. For some, this was because they found it intrusive or did
not want to be identified by their condition. Some young people declined an interview and their
interviewed parents reported that this was due to ‘overload’. For example, one young person had recently
taken part in clinical trials, been involved in the CS1 schools protocol launch and had given a diabetes
presentation at his school. Hence, once a young person had become engaged, there was a process of
disengagement because of involvement overload. This is in contrast to Figure 10 and suggests that a
different model of engagement and involvement is required for young people.
While there was a desire for ‘new faces and fresh blood’ and engagement with harder-to-reach groups,
there was also an acknowledgement that long-established relationships should not simply be cut.
Although local LINks members were not seen as being an effective conduit to the harder-to-reach groups,
they were acknowledged as having a long history of involvement in the local health service and as
understanding how the system worked. Hence a balancing act was evident during the transition phase
between developing new PPEI strategies and retaining and valuing established PPEI relationships. One
mechanism employed for this balancing was to limit157 the LINks PPEI representatives to certain areas and
use selective access criteria for the new PPEI roles.
Barnes et al.107 describe the discursive practices of an organisation that helps define who is seen as a
‘legitimate public’. Legitimacy appeared to be normatively defined by commissioners in terms of what
experience the lay person bought with them, and how they should behave (Figure 13). This definition was
framed by an understanding of PPEI as a facet of consumerism, a binary division between ‘usual suspects’
and ‘hard-to-reach groups’, and an assumption that the public could be neatly packaged into
distinct groups.108
Particular skills the CCG
could use, for example
governance, able to link
with harder-to-reach
groups







FIGURE 13 Clinical Commissioning Groups’ ideal PPEI representative.
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While commissioners in our case study sites were able to articulate the ‘ideal’ PPEI representative, it was
clear that the members of the public, service users and their representatives identified their capacity
to represent in similar terms, through their personal experience (e.g. living with a LTC), personal
characteristics (e.g. able to function effectively within a committee), and through merit of their links via
informal networks. Legitimacy, therefore, seemed to rely more on who the shadow CCG felt that they
could work with, and the more formalised approach to recruitment ensured that this was focused on.
Patient and public engagement and involvement: who was leading the agenda?
As PCT commissioners faced increasing uncertainty in terms of their future and current service
developments, there was evidence in our case studies of decreasing PPEI and the creation of a void. Service
user groups felt the impact of this void; conversations with commissioners ceased and the service user
voice hit a vacuum. The early transition phase was characterised by service user representatives desperately
searching for the new agenda leaders in the embryonic organisations. Voluntary organisations that were
used to playing an active role in decision-making with commissioners (e.g. Diabetes UK) were suddenly
outside any communication loop and had little knowledge of how service initiatives were developing.
Voluntary groups played a major role in each of our case studies prior to the reorganisation and some
were particularly effective in lobbying. Our case studies had examples of where the MS Society and
NRAS had influenced local service commissioning. However, these groups were also in competition with
each other108 and were very aware that diabetes was commissioners’ key priority. Furthermore, where
smaller groups representing people with long-term neurological conditions had strategically merged,
there was evidence that they were actively keeping out other long-term neurological condition
organisations representing larger populations to ensure that their own voice was not drowned out.
The PRUComm research also suggested that commissioners were grappling with such groups having
a very condition-specific focus rather than being the voice of the wider community. Nevertheless, these
groups and their alliances are likely to continue trying to influence commissioners’ agendas through
increasingly sophisticated ways. For example, the Neuronavigator was a web-based tool developed by
Neurological Commissioning Support and promised to be a user-friendly tool designed to help to deliver
QIPP for neurology. This is an example of service user representatives responding to the broad NHS agenda
(QIPP), and trying to ensure representation at the local NHS table by offering a clear ‘added value’ that
was of immediate use to local commissioners. The tension between having to respond to an agenda
set by someone else and then shaping it any way possible to serve the needs of the service users
represented was often evident within all three case studies.
Nevertheless, at shadow CCG board level there was little evidence of the service user voice influencing the
agenda. While this probably reflected the frenetic focus on the authorisation process, it is interesting that
PPEI representatives in both the EVOC research and another external evaluation163 were periphery to
decisions being made during authorisation. It was too early to tell whether or not this reflected earlier
findings from some of our case studies, where PPEI representatives were invited only once key decisions
had been made. Our shadow CCG board lay representatives suggested that they were listened to by the
CCG, but were less certain about the amount of influence they would have on the agenda, reflecting
Sullivan and Skelcher’s89 suggestion that lay representatives may be marginalised and have less influence
than senior organisational members on a board. The EVOC summative workshop was attended by CCG
board members outside the EVOC case study sites; there was a minority who reported a sense of
marginalisation, which was exemplified by their being the only board members without voting rights.
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Mapping the case studies against the ‘ideal’
In addition to highlighting tensions in the rules and norms of public participation, specifically access,
agenda and deliberation, the work of Barnes et al.106–109 also reveals the importance of emotional and
figurative deliberation based on experiential knowledge. Enabling forms of exchange designed to offer
recognition of the patient and public experience is seen as an essential feature of deliberation alongside
purposive-rational discussion. This not only enables commissioners to understand the service user
perspective but also demonstrates ‘deliberation with care’.106 This embrace of emotional and expressive
narratives is characterised by four moral principles of care: attentiveness to others, responsibility for action,
competence in deliberative care and responsiveness to the service user and carer perspective.110 These
moral principles underpin one of the evaluative questions posed by Gibson et al.105 as new PPEI structures
are developed. These questions interrogate the notions of legitimacy through asking whether or not the
new structures relate to the public solely in purposive-rational terms or whether or not they also fully
attend to the emotional and expressive narratives. As can be seen from Figure 13, while ‘real’ patients
were sought, their expected behaviour was bounded by rationality and a business-like confidence in
meetings. Gibson et al. go on to ask four further questions of proposed structures:
l Does the new system allow a plurality of public arenas where the service user voice can be heard?
l Which areas of decision-making will be open to influence by PPI and which will not?
l Which proposed solutions will be acceptable and unacceptable to the various stakeholders?
l Is the host organisation prepared to change to accommodate some of these solutions?
While we can map the case studies to these questions to a certain extent (Table 12), our data collection
ceased at the time of CCG authorisation and hence it was too early to judge the impact and responses to
PPEI-initiated solutions.
In addition, while Gibson’s framework provides a set of idealistic evaluative criteria, it needs to be framed
in terms of resource and other constraints. Therefore, if PPEI-initiated solutions would be impossible to
operationalise, then they are unlikely to be acceptable to the CCG. However, the EVOC evidence suggests
TABLE 12 Map of case studies to Barnes and Gibson et al.’s continuum of legitimacy
Structures relate to public in
purposive-rational terms
CS1 had developed a Patient Experience Blog to
capture patient narratives illustrating, albeit in virtual
form, some attentiveness to service user perspectives.
However, the response to these narratives was
questioned, and a clear line of responsibility for action
was unclear. None of the case studies engaged
directly with patients with an explicit intention of
listening to their narratives
Structures also relate to public
in terms of expressive-
narrative terms
Few arenas where public
voice is heard
CS1 and CS3 had developed a number of arenas for
the public voice to be heard. In CS2, it was less clear
how the arena was being multiplied other than a
process of outsourcing
Plurality of public arenas
Decision-making not
influenced by PPEI
There was minimal evidence of PPEI influencing
decision-making during data collection in the
transitional phase to CCG
Decision-making influenced
by PPEI
Solutions suggested by PPEI
unacceptable to CCG
There was minimal evidence of PPEI initiated solutions
during the transition phase to CCG
Solutions suggested by PPEI
acceptable to CCG
CCG not prepared to change
to accommodate proposed
solutions
Too early to judge whether or not the established
CCG in each of the EVOC case study sites would
be prepared to change in response to PPEI-initiated
solutions
CCG prepared to change to
accommodate some of
these solutions
DOI: 10.3310/hsdr02440 HEALTH SERVICES AND DELIVERY RESEARCH 2014 VOL. 2 NO. 44
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Peckham et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
81
that the majority of service user representatives were cognisant of these constraints and were willing to
work within them. What appeared clearer within our data is that the new structures were enabling a
plurality of arenas in at least two of our case studies, but that it was not clear how the expressive-narrative
service user voice was being captured and listened to by the shadow CCGs.
In addition to it being too early to evaluate our case studies on all of Gibson et al.’s criteria,105 the
complexity of the new structures may be further compounded as new processes become embedded.
In particular, the housing of PPEI across the local authority–health service interface will inevitably lead to
some tensions in terms of existing institutional frameworks, professional, political and organisational
norms.108 Hence the journey has only just begun and these new relationships need to be navigated.
The future of patient and public engagement and involvement: what work
needs to be done to embed it?
While incentives clearly trigger increased operationalisation of PPEI such as in research164 and general
practice,141,160 this does not necessarily lead to a scenario where PPEI is normalised. As data collection
completed, structures for PPEI had yet to embed within the new infrastructure; however, some case studies
provided more evidence of work around this embedding than others. Normalisation process theory134,135
provides a useful explanatory framework to explore the differences further, and to usefully tease out the
work needed to be done in order to make PPEI an integral part of a CCGs work. The theory was originally
developed to assist in explaining why complex interventions often failed to be incorporated into routine
practice134,135 and was developed from secondary analyses of qualitative data from a broad range of studies
investigating complex interventions. Normalisation process theory focuses on how legitimate space is
created for the work of the intervention to become a routine part of the landscape.165 It is increasingly
being used as a retrospective explanatory framework whereby thematic findings from qualitative data can
be mapped against the key constructs,166,167 and has recently been used as a theoretical underpinning for
PPI in research.168
Patient and public engagement and involvement: issues of sustainability
Normalisation process theory suggests that, in order to sustain PPEI as normal practice, four areas of work
must be achieved. First, PPEI in the new structures must be understood individually and collectively as
something different from that previously known (coherence). Second, there needs to be an individual and
shared understanding of what PPEI requires of each stakeholder, and that it is seen as potentially valuable
by all (cognitive participation). Third, the actual tasks and resources required to sustain PPEI (collective
action), and, finally, individual and communal appraisal of PPEI and adjustments to structures and
processes if assessed as necessary (reflexive monitoring).135
Coherence and cognitive participation
The respondents in our case studies could clearly identify the potential value of PPEI for their work;
however, this was not without caveats around potential barriers. It was also clear that commissioners and
service users and the public offered slightly different interpretations of the role requirement.149 At the time
of data collection, we did not find any clear role specification for the PPEI representatives, and participants
at the summative workshop identified this as an essential tool for sustainability.
As already discussed, there was a palpable tension between continuity and bringing in new approaches
and PPEI representatives. Our service user respondents remained largely unchanged and, equally, their
narratives on PPEI demonstrated little shift. However, the new cadre of commissioners did speak of PPEI in
different terms, particularly in describing PPEI at the strategic level. For future sustainability, the individual
and communal specification of what PPEI is will need closer alignment.
Embedding PPEI also requires a key individual to drive it forward and that stakeholders continue to support
it. We found clear evidence in one of the EVOC case studies that having an external project lead had led
to the working up of a more developed strategy. Conversely, relying on an external source for this
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leadership may have future consequences in terms of continued support. It was too early to explore the
consequences of having an internal or external PPEI project lead on continued buy-in.
Collective action
Perhaps the most obvious area of PPEI sustainability within the normalisation process theory framework is
the performance and appropriate allocation of tasks required by PPEI, the relationships between
stakeholders and the organisational support for PPEI. The reliance on just a few service user or lay
representatives could lead to overwork and disillusion,169 with participants at the summative workshop
highlighting the need for co-option and time-limited appointments. However, this was balanced with the
need for time to develop relationships and trust, a key component for successful PPEI. There was evidence
that PPEI representatives for the CCG board were being selected because this relationship had already
been developed; potential candidates already known to CCG board members were being actively
approached as they had been ‘good to work with’ in the past.
Perhaps the largest gap identified in the sustainability of PPEI was the lack of training for these new roles,
for both the lay representative and the professional. In two of our case study sites, CCG board members did
have access to a training programme run by the SHA. However, as can be seen by the structures presented
in each case study, they were a very small, albeit central, part of the overall PPEI structure. During interviews,
discussions and workshops, the need for training and preparation for PPEI was a repeated theme. While we
did observe some training workshops that had a combined lay and professional audience, in view of the
different interpretations of PPEI highlighted above a more extensive joint programme would be merited.
Reflexive monitoring
The final area of work within normalisation process theory is around systematically evaluating PPEI and
reconfiguring PPEI strategies and processes in the light of this appraisal. There was little evidence of how
this was to be approached within our case study sites. However, participants at the summative workshop
suggested a number of approaches to monitoring PPEI (Box 3).
BOX 3 Approaches to monitoring PPEI
l Record changes made as a result of PPI (as routine).
l Evaluate outcomes – having measurable outputs agreed by patients and public.
l Performance dashboard at CCG board.
l Equality analysis (legal requirement).
l Through provider contract with ‘consequences’.
l National Commissioning Board to overview.
l Annual PPEI report.
l Research – how CCG services look from different perspectives – 360 degree (national GP survey, hospital
survey, LINks – compare and contrast).
l Disseminate research outcomes.
l JSNA and use of LA – powerful monitoring tool.
l Healthwatch as monitor.
l Use of website – results of feedback – actions taken (you said – we did).
l CQC inspection of GP practices.
l Benchmarking: throughout patient pathway and against ‘most similar family’ (comparable CCGs).
l Capturing patient experience over time/throughout service changes.
CQC, Care Quality Commission; LA, local authority.
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While PPEI during the transition phase from PCT to CCG had evolved from pathway focused to a strategic
level, issues around sustainability still need to be explored. Equally, if the health service is to fit the needs
of the service user rather than vice versa,170 then PPEI needs not only to be sustained but also to be
developed further.
Some future models of patient and public engagement and involvement
When the EVOC project commenced, our remit was focused on exploring PPEI within the LTC pathways
and set against the choice agenda. This landscape changed significantly, with PPEI functioning at a more
strategic level and within an environment increasingly framed by limited resources. Within some of the
case studies, we found perceptions from some commissioners that the public would be unwilling to
engage in decision sharing over limited resources. However, our findings suggest that the service user and
public respondents were often only too aware of the challenges facing the health service and were willing
to enter dialogue on these issues, a finding mirrored elsewhere.171 This desire for active involvement in
decision-making is in contrast to an alternative model of patient-focused commissioning which draws on
virtual patient narratives. Experience-led commissioning is a model developed by a private consultancy in
association with the Health Experiences Research Group at the University of Oxford. They suggest that
using the Healthtalkonline (www.healthtalkonline.org) national data set of qualitative interviews of over
2000 patients living with 55 different conditions provides equivalent narratives when compared with the
local patient population, and can be used when supplemented by a local needs analysis to commission
services. However, it is not clear how this virtual form of patient experience will help the commissioners in
making difficult decisions, or how it fits with the drive to localism which was expressed by a number of the
EVOC respondents.
Perhaps more congruent with our findings from EVOC are the suggestions offered around the concept of
patient leaders. Gilbert169 suggests that PPEI involves a twofold role: first, to be a community channel and
provide a conduit to local communities and wider perspectives, and second, to be a critical friend ‘offering
strategic advice from a non-institutional perspective’. These roles were clearly reflected in the EVOC data.
With the appropriate learning and training, Gilbert also suggests the emergence of two types of patient
leader: those who want to improve health and social care by being involved in the transformation of
systems, and those who want to actively improve health and well-being within their local communities.
However, robust support and development will be key to these leadership roles, an area lacking to
date.170,172 Resources to provide appropriate training for all concerned are scarce and will continue to be
so. However, within the EVOC study, we saw the continuation of forms of PPEI silo work. While the CCG
PPEI plans took a more strategic approach and built linkages with the local authorities, at the same time
other links were being loosened or lost, for example with provider PPEI groups and some voluntary groups.
The potential for sharing resources for PPEI training and development is significant, particularly in the new
landscape and burgeoning of PPEI within new structures such as the Academic Health Science Networks
and second wave of Collaborations for Leadership in Applied Health Research and Care (CLAHRCs). This
may be the way forward for developing a more synergistic and effective PPEI.
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Chapter 9 Conclusions and recommendations
Introduction
The project’s initial aim was to examine how commissioners enable voice and engagement of people with
LTCs and to identify what impact this has on the commissioning process and pattern of services. A key
outcome of the research was to provide guidance for commissioners on the skills and expertise needed by
different commissioners, what actions are most likely to lead to responsive services and the most effective
mechanisms and processes for active and engaged commissioning for people with LTCs. Our specific
objectives were to:
1. critically analyse the relationship between the public/patient voice and the impact on the
commissioning process
2. determine how changes in the commissioning process reshape local services
3. explore whether or not any such changes in services impact on the patient experience
4. identify if and how commissioners enable the voice and engagement of people with LTCs
5. identify how patient groups/patient representatives get their voice heard and what mechanisms and
processes patients and the public use to make their voice heard.
In addition to our key objectives, we were also able to observe how the NHS reforms in England impacted
on approaches to PPEI. These reforms commenced before the start of our research with the merger of
PCTs into clusters during 2009–10. However, following the election of the coalition government in 2010
and publication of the White Paper Equity and Excellence: Liberating the NHS,7 the path of reform shifted
to include a complete restructuring of commissioning arrangements in the English NHS. From January
2011, new ‘Pathfinder’ GP-led commissioning groups began to develop, leading eventually to the
establishment during 2012 of new CCGs. These CCGs took over statutory responsibility for some 60% of
the NHS budget from April 2013 to commission local community and hospital services. At the same time,
PCT clusters evolved into CSUs and NHS England was established with responsibility for 40% of the NHS
budget with a specific emphasis on specialist services, national GP, ophthalmic, pharmaceutical and
dental contracts, prison health, armed forces and a number of national public health programmes (see
Appendix 11). In addition, public health, including the commissioning of public health services, moved
from PCTs to local authorities.
While all three new commissioners – CCGs, NHS England and local authorities – have responsibility for
commissioning services for people with LTCs, our study specifically focused on local relationships and,
therefore, did not examine what developments have occurred in relation to NHS England on PPEI except
where this organisation established the authorisation process for CCGs. The commissioning activities
of local authorities of public health interventions that affect people with LTCs did not commence until
the very end of our study (from April 2013), and so it was not possible to explore the impact of this.
Thus, the findings from this study relate specifically to the developing role of CCGs and PPEI and,
in particular, the relationships between local commissioners, local providers and patients and the public.
In this chapter, we summarise our main findings for each of our key research questions. We then go on to
discuss some reflections on the research process and limitations of our research. Finally, drawing on the
key findings discussed in the case studies, analysis and discussion, we provide guidance for national
organisations, local health-care commissioners and providers, and patient and third-sector organisations,
identify key local and national policy issues and make recommendations for further research.
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What kinds of relationships existed, and were developing,
between the public/patients and commissioners?
In common with previous research on PPEI,149,150 we found that there were different understandings of
involvement in terms of how it was understood and what is was for. Our findings demonstrate some clear
distinctions between commissioners, providers, patients and the public about what the purpose of PPEI
is (Box 4).
We also identified that there are distinct different meanings associated with, or attached to, ‘involvement’
and ‘engagement’. We suggest that engagement is a pre-determinant of involvement and that
involvement is seen as ‘active’; engagement is a passive activity but forms part of a commitment to involve.
As discussed in Chapter 8, these different understandings and perceptions are important in terms of what
PPEI takes place locally and how it is supported.
We found that the factors that drove PPEI in commissioning organisations were broadly threefold:
l In some organisations there was a clear organisational ethos for PPEI. It was seen as central to the
activity of the organisation. This view was reflected in our case studies 1 and 2.
l Other organisations engaged in PPEI because it was a statutory requirement – something they had
to do. Responses to the CCG authorisation process are an example of this.
l The third group of organisations responded mainly to external incentives to undertake PPEI, such as the
provision of resources and funding. The development of practice-based PPGs following the introduction
of the DES supplement to the General Medical Services contract is a good example of this.
It was clear from our research that commissioners continue to define who has a legitimate lay voice.
As Barnes et al.107 have described, PPEI is framed by an understanding that there are two distinct legitimate
voices based on (1) experience where CCGs identify useful skills and (2) behaviour where the lay voice
is viewed as rational and can, therefore, contribute with confidence. The corollary of this is that there is a
group of ‘non-legitimate’ lay voices to be kept out of processes. This distinction has been observed over
many years8 but still seems to be a key factor in current practice.
While incorporating the experiences of young people proved a challenge in this project, we were able to
identify some key issues relating to PPEI and young people. Our research also demonstrates that young
people and adults have different experiences and perceptions. We found that, for adults, engagement and
experience provide the key underpinning for developing involvement in decision processes (see Chapter 8,
Figure 10). However, for young people the combination of experience and engagement tends to lead to
a withdrawal of interest. From our research it is not clear why this should be so, although there was a
BOX 4 Summary of findings
Commissioners: view involvement as a rational process, part of the activities that are undertaken within the
commissioning cycle. The emphasis is on getting the structures and processes that feed into the commissioning
process right.
Providers: view involvement as a ‘fine-tuning’ process to get their services right or a way of exerting leverage on
commissioners. PPEI is, therefore, predominantly a self-interested activity.
Patients and the public: view involvement as a wide spectrum of activities ranging from involvement in care to
more strategic purposes. Identify a need for a variety of occasions and places in which they can be engaged
and involved.
CONCLUSIONS AND RECOMMENDATIONS
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general reluctance by young people to discuss their experiences of the process of PPEI. It is critical that
further research is undertaken with young people to understand the reasons for this and how young
people’s involvement can be supported and sustained.
The structural changes to the English NHS affected both the organisation and roles of commissioners,
and the more formal structures and processes for PPEI. In commissioning organisations, people changed
roles and organisations or left the NHS. This severed existing relationships, requiring new ones to be
formed. In addition, the shift from the previous LINks structures to the new PPEI structures was also
disruptive and created tension and a lack of sign-up to the new processes. More needs to be done to
keep individuals ‘on board’ during periods of transition. We found that PPEI at a grassroots level became
removed from the core CCG through the creation of various hierarchies – both within the CCG and in
newly established structures for developing PPEI. Investing in a designated lead and getting whole-CCG
sign-up and investment helped, but involved a substantial resource and energy investment into building
relationships. Incentivising and having a budget for PPEI would be useful to support this type of work.
What impact did the public/patient voice have on the
commissioning process and decisions made by commissioners?
As research on CCGs has shown,22 the reforms led to a lack of clear focus on commissioning developments.
For CCGs, the key focus through 2012 was on the authorisation process. Given the substantial changes
occurring in local commissioning structures and the impact that this had on PPEI activities, it is not surprising
that we did not identify many examples of public and patient voice impact on commissioning decisions.
Not only was organisational change a key focus of local organisations, but we found a lack of continuity of
staff within the evolving organisations, meaning that initiatives and activities such as PPEI were disjointed or,
as in our CS3, started from the beginning again. It is perhaps instructive, however, that we found little
evidence of any PPI in this process at CCG level. This peripheralisation of PPEI representatives was
also found in another study.163
Successful approaches by patients to influencing commissioning agendas were generally evidenced where
voluntary and larger patient organisations were involved. These groups played a significant role in trying to
influence commissioners. The importance of collectivity was also observed where small groups of patients
collaborated to influence agendas and to ensure that their voice was heard as well as, or in cases, instead
of that of larger patient organisations. Larger user groups appear to be well placed to provide tools for
commissioners, although generally this was observed as responding to NHS agendas (such as QIPP) but
trying to shape that agenda to meet the needs of service users. We did not, however, find any strong
evidence of PPEI influence on commissioning discussions at board level; in particular, lay board members
were unsure about their level of influence, even if they were listened to.
To what extent did any such changes in the commissioning
process reshape local services?
Given the difficulties described in this report about continuity and the limited evidence of impact that
resulted from the impact of reform, we found few examples of how PPEI impacted on service changes.
However, we found some evidence that PPEI in commissioning did lead to the reshaping of local services
for people with LTCs. This was perhaps strongest where national third-sector organisations were involved,
such as in the example provided for MS and Parkinson’s disease services. Service user representatives
lobbied for support in the form of dedicated nurse specialists for their respective conditions and these were
eventually commissioned (supported by pump-prime funding from the respective third-sector national
organisations) in CS1 and CS3. At a more local level, service users also managed to influence the
development of a protocol for supporting children with diabetes in schools in CS1 as well as others having
a major role in reshaping local diabetes services in CS2. For RA there was less evidence of direct influence,
DOI: 10.3310/hsdr02440 HEALTH SERVICES AND DELIVERY RESEARCH 2014 VOL. 2 NO. 44
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Peckham et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
87
but one local group in CS3 did push for the provision of a dedicated ‘rheumatoid arthritis’ physiotherapy
service within their local trust.
Our findings relating to identifying changes were significantly limited by the rapidly changing organisational
and commissioning environment. This led to interrupted developments as those responsible for service
developments left organisations. For example, in CS3, the work on developing a commissioning strategy for
people with LTCs was restarted when responsibility moved from the old PCT to the CCG. The exception
was the development of the protocol for children with diabetes (in CS1). Here, there was continuity,
as the protocol was developed outside of the NHS. However, implementation was a problem because
there was no mandatory application of the protocol in schools. Our findings highlight the importance of
organisational stability and the need for continuity and for processes that ensure responsibility and
accountability for implementation. In CS3, the service that was identified in the exemplar case of diabetes
services for people in BME communities was noted by the expert reference group as a service that was
based on good clinical practice – and therefore likely to be of benefit – but was not influenced by the
engagement activity with BME groups.
Did any such changes in services impact on the patient experience?
Given the time frame of the research, it was anticipated that most of the data we would collect would
examine process aspects of PPEI and identify whether changes had been made in services or new initiatives
commenced as a result of PPEI. Given the lack of research evidence on impact, a key objective of this
research was to identify outcomes that were beneficial to patients. As described in the methods chapter,
we established an expert reference group to review a selected number of exemplar initiatives. We selected
exemplars that were sent to a virtual expert reference group consisting of a number of external key people
with a wide variety of expertise and experience relating to patient involvement, clinical skills and knowledge
and clinical practice around LTCs in general and/or specific to the tracked tracer conditions. We asked the
‘experts’ to provide comments on the identified exemplars of PPEI practice tracked in phase 3. The aim was
to bring some external verification of whether or not the interventions, services of processes, developed
through PPEI, were likely to lead to improvements and benefits for patients, given that within the time
frame of the research this was not possible. This stage of the research was undertaken after we had
analysed our data and identified our key findings (as outlined in the previous chapter). The purpose of this
external assessment was, therefore, to identify whether or not our conclusions were valid and, thus,
this information is presented here rather than as part of the general discussion of our findings.
The examples provided in our case studies demonstrated that impact on patient experience was more of a
challenge as there were limited ‘hard’ service evaluative data to make an overall assessment. Some of the
changes were too recent and had not yet been evaluated (RA, physiotherapy) and others had not yet been
implemented (schools protocol for diabetes). Data obtained from qualitative interviews suggest that the
specialist support nurses for MS and Parkinson’s disease had improved patients’ quality of life, which is
supported by previous research.173 The case has also been made by the MS Trust and Parkinson’s UK that
these nurse specialists reduce unplanned hospital admissions and are cost-effective.174,175 Evaluative data
from the diabetes service reconfiguration in CS2 revealed that the service was popular with the public as
well as meeting other quality and efficiency targets (see Chapter 5 and Appendix 5).
We selected three examples of practice, or exemplars, reflecting developments initiated by patients and/or
the public. The selection of case study exemplars was based on data from each case study and in each case
a diabetes service development was selected. Summaries of these were sent to expert reference group
members (see Appendices 5–7 for details). We asked members of the expert reference group to comment
on both the process of involvement and whether or not the initiative identified sufficiently demonstrated
a high degree of patient/public involvement, and what the potential benefit of the development would be
to patients. In this sense, we were asking about more than just clinical or health benefit.
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For the exemplar in CS1, we selected a protocol developed by parents for supporting children with diabetes
in school. Interestingly, as discussed elsewhere in this report, this initiative was developed by parents who
engaged with schools and only later was supported by the local LINk. In a sense this was undertaken
outside the health system, yet of the three initiatives – all relating to diabetes – this one was rated as having
the potential for the most patient benefit. The reference group members’ assessment of the exemplars from
CS2 and CS3 was critical both of clinical benefit and of the process of engagement; this was particularly
true for the exemplar from CS3, which involved a development that was intended to address the needs of
people in BME communities with diabetes. The assessment of these exemplars demonstrates some of the
key findings of this study relating to the fragility of PPEI where it occurs, poor PPEI processes and the lack of
support by health agencies, issues of short-termism and impact of constant health service reorganisation.
Yet they also suggest that PPEI can have positive impacts and that, where initiatives are driven by strong lay
perceptions built on experience, there is the potential to develop approaches of real benefit to patients.
Getting formal support from health-care agencies can, however, be difficult and, in the case of the school
protocol, the lack of a mandatory system for ensuring that it was implemented in schools limited the
potential of the protocol and the work put in by parents and others.
The expert reference group also identified a number of key weaknesses in process, such as the focus on a
single group in CS3 or relying on communication (in CS2) as a means of engagement without considering
how the patient/public voice is heard or taken into consideration. These themes emerged across our case
studies and are reflected in the wider PPEI literature.
How did commissioners enable the voice and engagement of people
with long-term conditions in the commissioning process?
Our study found that commissioners use a range of approaches to PPEI. However, while we identified an
extensive range, the move to CCGs suggests some broad common themes emerging. Our study was able
to observe how the organisational changes in commissioning impacted on PPEI during January 2011 to
May 2013. It was clear from our case study research and also from the findings of the PRUComm research
and analysis of CCG authorisation documents that CCGs saw themselves as wanting to be more
innovative in their PPEI strategies and activity. In some cases CCGs were critical of previous approaches
to PPEI, such as the role of LINks perpetuating a limited approach to representation – especially from
harder-to-reach groups. However, it was clear from our study that the organisational changes to the NHS
led to fragility in PPEI initiatives and some – such as in our CS3 – were lost completely. At the same time,
while commissioning organisations suffered substantial changes in organisation and staff, there was a
degree of continuity in the patients and public involved in lay structures – moving from the old to the new
PPEI structures. In addition, despite the commitment to innovation, we observed that PPEI was,
in many cases, brought under the umbrella of communication and engagement strategies within CCGs,
with the activity then outsourced to CSUs or other external agencies. Such moves may make PPEI
vulnerable to CCG organisational priorities. Two of our exemplars (CS1 and CS2) show how NHS and/or
clinical priorities are prioritised over lay perspectives.
One of the key findings from our research is the fact that PPEI is a fragile activity that is subject to pressure
from organisational change and pressure from policy directives. Only one of our case studies (CS1) had sought
to embed PPEI within its organisational ethos, while activity in the other two case studies was driven mainly
by top-down policy and guidance. NHS reform adds another dimension of fragility and contributes to
short-termism in approaches to PPEI. These factors are reflected in the assessment of the exemplars discussed
above. In particular, the CS3 exemplar demonstrates how changes in the organisational structure of the NHS
have a detrimental impact on PPEI. It is also clear from our data that engagement and involvement is not a
linear process. There is a circular process and this is, in itself, extremely fragile. This circular process can be
‘virtuous’, in that good engagement can lead to improved involvement if it is not tokenistic and does not lack
sustainability. However, where involvement is tokenistic or ends, patients and the public become disengaged
and less involved, and this can be described as a ‘vicious circle’.
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Drawing on the data from our case studies, we identified a number of different ways in which local
structures for PPEI were developing. The organisational structures for PPEI identified in each of the case
studies show how these structures are developing differently in each of. In CS1 and CS2, the PPEI
structures are hierarchal in one sense, but with separate pathways developing between PPEI driven from
PPGs and broader representation from community and voluntary sector groups. In contrast, in CS3 PPEI
appears to be developing a more complex system, with a number of distinct elements feeding into the
CCG mediated through Healthwatch and the HWBB as well as through specialist groups. One result
of this formalisation of PPEI structures and processes is to remove PPEI from the core work of CCGs as
commissioning organisations. In addition, these do not represent model structures, but demonstrate how
distinct structures can emerge which do not, in themselves, pre-determine the nature or quality of PPEI.
It is instructive that the service initiative found, in this study, to represent the most potential beneficial
impact for patients (assessed by the external reference group as most beneficial) was the school diabetes
protocol (CS1), which was developed outside the health-care system and whose implementation relied
predominantly outside the health system.
In Chapter 8, we mapped the case study activity against an ideal model.105 Key to supporting PPEI is the
requirement for a plurality of arenas where the patient and public voice can be heard. These were found
more in CS1 and CS3. These were, from our data, the only elements of what might constitute an ‘ideal’
that were observed. While this may be a reflection of the early stage of CCG development and more
general impact of the very recent reorganisation of the NHS, it does highlight how such structural change
can impact on PPEI which is already a fragile area of activity. As shown in CS3, the preceding work
developing PPEI with BME groups simply disappeared with the change and a whole new process is to be
started. Our findings also suggest that there is a lack of reflexive monitoring to learn from experience.
While organisational changes and restructuring had a part to play in our study, there was also evidence
that organisations constantly restart PPEI processes.
Consultation events where patients and carers are invited were characteristic of approaches used in our
case studies. This reflects the findings of other research on PPEI18,104 and also on commissioning for LTCs.55
Interestingly, the study by Smith et al.55 also highlights the involvement of providers, often in the same
forums as patients and carers. Our study supports the view that for people with LTCs, greater collaboration
between commissioners and providers is important for service development – particularly to support
stronger PPEI building on existing, and often, extensive contact between providers and patients and their
carers as well as groups representing patient and carer interests. Recent research in Scotland has
highlighted that building on existing ‘volunteerism’ in participation provides a useful way of engaging and
involving patients and the public in local decision-making and this needs to be done by identifying
whether particular groups are marginalised or excluded rather than being classed as unrepresentative.176
None of our case studies had developed ways of measuring or systematically identifying the benefits or
otherwise of PPEI. There was no attempt to build in processes for monitoring the impact or costs of PPEI.
This is an issue that has been identified in the existing literature on PPI.103 The findings of this study reflect
discussions in the literature on PPEI regarding the accepted view that PPEI is a good thing in its own
right – that its benefit is self-evident.177,178 Current evidence focuses mainly on the impact of involvement
on those participating, with less emphasis on the benefits to decision-making in health care. As a recent
review by RAND concluded:
We find evidence for the developmental role of public involvement – such as enhancing awareness,
understanding and competencies among lay participants of healthcare decision-making – while the
evidence for instrumental benefits of public involvement initiatives, that is whether public involvement
improves decision-making and policy in terms of processes and/or outcomes, is less well documented.
Yet overly focusing on outcomes of public involvement risks missing the normative argument that
involving the public in the process may be seen to be of intrinsic value in itself.
p. ix178
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Commissioners, and providers, in our study tended to focus more on the idea that patients and the public
should be involved, without determining how the benefit, or otherwise, of that involvement would
be measured.
How did patient groups/patient representatives get their voice
heard and what mechanisms and processes did patients and
the public use to make their voice heard?
Our study found that patient groups and representatives employed a number of mechanisms and
processes to make their voice heard. While patient group involvement may be viewed as ‘meliorist’179,180
in trying to support health-care agencies (commissioners and providers) to make improvements to the way
they do things the strategies used varied. These could be broadly mapped upon a continuum between
benefit and threat. For the latter, there was evidence of patient groups actively following the ‘threat route’
by initiating complaints and using the press and local parliamentarian to coerce commissioners into
change. The demarcation between this approach and those employing an asset-based strategy was
often marked particularly at the EVOC workshops. Patient groups following the ‘benefit route’ ensured
a strategic message to commissioners that highlighted the benefit, generally in terms of cost, of their
suggestions for service development. In common with other studies, our findings suggest that measures
of success for patients and the public are often different and more incremental than for health agencies,
and that networking resources, such as funded support workers or support from larger voluntary groups,
is a crucial support factor for PPEI.181
During the transition period to CCG, the lack of certainty about who the actual commissioners were
resulted in less of a coercive response and more of a focused effort to ensure that the patient and
public voice remained audible by proactively highlighting the benefits of adopting the patient/public
representatives’ suggested PPEI processes. In some of our case studies, LINks were particularly active in
this through endeavouring to shape recruitment processes for PPEI, and attempting to take on a
consultancy-type role in advising shadow CCGs on PPEI. The ensuing negotiation between established PPEI
representatives and new emerging forums such as the local Healthwatch involved establishing structures
which provided an arena for previous PPEI groups such as LINks and neighbourhood forums, but also
developed new arenas where the ‘new PPEI’ representatives would sit. The funnelling of ‘new’ and ‘old’
PPEI into various components of the overall PPEI structure was enabled by CCG outsourcing or targeted
recruitment. There were also proactive attempts to ensure a seat within the new components of the
structure, such as in CS1 where the local MS Society branch had encouraged one of their members to be
recruited onto Healthwatch. It was also clear, however, how fragile even well-developed approaches to
engaging service users were at this time of change. In CS3, considerable community and health service
resources had been involved in working with BME communities to input into service development. Despite
this, the new commissioners decided to disengage from the process and start their own new approach to
service development, demonstrating the fragility of even well-developed processes.
Key conclusions from study findings
The finding that there were different understandings of involvement was not surprising. However, the
different understandings between commissioners, providers and patients and the public are of particular
importance. These understandings lead to different to important differences in not only the perceived
purpose of PPEI but also how it is undertaken. Our findings suggest that getting a shared understanding of
the purposes and form of PPEI is key to developing effective PPEI processes. It is also clear that getting
processes for implementation is essential to success. To develop circles of PPEI that inform the development
of services, it is important that there is demonstration of actual influence. We also found that providers are
of particular importance in PPEI processes. In our case studies, the structures for PPEI tended to formalise
PPEI within structures that were not central to commissioning activity within CCGs. Commissioners need to
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work with providers on developing more integrated approaches to working in partnership with patients and
the public. The need for more close working between commissioners and providers has also been
highlighted in a study of commissioning for people with LTCs.55
In considering PPEI in commissioning, we identify three areas that frame approaches to PPEI and provide an
analytical framework for evaluating PPEI. These draw on the theoretical concepts developed by Barnes et al.
and Gibson et al.105–109 and the three main paradigmatic stances towards PPEI.168 When explored through
NPT concepts,134,135 viewing PPEI by asking whether or not it is moral, whether or not it is approached
methodologically and how the policy imperative is enacted begins to help to shape a potential evaluative
frame for PPEI. Table 13 shows how this framework sets the context and analytical framework for considering
PPEI, and provides possible applications in practice. Implementing these practice applications across all three
PPEI stances enables a more holistic approach to PPEI, recognising and bringing together the differing
viewpoints we found in our study in order to move towards a more congruent approach.
TABLE 13 Framing PPEI
NPT concept Sense making Evaluation frame Application in practice
Moral PPEI as a right for the






a voice? Is there
deliberation with
care? Is involvement
seen as a moral
right? Is there more
transparency?
Ensuring PPEI processes and structures enable the
voice of the public who are the most vulnerable such
as people with long-term health conditions (mental
health problems; dementia; learning disabilities),
long-term socioeconomic conditions (homeless
people, traveller groups, sex workers, refugees,
asylum seekers, prisoners/ex-offenders, people living
with persistent poverty/lower levels of education),
and those from BME communities
Enabling deliberation with care through having a
highly visible and accessible main point of contact for
the public and focusing on relational integration such
as the fostering of relationships and trust. Consistently
providing timely and informative feedback
Provision of clear and accessible information
regarding service users and the public’s rights in
involvement with local health and care services











Developing an evaluative framework to measure how
PPEI has led to improved patient experience and
safety
Using patient experience and collaborative work
with the public to commission and develop
experience-based services
Measuring the potential economic costs benefit of
more effective PPEI





Conducting policy evaluations to understand the
mechanisms associated with embedding PPEI as a
policy initiative
Collecting indicative data to understand the local
contextual enablers and barriers to implementing PPEI
Sharing and learning from best practice in PPEI
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However, congruence is difficult to maintain during times of significant change, and a key theme that
emerges from our data is the need for stability in order for relationships to develop. As Barnes has argued,
enabling forms of exchange designed to offer recognition of the patient and public experience is seen as
an essential feature of deliberation alongside purposive-rational discussion.108,109 Our findings have clearly
demonstrated that more needs to be done to maintain PPEI processes and activities during periods of
transition. Of concern is our finding that PPEI at a grassroots level became removed from the core activities
and functions of the CCG through the creation of various hierarchies within the CCG. Of more concern,
though, was the removal of grassroots-level PPEI from the newly established structures for developing PPEI.
Reflections on and limitations of the research
Researching PPEI is complex and the changing organisational context of the English NHS occurring during
the undertaking of this research, while offering a unique opportunity to observe change, also created
methodological problems and a need to make revisions to our research protocol. We were also faced with
a number of key challenges in undertaking this project which have had an impact on our research
findings. These included:
1. the changing organisational context in our case study sites
2. gaining access to case study sites
3. staff changes in commissioning organisations
4. undertaking research with young people.
The changing organisational context in our case study sites
We have discussed elsewhere in this report the substantial changes to the organisational context in which we
were undertaking research. The lack of commissioner continuity and the uncertainties created by both the
reforms themselves and the uncertainties that emerged until the Health and Social Care Act was given Royal
Assent led to a number of problems in applying our original methodology. Access and staff turnover were
two key problems and these are discussed separately. However, organisational turbulence, fragmentation and
uncertainty led to significant challenges. Changes led to substantial loss of organisational and institutional
memory.154 In many cases, there were periods where organisational structures were transitory and it was not
clear which organisation was responsible for what. Negotiating and maintaining relationships with key
stakeholders was both time-consuming and very complex. It also involved having to restate the purposes of
the research over and over again. Changing organisations also raised problems for research governance, as
we had to constantly gain permission and access to staff members and patients.
Gaining access to case study sites
While access to CS1 was facilitated by good existing relationships and keenness of the PCT to engage
with the research and support a management fellow, access to the two other sites was more complex.
In CS2, the existence of a strong PBC was identified via the local CLAHRC. While a positive focus, the PBC
was at that time in a state of reform responding to changes in 2010 as a result of the new plans for NHS
commissioning outlined in Equity and Excellence.7,163 This led to a period of disengagement, given the
organisational change priorities. However, the team was supported by key local stakeholders, enabling
the research to develop around a key priority area (diabetes) that had been identified by the PBC.
However, recruiting a third site was frustrated by the rapid organisational changes, and while a number
of potential sites were approached, there was uncertainty about who the lead commissioner organisation
was or it was the case that the organisations were too involved in changes to want to be involved in the
research project. Thus, it was some time before a third case study site was recruited, leading to a delay in
the phasing of the research. In the end, we treated each case study site separately, undertaking the phases
of research as set out in the research protocol but concurrently across sites. This had the effect of
lengthening the overall time frame for the research project.
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Given this, we also felt that this provided an opportunity to examine some of the changing context in
more detail and follow developments up to the point at which the new CCGs became statutorily
responsible for commissioning in April 2013. As a result, we suggested to NIHR that the research should
be extended by 9 months. This would enable this project to draw on data from the case study research
and surveys on CCGs being undertaken by the PRUComm being undertaken in 2011–12 (which involved
the principal investigator of this research project). In addition, we were able to undertake an analysis of
PPEI plans in CCG authorisation documentation. This involved an analysis of the process and criteria and
detailed documentary analysis of a sample of CCG authorisation submissions.
Staff changes in commissioning organisations
One of the key impacts of the NHS reforms was on staff. As Pollitt150 has previously described,
organisational reform can lead to career jumping and staff continually negotiating changing short-term
roles. These were distinct features observed in our research. Our original protocol involved longitudinal
data collection in phase 3. Our original research method was to track some specified developments in each
case study with a purposive sample of stakeholders. This involved repeated interviews and the completion
of ‘Star Charts’ (see Chapter 3 for further details). However, we found that commissioning staff, in
particular, changed very rapidly and it was not possible to follow staff members over time. This led to a
lack of longitudinal and comparative information over time. We were able to collect sufficient data in order
to provide a rich picture. It is perhaps ironic that the main continuity over the period that we undertook
our research was in the patient/public representatives and this represents a key lesson for organisations
and perhaps an important factor for underpinning why PPEI is crucial.
Implications for research with young people
The inclusion of young people in projects relating to LTCs is important to consider, as young people have
distinctive service needs and experiences of their conditions from adults.
The difficulties encountered in this project of recruiting young people and even gaining access to ask them
if they wanted to participate, however, illustrate some of the key challenges for researchers in obtaining a
young person’s perspective. The project team adhered to the recommendations in relation to research
with young people and our approach was in line with existing work in the field.122–126 We wish to highlight
the importance of such strategies in the context of research that spans new and emerging domains of
work, but we identify the following lessons from this project that highlight the need for future research to
consider the following:
1. The challenge of involving young people needs to be anticipated from the outset and sufficient
dedicated resources allocated to this aspect.
2. Young people are likely to require specialised and specific information that needs to be developed in
partnership with young people.
3. Young people may require specific approaches to the conduct of the research that impacts on the
project organisation and methodology of the research; for example, they may not be in, or wish to join,
condition-specific groups. Including charities that work with children and young people in the proposal
development stage may be one way to address this issue and improve recruitment. This may also help
to allay the concerns of gatekeepers about the participation of young people in research.
The involvement of a management fellow
The research team were extremely positive about the inclusion of a management fellow, and Joanne
Reay’s role was key in the early stages of the research. We were fortunate to get support from the PCT in
CS1 and the PCT was particularly keen to nominate a management fellow. Having the fellow played a key
role in supporting access to the case study in terms of both the contacts of the management fellow and
the support received for the fellow which made the PCT more aware of the research. The management
fellow’s insights to commissioning processes and NHS structure were also extremely helpful. In the later
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stages of the research, the role of the management fellow became more uncertain. There were two
reasons for this. The first was the NHS reorganisation, which resulted in the management fellow’s NHS job
being placed at risk. Her NHS role was reorganised a number of times and also included a period of
potential redundancy and uncertainty about her future. This impacted on the contribution she could make
to the research project. It also meant that the original support structure within the PCT also disappeared.
Thus, the original intention of the management fellow acting as a bridge between research and practice
was severely curtailed. The other reason for uncertainty was due to the changes within NIHR and the
seeming withdrawal of the management fellow programme and support structures within NIHR. This left
the fellow and the research team uncertain about how the management fellow concept was to be
incorporated into research activities.
Reflecting on our experience, we would definitely support the idea of involving NHS managers and
practising clinicians in research projects. This would require stability and continuity from NHS organisations
to facilitate the maximum benefit from a fellow. The selection of fellows is extremely important and both
the research team and the employing organisation need to be clear about joint objectives. It would help if
fellows have some research training – probably through postgraduate education programmes – prior to
being involved in research projects, but additional training should be a key element of the management
fellowship. It is important that NIHR supports management fellows across research projects.
Guidelines for practice and recommendations for future research
The findings set out in this report identify some key areas where improvements to practice in relation to
PPEI can be made. In particular, these findings point to two broad areas of action. The first relates to the
framework or infrastructure arrangements for PPEI and how PPEI can be supported in the NHS and other
organisations. The second area of action relates to the process for PPEI and how it should be undertaken.
These action areas are relevant to national organisations (and the new regional structures and
organisations developing within the reformed English NHS) and to local commissioners (the CCGs) and
service providers. In addition, the research has identified a number of key research issues about
methodology and areas for further research that should be considered by research funders
and researchers.
Implications for national organisations
l National agencies should ensure that training and development programmes on PPEI for
commissioners, providers and patients and the public are implemented: these can be delivered
nationally or support local training and development initiatives.
l National organisations such as NHS England and National Healthwatch need to develop monitoring
criteria for PPEI.
l There needs to be clarity about terminology, with agencies being specific about the meaning of terms
such as engagement and involvement. These terms carry different meanings to different people.
l National and regional agencies need to develop and support a sustainable environment for PPEI in
which local relationships can develop and flourish.
l At a regional level, organisations need to ensure that resources and structures for PPEI are shared,
for example supporting networks, sharing resources, jointly supporting infrastructures.
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Implications for health-care commissioners and providers
l Commissioners need to embed PPEI throughout the commissioning cycle.
l Commissioners need to understand that strategies for engagement, while important, do not substitute
for involvement – this is a contributing stage but does not constitute active participation.
l Commissioners and providers need to agree measurable outcomes of PPEI with patients and public,
and evaluate these annually.
l Commissioners and providers need to work together on PPEI as providers have more opportunities for
engaging with patients and carers.
l Commissioners, providers, patients and the public should work together to develop a shared vision
of PPEI.
l Agencies should participate in existing networks and forums – such as participation in a
neurological network.
l Agencies should co-operate on the mapping of local PPEI.
l While PPEI requires an organisation-wide approach, organisations require dedicated resources
(staff, funding) for PPEI.
l Commissioners and providers should develop a shared framework for evaluating PPEI and its
outcomes – for example, in relation to improved patient experience and safety.
l Indicative data should be collected to understand the local contextual enablers and barriers to
implementing PPEI.
l PPEI processes and structures should enable the voice of the public who are the most vulnerable, such
as people with long-term health conditions (mental health problems, dementia, learning disabilities) or
long-term socioeconomic conditions (homeless people, traveller groups, sex workers, refugees, asylum
seekers, prisoners/ex-offenders, people living with persistent poverty/lower levels of education) and
those from BME communities.
l A highly visible and accessible main point of contact for the public should be provided, focusing on
relational integration such as the fostering of relationships and trust and consistently providing timely
and informative feedback.
Recommendations for future research
l Our research suggests that further research is urgently required to examine how PPEI is being
developed within the reformed English NHS. Our research has demonstrated the fragility of PPEI and
how reorganisation can impact negatively of PPEI processes and developments.
l Research on PPEI among young people and children requires dedicated research projects where all
resources and activity are focused on accessing, involving and supporting young people.
l This project has demonstrated the value of linking research between similar research projects – in this
case linking with the PRUComm research on CCGs – allowing the pooling of data.
l This project has demonstrated the value of participative and iterative methods for investigating PPEI
and researchers should be encouraged to utilise similar methods in future studies.
l There is still a need for research to measure the potential economic costs/benefits of PPEI.
CONCLUSIONS AND RECOMMENDATIONS
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Appendix 1 Interview guide
Interview guide: commissioners/providers/patient and public
involvement and service users’ representatives
1. General role and experience of PPI:
Can you tell me a bit about your role?
What is your general understanding of what PPI means?
What is your personal experience of PPI?
2. General understanding of PPI and commissioning:
Do you think PPI is necessary in the commissioning process? Why or why not?
What is the reasoning behind PPI forums?
What do you think are the advantages and disadvantages of PPI in commissioning?
One of the themes that has come up in workshops is that service users can identify gaps in services.
What is your experience of this?
Can you give me a specific example of PPI in commissioning?
3. Impact of PPI on decision-making in commissioning:
Thinking more about the example you have given me can you tell me how and in what way service
users’ views were listened to?
What lines of communication were there between the commissioners and the public? Who talked to
whom and who didn’t?
Were there any disagreements or challenges and what happened?
Did PPI actually change services and in what way? If not what were the barriers?
4. Representativeness:
Is PPI the best way to represent the views of a particular population?
Does representativeness actually matter?
What about under-represented groups?
Are there over-represented groups – what impact do they have?
Who are PPI accountable to? What is their accountability?
5. Power:
Do you feel the service representatives have any power or is it just a ‘tick-box’ exercise?
6. Future:
What do you think should happen to PPI in commissioning? How realistic would this be?
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Appendix 2 Information about interview
London School of Hygiene & Tropical Medicine
(University of London)
Switchboard: 




SERVICE USER INFORMATION SHEET
Commissioning for Long Term Conditions
You are being invited to take part in this research study. 
Before you decide it is important for you to understand why the research is being done and 
what it will involve.  Please take time to read the following information carefully. Talk to 
others about the study if you wish.
· Part 1 tells you the purpose of this study and what will happen to you if you take part.
· Part 2 gives you more detailed information about the conduct of the study. 
Ask us if there is anything that is not clear or if you would like more information.  Take time 
to decide whether or not you wish to take part.
Thank you for reading this.
Part 1:
What is the purpose of the study?
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The purpose of the research is to examine how Primary Care Trusts (PCT) takes into account 
the views of people who have a long term condition and to identify what impact this has on 
the commissioning process and pattern of services. 
Commissioning is the process through which a PCT decides what NHS services are needed 
and should be provided, who should provide the services and how they should be paid for.
The main aim of this study is to find out how service users are involved in the commissioning 
process.
Why have I been invited?
We are inviting you because you are a service user, or care for someone with a long term 
condition, or represent service users with long term conditions within one of three PCT case 
study sites around England. 
Do I have to take part?
Absolutely not. It is up to you to decide whether or not to take part. 
If you decide to take part you are still free to withdraw at any time and without giving a 
reason.  A decision to withdraw at any time, or a decision not to take part, will not affect the 
standard of care you receive.
What will happen to me if I take part?
If you agree to take part in the study one of the researchers will contact you. They will 
arrange a convenient time to interview you. This could be face to face in a location 
convenient for you, or if you prefer a telephone interview. With your permission the 
interview will be recorded, but only the research team will have access to the recordings and 
they will be deleted at the end of the study. The interview will take about 1 hour and will seek 
your views on how service users are involved in deciding which and how long term condition 
services are provided. At the end of the interview we will ask you to complete a quick rating 
scale about service user involvement. We will invite you to attend a workshop at the end of 
this phase of the study (in about 4-5 months time) where we will explore local issues and 
approaches to commissioning in more depth.
If you do have to travel for the interview or workshop please give us your receipts and you 
will be reimbursed for your travel expenses. 
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What do I have to do?
If you agree to take part in the interview, simply sign the response form and return to us in 
the pre-paid envelope. We will then contact you to arrange a time and place for the interview. 
Before the interview starts the researcher will answer any questions you have. You will be 
asked to sign a consent form giving us permission to interview you. You can stop the 
interview at any time.
What are the possible disadvantages and risks of taking part?
There are no disadvantages except the time element required from you. 
You can withdraw from the study at any time.
What are the possible benefits of taking part?
There is unlikely to be any personal benefit from taking part. However, your participation 
may help PCT’s to involve service users more effectively in the commissioning process.  
What happens when the research study finishes?
The findings will be available to you on the project website. A report will be sent to the 
funders of the research and each PCT involved in the study.
What if there is a problem?
It is unlikely that something may go wrong during the interview, however if this does happen 
it will be dealt with immediately. The detailed information on this is given in Part 2.
Will my taking part in this study be kept confidential?
Yes. All the information about your participation in this study will be kept confidential.  The 
details are included in Part 2.
For more information about this study please contact:
Lorraine Williams
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Department of Health Service Research and Policy
London School of Hygiene and Tropical Medicine
Telephone: 
Email: 
If the information in Part 1 has interested you and you are considering participation, please 
read the additional information in Part 2 before making any decision.
Part 2
What if there is a problem?
As this is an interview, it is very unlikely that anything could go wrong. However if you have 
a concern about any aspect of this study, you should ask to speak with the researchers who 
will do their best to answer your questions. Please contact Lorraine Williams on 020 7927 
2671.
If you are harmed by taking part in this research project there are no special compensation
arrangements. If you are harmed due to someone’s negligence then you may have grounds for 
a legal action for compensation against the London School of Hygiene and Tropical Medicine
and the University of Hertfordshire but you may have to pay for it. 
The normal NHS complaints mechanism is available to you if you wish to complain about 
any aspect of the way you are approached or treated during the course of this study. Formal 
complaints should be addressed to:
Patient Advice and Liaison Service (PALS) 
(removed for confidentiality)
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Should you require independent advice about making a complaint or seeking compensation 
you may wish to contact:
(removed for confidentiality)
Will my taking part in this study be kept confidential?
All information collected in this project will only be accessible by the relevant research staff. 
The information we collect will be kept on secure university computers only accessible to the 
research team with password protection. All the information you provide will be treated 
confidentially. Your comments may be used as quotations within the study findings but will 
be anonymous and you will not be identified. You will also not be identified in any report or 
publication arising from this project. The research team will not have access to your medical 
records.
Who is organising & funding the study?
The study is being organised by a team of researchers at the London School of Hygiene and 
Tropical Medicine and the University of Hertfordshire.   They are being funded to do the 
study by the National Institute of Health Research.
Who has reviewed the study?
All research in the NHS is looked at by independent group of people, called a Research 
Ethics Committee, to protect your interests. This study was given a favourable ethical opinion 
for conduct by the Great Ormond Street Hospital/Institute of Child Health Research Ethics 
Committee.
THANK YOU FOR READING THIS INFORMATION SHEET.
YOU MAY KEEP THIS INFORMATION SHEET.
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Yes, I am interested in taking part in an interview and am happy for the 
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Appendix 3 Consent form
London School of Hygiene & Tropical Medicine
(University of London)
Switchboard: 




Participant Identification Code for this study:
CONSENT FORM
Commissioning for Long Term Conditions
Researchers:
Stephen Peckham, Sally Kendall, Tricia Wilson, Fiona Brooks & Lorraine Williams
Please initial box
1. I have read and understand the information leaflet
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dated 6/1/10 (version 1) about the study. I have had the opportunity to consider 
the information, ask questions and have had these answered satisfactorily.
2. I understand that my participation is voluntary and that I am free to withdraw at 
any time without giving any reason, without my medical care or legal rights being 
affected. 
3. I understand that data collected during the study may be looked at by 
individuals from the research team, from regulatory authorities or from the 
NHS Trust, where it is relevant to my taking part in this research. 
4. I agree to take part in the above study. 
________________      __________  ________________
Name of participant       Date Signature
________________     ___________  ________________
Name of researcher      Date   Signature
When completed, 1 for participant, 1 for researcher
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Appendix 4 Case study 1 exemplar
CS1 School Protocol for Children with Diabetes Type 1 
Background 
There are about 29,000 children and young people with diabetes in the UK. About 26,500 of 
them have Type 1 diabetes (insulin dependent) and about 500 have Type 2 diabetes. There 
are a further 2,000 children and young people in the UK with diabetes whose diagnosis is not 
known 1.  
 
· The current estimate of prevalence of Type 1 diabetes in children in the UK is one per 
700–1,000.  
· The peak age for diagnosis is between 10 and 14 years of age 2. 
· Local authorities and primary care trusts (PCTs) can expect between 100 and 150 
children with diabetes to live in their area. In July 2009 45% of schools from the 
whole county in which case study 1 (CS1) is situated responded to a request for 
information and reported 214 children with type 1 diabetes and 19 with type 2 
diabetes. 
The Juvenile Diabetes Research Foundation (JDRF) and Diabetes UK have worked together 
to develop a protocol for children with diabetes in school to encourage a partnership between 
the NHS, the Local Authority and parents. Prior to this there have been no guidelines in place 
for schools. The protocol was launched in February 2011 after two years of discussions 
between parents and CS1 County Council.  
CS1 School’s protocol for children with diabetes 
The CS1 protocol (appendix 5) is a set of guidelines ensure that school staff are supported 
and given the right equipment to support pupils with diabetes. The protocol outlines 
recommendations on how schools can provide medical care and emotional support to children 
who have diabetes. This includes an individual care plan for each child and providing a place 
for a child to test their blood glucose levels or have their insulin injection. Extra training for 
school staff prevents situations where children are prevented from going on day outings or 
residential trips and allowing children to eat snacks to regulate their blood glucose levels. 
The protocol was developed in response to a group of parents making a request for more 
support for pupils with diabetes in CS1 schools.  CS1 and the Local Involvement Network 
(LINks) has worked in partnership with CS1 Local Education Authority and Diabetes UK 
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(Regional Office), a Paediatric Diabetes Specialist Nurse from a local hospital and other 
interested parties to create a protocol/guidance document for implementation in CS1 
schools.  The problem in schools is a nationwide issue and it is hoped that this protocol will 
be used as guidance for other counties wanting to produce their own guidance.  This 
document can be reproduced provided acknowledgement is made therein to the CS1 County 
Council. 
Shortly before the Protocol was due to be published the parents from the working party were 
contacted by CS1 and LINks asking if they would be interested in being part of an CS1 and 
LINks Working Party to arrange a conference to launch the protocol to CS1’s schools.  CS1 
and LINk won a bid on their own initiative for funding to host a conference to launch the 
Protocol and to roll it out across CS1 schools.  The conference was in February 2011. 
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1.0      INTRODUCTION 
The burden of diabetes in school age (5-16) children is high. There are at least 
15,400 children in schools in England with diabetes. This has significant 
implications for schools and families, as more children require management for their 
diabetes during school hours.1  Whilst some older children may be fully independent 
with their diabetes care, younger or disabled children may require support and 
assistance from school staff during the school day. 
Education is a valuable part of children’s and young people’s lives. Appropriate 
diabetes care in the school and day care setting is necessary for the child’s immediate  
safety,  long  term  well  being  and  optimal  academic  performance.2 Diabetes 
should not alter a child’s academic potential.3 
It is therefore essential that all school staff have an awareness of this medical 
condition and the child’s needs during the school day. 
These guidelines have been produced with parents to ensure that school staff 
are supported and equipped to support children with diabetes. Where schools 
are insured through the Council and have followed these guidelines then they 
will be fully covered by the insurers. 
2.0      INDIVIDUAL HEALTH CARE PLANS (IHCP) 
All children in school with a medical need should have an individual health care 
plan  as  recommended  by  the  DfES  2005  guidance  Managing  Medicines  in 
Schools and Early Years Settings.  An IHCP is a useful tool for the school to 
record important details about an individual pupil’s medical needs, their triggers, 
signs  and  symptoms,  medications  and  other  treatments,  as  well  as  contact 
details and emergency numbers.  It should also include permission from parents to 
share confidential information about their child’s health and health needs. 
The IHCP should describe the responsibilities of all parties. In the case of 
children with diabetes this is usually provided and written by the child’s diabetes 
specialist nurse (PDSN/CDNS). The parents will tell you who this is and how to 
contact them. It is essential to involve the child, their parents and school nurse, 
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and good practice to involve relevant school staff such as head teacher, nominated 
school staff, as well as the school Special Educational Needs (SEN) representative. 
Everyone who is involved in the individual health care plan (IHCP) should keep a 
copy. An IHCP should be completed at the beginning of each school year, or 
when the child enrols.  It should be updated  at least yearly and whenever  an 
1  Growing Up with Diabetes:  children and young people with diabetes in England.  
Research Report by the Royal College of Paediatrics and Child Health.  March 2009. 
2  Department of Health (2007).  Making every young person with diabetes matter. 
3  International Society of Paediatric and Adolescent Diabetes (ISPAD 2000).  
Consensus Guidelines for the management of Type 1 Diabetes Mellitus in Children and 
Adolescents.
APPENDIX 4
NIHR Journals Library www.journalslibrary.nihr.ac.uk
124
individual pupil’s medical needs change. Parents have the prime responsibility for 
their child’s health and should ensure their child is well enough to attend school. 
Parents are responsible for providing schools with up to date information about 
their child’s health. 
3.0      PLANNING AN ADMISSION 
Parents  should  arrange  an  introductory  meeting  with  their  chosen  school’s 
head teacher before their child enrols or when the child first develops diabetes. 
(DfES / DH 2005). 
This  is  best  done  in  the  term  before  they  are  due  to  start/transfer  to  allow 
adequate time for planning meetings and training of staff, and to ensure an IHCP is 
in place by the time the child starts. 
 The parent should inform the school of their child’s needs at this initial 
meeting. 
 The parent should provide the school with contact numbers for the child’s 
PDSN/CDNS. 
 The head teacher should contact the school nurse and SEN 
representative at this stage. 
 The head teacher should identify at least 2 suitable members of staff to 
take on a supportive role for the child. 
 The head teacher should contact the PDSN and arrange training. 
The training should involve the child (if appropriate), parent, head teacher, 
nominated members of staff, PDSN and school nurse. In some areas the initial 
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Stages Process Who 
1 Parent notifies school. 
Arranges meeting with Head Teacher 
• Parent 
2 Prior to meeting Head Teacher informs 
School Nurse and SEN representative. 
• Head Teacher 
3 Introductory meeting. 
Parent identifies child’s needs and provides 
PDSN/CDNS contact details. 
• Parent 
• Head Teacher 
• School Nurse 
4 Head teacher contacts PDSN/CDNS. 
Arranges training meeting. 
• Head Teacher 
5 Planning meeting. 
PDSN/CDNS discusses IHCP and identifies 
training needs, and dates for training. 
• Parent 
• Head Teacher 
• PDSN/CDNS 
• School Nurse 
• Nominated staff 
 PDSN/CDNS or school nurse and parents 
provides school with IHCP. 
• PDSN/CDNS 
• School Nurse 
• Nominated staff 
 Training. 
PDSN/CDNS or school nurse AND parents 
provides training to school staff until competent. 
This may occur in one meeting 
PDSN/CDNS or School 
Nurse and Parents 
6 SEN representative informs the LA of child’s 
details and names of nominated staff. 
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4.0      STAFF TRAINING 
All school staff should have a general awareness and knowledge of diabetes and 
know what to do in an emergency (for example, a hypoglycaemic episode) when 
they have a pupil with diabetes in their school. 
General awareness training can be provided to individual schools by the child’s 
diabetic health care team (PDSN/CDNS) or the school nurse AND parents on 
request. It is the head teacher’s responsibility to arrange training. The parents 
can provide contact  details.  Alternatively, head teachers  can contact  Head  of 
SEN and Children with Additional Needs at the relevant County Council  who 
hold a list of all Diabetic Specialist Nurses in their region.  
The head teacher should nominate at least two members of staff who are willing 
and able to undertake further training to enable the school to meet the health care 
needs of the child. This ensures cover when one is absent. 
In order that schools comply with the recommendations from the DH/DfES 
guidelines Managing Medicines in Schools and Early Years Settings 2005 and 
the  Disability  Discrimination  Act,  head  teachers  need  to  ensure  they  have 
sufficient members of support staff who are employed and trained to manage 
medicines as part of their duties. 
Where this is not the case, head teachers must ensure that when staff contracts are 
reviewed or new posts  created  this role is incorporated  in order  that the school 
complies with their Disability Equality Duties (DDA 2005). 
Training of school staff is done on an individual school basis by the child’s 
PDSN/CDNS and/or school nurse and parents. Staff can be trained to take on 
a variety of skills including blood glucose monitoring and insulin 
administration. 
The  child’s  PDSN/CDNS  and/or  school  nurse  and  parents  will  update 
school staff training and reassess their competence annually. 
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STAFF INDEMNITY 
County Councils fully indemnifies school staff that are insured through the county  
council’s  insurance  scheme  against  claims  for  alleged  negligence, providing 
they are: 
1.   Acting within their scope of duties; 
2.   Have followed documented procedures set out within this guidance; 
3.   Have received up to date training from an appropriately qualified health 
care professional; 
4.   Have been assessed as competent; and 
5.   Have maintained their competence by regular practice of the skill. 
 
5.0      WHAT IS DIABETES? 
Diabetes mellitus is a long term medical condition where the amount of glucose 
(sugar) in the blood is too high. This is because the pancreas does not make any or 
enough insulin, or because the insulin does not work properly or both. There are 
two main types of diabetes: 
 
5.1      TYPE 1 DIABETES 
Type 1 develops when the pancreas is unable to make insulin. It usually presents 
before the age of 40. The majority of children and young people have Type 1 
diabetes.4        Children  with  Type 1 diabetes  will need to replace  their missing 
insulin. This means they require insulin by multiple daily injections or an insulin 
pump for the rest of their lives. It is not related to diet or lifestyle and there is 
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5.2      TYPE 2 DIABETES 
Type 2 diabetes is most common in adults, but the number of children with Type 
2  diabetes  is  increasing,  largely  due  to  lifestyle  issues  and  an  increase  in 
childhood obesity. It develops  when the pancreas can still produce insulin but 
there is not enough or it does not work properly. 
It often appears after the age of 40. This type is linked, to among other things, 
being overweight. 
It  can  be  managed  with  diet  and  exercise  alone,  but  may  require  tablets  or 
insulin. 
4  Growing Up with Diabetes:  children and young people with diabetes in England.  
Research Report by the Royal College of Paediatrics and Child Health.  March 2009. 
6.0      TREATING DIABETES 
Children with Type 1 diabetes manage their condition by the following: 
• Regular monitoring of their blood glucose levels 
• Insulin injections or use of an insulin pump 
• Eating a healthy diet 
• Physical activity 
The  aim  of  the  treatment  is  to  keep  the  blood  glucose  (sugar)  levels  within 
normal limits. People who do not have diabetes have blood glucose levels that are 
<7 mmols.  Blood glucose levels need to be monitored several times a day. It is 
likely that a child will need to do this at least once whilst at school. Younger 
children may need help with this. 
Poorly  controlled  diabetes  increases  the risk  of developing  long  term 
complications such as damage to the eyes, kidneys, nerves, heart and blood vessels. 
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6.1      BLOOD GLUCOSE MONITORING 
At school this may need to be done before a meal, anytime the child feels unwell and 
possibly before or after physical activity.  Exact details will be discussed and 
documented in the child’s Individual Health Care Plan (IHCP). 
Blood glucose monitoring involves the pricking of a  finger to obtain a tiny drop of 
blood using a special device called a lancet. A small amount of blood is placed on 
a test  strip  into a small  electronic  meter  which  displays  the  reading.  The 
reading is displayed as a number in mmol/l.  The target range for most children 
with  diabetes  is  between  4-8  mmol,  but  children  may  have  individual  target; 
however this can be difficult to achieve particularly in the under 5s and during 
puberty. The test takes as little as a minute. This testing is vital to the management  
of  the  condition  and  regulation  of  insulin  and  must  be facilitated by a 
member of staff if the child is unable to do so themselves. 
The child should be asked if they wish to do this testing in private and a suitable place 
made available (not the toilet), though does not need to be out of the classroom. 
The child should carry their own blood testing kit and should have it with them at 
all times. Some children will be able to do this independently whilst others, 
particularly  primary  school  age,  may  need  supervision  or  assistance  from  a 
member of staff. If it is not feasible for the child to carry their blood glucose meter 
with them, it should  be stored  in a safe  place,  obtainable  at all  times.    It is 
important however to discuss the safe use and disposal of equipment in the 
classroom. 
A sharps bin should be provided for safe disposal of sharps and locked away 
when not in use. Contact your school nurse for advice on the supply and collection 
of sharps bins. 
• Refer to local sharps policy (School nurse should have local policy) 
• Trained staff can refer to Procedure on Blood Glucose Monitoring in their 
individual training package. 
The child’s Individual Healthcare Plan (IHCP) will specify their individual blood 
glucose monitoring regime. 
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6.2      DIET 
As with any child, a balanced and healthy diet is important (one that is low in fat, 
salt  and  sugar).  A regular  intake  of  starchy  carbohydrates  (bread,  cereals, 
potatoes, pasta or rice) is important to provide an energy source.   Fruit and vegetables  
should  be  encouraged  and  sugary  drinks  and  very  sweet  foods avoided. Details 
should be contained within the IHCP, or advice sought from the diabetes nurse, 
particularly for children who adjust their insulin dose according to food intake or use 
insulin pumps who may be allowed some sugary foods. 
Children with diabetes may choose to have school dinners or a packed lunch. 
Whichever they choose, the meal should contain: 
 Starchy carbohydrate e.g. pasta, rice, potato, bread 
 Fruit, vegetables, salad 
 A drink that is water, or sugar free. 
Some children will need to eat approximately the same amount of carbohydrate at 
lunch times to keep blood glucose levels under control.  Others will be required to 
count the carbohydrate content of each meal and snack. Further information on this 
can be obtained from the child’s parents or Diabetes Specialist Nurse. 
It is important to know the times the child needs to eat and organise this 
accordingly, e.g. they may need first sitting of lunch. In larger schools it may be 
useful to supply the child with a dinner pass that allows them to jump the 
queue. 
School Dinners 
Younger children on school dinners should be supervised by a member of staff to 
ensure they choose the right things, and that they eat all of their dinner. The 
head  teacher  is  responsible  for  selecting  members  of  staff  for  this  duty  and 
ensuring  it  is  carried  out.  Where  schools  have  a  pre-planned  rolling  menu, 
parents should be able to select the choices with their child beforehand and give this 
to the head teacher. The head teacher should ensure that all staff involved with 
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school dinners know which children have diabetes and provide them with a copy of 
the child’s  pre-planned  menu  choices.      The insulin dose may vary according  to 
what the child has eaten and their blood glucose reading.   This should be 
documented in the child’s ICHP. 
Packed Lunch 
Younger children with a packed lunch should also be supervised to ensure they eat 
all of their lunch and that they don’t swap items with other pupils. Parents are 
responsible for providing the packed lunch. The insulin dose may vary according to 
what the child has eaten and their blood glucose reading. This should be documented 
in the child’s IHCP. 
If the child has their normal insulin injection and does not eat all of their lunch, 
please contact the parents for advice. 
Older children are usually more knowledgeable about their choices and may alter 
their insulin dose depending on what they have eaten. School staff should encourage 
them to make healthy choices, and still contact the parents for advice if they have 
concerns. 
Snacks 
Some pupils with Type 1 diabetes need to eat at regular intervals. Missing a meal or 
snack could lead to a low blood glucose level requiring emergency treatment. 
Whilst the child will normally do this at school break times, there may be 
occasions when a snack will need to be taken during lessons. This may be 
particularly important before P.E. or during times of stress e.g. exams. 
If a child with diabetes asks to eat during a lesson this should be accommodated. 
Under no circumstance should a child be refused or told off for this request. It may 
be useful for the teacher to explain the nature of diabetes to the class to enable the 
other pupils to be supportive and understanding. This of course  should  only  be  
done  with  the  child’s/parents  consent.  The  Juvenile Diabetes  research 
Foundation  (JDRF) can provide teachers  with class activity plans to help with this. 
Visit  www.jdrf.org.uk 
The child’s IHCP will state dietary routine whilst at school. 
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6.3      INSULIN THERAPY 
Most children have Type 1 diabetes.  This means that it is highly likely pupils will 
require one or more insulin injections during the school day. Insulin can only be 
given as an injection or via a pump device. 
Some children are prescribed a fixed dose of insulin, but other pupils may need to 
adjust their insulin dose according to their blood glucose readings, food intake and 
activity.  Insulin is absolutely vital to their everyday life. Without it, they would 
die. Some pupils use a pen-like device to inject insulin several times a day, but 
some may receive continuous insulin through a small pump. 
Insulin pens 
Insulin pens are very popular with young people as they are discreet and easy to use. 
The insulin pen should be kept at room temperature but any spare insulin should 
be kept in the fridge. When opened it should be dated and discarded after 
1 month. The head teacher should nominate a member of staff to liaise with the 
child (older) and their parents to check stocks and dates weekly. Parents should 
ensure  enough  insulin  is  available  at  school  and  on  school  trips  at  all 
times. 
Insulin should not be kept in direct sunlight or near a radiator as it is destroyed by 
extreme heat. Older children will probably be able to independently  administer 
their insulin. However, smaller children may need supervision or an adult to do 
this for them. Always  refer to the child’s Individual  Healthcare  Plan regarding 
their insulin requirements. 
• Trained school staff can refer to the procedure on How to inject insulin 
using an insulin pen, contained in their individual training package. 
Insulin Pumps 
Insulin pumps are usually worn all the time but can be disconnected for periods of 
PE and bathing etc. They are about the size of a mobile phone and can be 
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discretely worn e.g. attached to a belt or in a pouch. They continually  deliver 
insulin into the layer of tissue just beneath the skin (subcutaneous tissue). Many 
insulin pumps can calculate how much insulin needs to be delivered when 
programmed with the child’s blood glucose level and food intake. 
Some children may be able to manage their pump independently, but others may 
require supervision or assistance. 
Always  refer  to the  child’s  Individual  Health  Care  Plan  for  the  child’s  insulin 
therapy requirements at school. 
• Trained staff can refer to Procedure for Insulin Pumps, contained in their 
individual training package. 
Medication for Type 2 Diabetes 
Although Type 2 Diabetes is mainly treated with lifestyle changes (e.g. healthy 
diet, losing weight and increased exercise) tablets or insulin may be required to 
achieve normal blood glucose levels. 
If medicines need to be taken during school time, the school should facilitate this. 
Your school will have an existing policy on medicines in schools which should be 
followed. 
• Refer to school’s Medication Policy or DfES guidance 2005. 
Always   refer   to   the   child’s   Individual   Health   Care   Plan   for   medication 
requirements. 
6.4      EXERCISE AND PHYSICAL ACTIVITY 
Exercise and physical activity have benefits for everyone, including children with 
diabetes. People with diabetes are more at risk of heart disease, so it is essential that 
children with diabetes are included in exercise at school. Having diabetes should not 
stop them from taking part in PE or even being selected to represent the school or 
other sporting clubs. 
However,  because  exercise  uses  up  muscle  fuel  (carbohydrate)  it  can  lower 
blood glucose levels, and therefore there is an increased risk of a hypoglycaemic 
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episode occurring in children with diabetes. With proper planning however, this 
can usually be avoided. 
All school staff involved in supervising exercise should: 
• Be aware of children with diabetes in their care and the effects of exercise on 
their blood glucose levels. 
• Make sure the child has taken a blood glucose reading (younger children 
may need help with this) just prior to the activity to check that it is safe to 
take part. This is particularly important for swimming. 
• Carry hypoglycaemia treatment with them and know where the emergency kit 
box is located. In larger schools it is a good idea to keep one in the PE 
Department 
• Allow the child to take a bag with them if it contains emergency supplies 
e.g. drinks and snacks. 
• Be able to recognise and treat a hypoglycaemic episode. 
• If planned exercise is prolonged (i.e. 45 minutes) the child may need an 
additional drink and snack before and/or during exercise.  (See Individual 
Health Care Plan). 
• Note that older children may alter their insulin around exercise so always 
check with them first as they may not need to eat a snack. 
• Be aware of those children using an insulin pump. Inform the child of the 
nature of the exercise and duration so that they can decide if they need to 
disconnect their pump. (Younger children may need help with this). 
• Check that the child has reconnected their pump at the end of the activity. 
(Younger children may need help with this) 
• Encourage the child to check their blood glucose reading at the end of the 
activity if required. (Younger children may need help with this). 
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• Contact  the  parents  for  advice  if  the  blood  glucose  is  outside  an 
acceptable range according to their IHCP.   If below 4mmol follow the 
hypoglycaemia protocol. 
PE TEACHERS – REFER TO IHCP 
7.0      DIABETIC EMERGENCIES 
A child’s blood glucose may vary during the school day. It may be too low 
(hypoglycaemia  or hypo)  or too high  (hyperglycaemia  or hyper).  Both of 
these situations can make the child ill and render them unable to safely look after 
themselves.  It is during  these  times  that  a child is most  likely  to need  adult 
support. 
All  school  staff  should  have  an  awareness  of  diabetes  and  be  able  to  offer 
practical assistance to the child during an emergency. 
All staff should know where the emergency kit box is kept. 
7.1      EMERGENCY KIT BOX 
An emergency kit box should be kept in school for each child with diabetes. It 
should  be  labeled  with  the  child’s  name  and  class  and  emergency  contact 
numbers. In larger schools it is a good idea to have several strategically placed. 
It is suggested the kit box should contain snacks, a sugary drink and dextrose tablets. 
However, the exact contents, as well as details relating to emergency action 
school staff need to take in the event of a hypo/diabetic emergency, will be stated in 
the child’s Individual Health Care Plan. 
The parents are responsible for supplying the school with the kit box and for 
keeping it stocked. 
The head teacher should make all staff aware of where it is kept and should 
inform the parents once supplies have been taken from it. 
The head teacher should ensure all school staff read this policy and that all new  
or  temporary  staff  are  made  aware  of  children  in  their  class  with Diabetes. 
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General awareness training for staff can be arranged by contacting the child’s 
PDSN/CDNS and/or speak to school nurse. 




This occurs when blood glucose levels fall too low (less than 4mmol/l). 
Hypos  are most  likely  to happen  before  meals,  if snacks  are missed,  during 
physical  activity,  after  physical  activity  or  when  the  child  has  diarrhoea  or 
vomiting. 
Teachers of PE in particular should be made aware of the signs. 
Hypos can occur if the pupil has taken too much of their diabetes medication, delayed  
or  missed  a  meal  or  snack,  taken  part  in  strenuous  or  unplanned physical 
activity, or if the child has been drinking alcohol. Hypos occur suddenly and cannot 
be predicted. Most children will have warning signs; however some children will not 
and may be completely unaware of their deteriorating state. Any child with 
diabetes who is feeling unwell should always check their blood glucose levels. 
A hypo should be treated quickly. If untreated, the child may become 
unconscious. Never leave a pupil alone during a hypo or send them off to get 
food alone. They should be supervised by an adult and someone sent to  get  
the  emergency  kit  box  if  the  child  does  not  have  their  own emergency 
supplies. Parents may need to be contacted if the episode is severe or the child 
remains unwell after treatment. 
Most children will know if they are hypo and will be able to take action or tell you 
what to do. They will normally require a sugary drink (not diet) or glucose tablets 
and sometimes  a snack from their school bag or emergency box.   Follow the 
child’s Individual Health Care Plan for specific treatment details. 
If unconscious place the child in the recovery position on their side, dial 
999 and contact the parents. Do NOT give them anything by mouth. When the 
paramedics arrive tell them the child has diabetes. 
The child’s Individual Health Care Plan will list the individual warning signs. 
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Warning signs may include: 
Feeling hungry 
Sweating Drowsy 
Glazed eyes, blurred vision 
Pale 
Shaky or trembling 
Headache 
Lack of concentration, vagueness 




• Refer to procedure for Hypoglycaemia. See child’s IHCP. 
• Trained staff can refer to procedure for Emergency Glucagon Injection p- 
contained in their individual training package. 
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7.3      HYPERGLYCAEMIA  (HYPER)  (BLOOD  GLUCOSE  MORE  THAN  
14 MMOL) AND KETOACIDOSIS 
This occurs when blood glucose levels rise and stay high.   Symptoms of 
hyperglycaemia  do not appear suddenly  but build up over time.   School staff 
need to be aware that whilst children can become unwell, they may show no 
symptoms.   A hyper may be caused by too little or no insulin, too much carbohydrate, 
stress, infection or fever.  Extra insulin will be required. 




Dry skin Nausea 
Blurred vision 
Prolonged hyperglycaemia can lead to a very serious condition called Diabetic 
Ketoacidosis  (DKA).   It can take anything from a few hours to a few days to 




Deep and rapid breathing (over- breathing) 
Breath smells of acetone (like nail polish remover) 
If a pupil displays symptoms of ketoacidosis, contact the parents immediately. If 
they are unavailable, call 999.   When the paramedics arrive tell them the child 
has diabetes. 
The child’s Individual Health Care Plan will list warning signs. 
 
 
DOI: 10.3310/hsdr02440 HEALTH SERVICES AND DELIVERY RESEARCH 2014 VOL. 2 NO. 44
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Peckham et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
139
HYPERs 
• Refer to procedure on Hyperglycaemia. See child’s IHCP. 
Staff training in diabetic emergencies is available from the child’s PDSN/CDNS 
and/or school nurse. 
8.0      SCHOOL TRIPS 
Pupils with diabetes must not be excluded from day or residential trips on the grounds   
of   their   condition.   They   are   protected   by   DDA   (Disability   and 
Discrimination  Act)  and  the  DED  (Disability  Equality  Duty).  However  good 
planning is essential. For residential trips parents should be informed at least 
7 days prior to the event and there should be a review of the risk assessment and 
the child’s individual health care plan with the appropriate diabetes nurse. 
Day Trips/Overnight stays 
Going on a day trip should not cause any real problems however staff should be 
aware that the routine is likely to be different from the normal school routine and to 
expect the possibility of hypos and hypers occurring.  As with residential trips, 
planning ahead is important to avoid any real problems. 
The child’s teacher should meet with the parents at least 72 hours prior to the 
trip to discuss arrangements and the child’s needs. There should be a review of  
the  existing  risk  assessment  tool  to  determine  if  any  additional  safety 
measures need to be taken. Teachers should choose the medical option when using 
this tool. 
All school staff on the trip should be aware of the child with diabetes and take 
with  them  a  copy  of  the  child’s  Individual  Health  Care  Plan  as  well  as  an 
emergency kit box for treating a hypoglycaemic episode.  Parents should ensure 
their child has all of their diabetic equipment and insulin with them and that they 
are happy with the arrangements. 
Overnight  stays  will  need  more  planning.  It  is  useful  to  have  copies  of  the 
itinerary  and  sample  food  menus  available  at  the  first  planning  meeting. 
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Involving the child’s Paediatric Diabetic Specialist Nurse (PDSN) and/or school nurse 
is advisable. Higher staffing levels may be required to supervise the child with 
diabetes more closely. 
If the child is unwell or loses equipment on the trip take them to the nearest 
Accident and Emergency Department. 
Check that travel insurance is suited. 
For information and advice about traveling abroad contact: 
Diabetes UK - 020 7424  1000 
www.diabetes.org.uk 
9.0 OTHER CONSIDERATIONS 
General Sickness 
If a child is unwell their blood glucose level may rise, even with a cold. 
Having high blood glucose levels may make the child thirsty and need to pass 
urine more frequently. If school staff notice this, they should contact the parents for 
advice as the child may need extra insulin. 
Vomiting 
If a child with diabetes vomits at school, monitor the child’s blood glucose level 
and contact the parents for advice. Look out for signs of a hypo or hyper and 
treat accordingly. 
10       HELP AND ADVICE 
School staff can obtain further help and advice from the following: 
1.  Diabetes UK 
Phone - 020 74241000, 
www.diabetes.org.uk 
Email -  info@diabetes.org.uk 
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2.   Juvenile Diabetes Research Foundation (JDRF) 
Phone-  0870 240 1640  - to order  a free cross-curricular  resource  and 
management tool kit. 
www.jdrf.org.uk 
3.  Department for Education (DfE) formally DCSF, 
www.teachernet.gov.uk 
4.   www.medicalconditionsatschool.org.uk 
5.  Your school nursing team 
6.  The child’s PDSN/CDNS 
7.  The child’s parents 
8.  Head  of  SEN  and  Children  with  Additional  Needs  based at the            
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• Policy for the management of diabetes in schools. Standard Circular HIS 
9. May 2008.  Fife Council Education Service. 
12       LEGISLATION 
Under Section 175 duties of the LA and Governing Bodies of the Education Act 
(2002) it states that; 
1.  A local authority shall make arrangements for ensuring that the functions 
conferred on them in their capacity as a local education authority are exercised  
with  a  view  to  safeguarding  and  promoting  the  welfare  of children. 
2.  The Governing body of a maintained school shall make arrangements for 
ensuring that their functions relating to the conduct of the school are exercised  
with  a  view  to  safeguarding  and  promoting  the  welfare  of children who 
are pupils at the school. 
Disability Discrimination Act (DDA) 1995 
Whilst a pupil with diabetes may not consider themselves to be disabled, in many 
cases they will meet the statutory definition of disability. 
SENDA 2001 
The Special Educational Needs and Disability Act affords protection to pupils. 
It is unlawful for schools to treat disabled pupils less favourably than their non- 
disabled peers for a reason that relates to the person’s disability (the reasonable 
adjustments duty). If a disabled pupil is, or is likely to be, at   a substantial 
disadvantage, schools are legally obliged to take all reasonable steps to prevent that 
disadvantage, by implementing reasonable adjustments e.g. a child with diabetes 
cannot be excluded from a school trip or sports event for a reason that directly 
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Disability Equality Duties (DDA 2005) & Equality Act 2010 
Requires schools to: 
 Promote  equality  of  opportunity  between  disabled  persons  and  other 
persons; 
 Promote positive attitudes towards disabled persons; 
 Take steps to take account of disabled person’s disabilities even where that 
involves treating disabled people more favourably than their non- disabled 
peers. 
Schools have to show they comply in everything they do - right from the planning 
stage onwards. 
 
Health and Safety at Work Act 1974 (HASAWA) 
Schools  have an obligation  to protect  pupils  against  risks to their health  and 
safety e.g. where a pupil suffers as a result of being denied treatment (this could 
include denying a snack to prevent/relieve hypo). 
Refer to the school’s Health and Safety Policy. 
National Guidance NUT - (Health and Safety Briefing on Diabetes) Encourages 
the uninterrupted education in schools and support of children with diabetes; 
Advocates the implementation  of policies with individual Health Care Plans.   
However, it states that there is no legal or contractual duty on teaching staff to 
administer  diabetes  medicines  and that this is nevertheless  voluntary. This 
briefing is available from NUT by phoning 0207 380 4775 or NUT website at 
www.teachers.org.uk. 
DfES - Managing Medicines in Schools and Early Years Settings 
Available from DfES by phoning 0845 6022260 
http://publications.teachernet.gov.uk. 
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Appendix 5 Case study 2 exemplar
The exemplar focuses on the development and implementation of a model of enhanced 
diabetes care within primary care settings, supported by specialist expertise. 
Background
A number of key factors influenced the re-design of diabetic services within case study 2 
(CS2).
Disease Projections: The number of patients with Type 2 Diabetes (T2DM) within CS2 in 
2008 was approximately 21,600; Type 1 (n=1700) – with another estimated 2,000 cases 
remaining undiagnosed, following diagnosis this group was more likely to present with 
established complications. Projections suggested that the number of diabetic patients would 
increase to over 30,000 by 2020 (Public Health Report 2008). 
Demands on Secondary Care: Approximately 430 patients per year were admitted to hospital 
as a direct result of their diabetes, and at any one time, more than 10% of patients in hospital 
had diabetes (Public Health Report 2008). In 2008, all patients with requirements above 
routine management were referred to hospital irrespective of need – this was felt to be 
unsustainable in the future. 
Stakeholder Feedback: A number of public consultations also identified the need to review 
services. A public consultation exercise ‘Achieving Balanced Health” (March – June 2007) 
identified a number of public priorities in relation to diabetes: -
· Improved communication between primary and secondary care
· Care nearer to home and at single location; 
· Better engagement with diabetic patients from Black and Minority Ethnic (BME) 
groups.
Similar issues were highlighted in the Health Commission’s National Patient Survey (2008) 
of people with diabetes (n=800 patient questionnaire). 
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Key Policy Drives and Service Gaps: Service review identified a lower uptake to retinopathy 
screening than the national average with an overall rise in admissions (Public Health Report 
2008).
Diabetes Service Re-design – Community Diabetes Service (TYPE 2 Diabetes)






The community service was to ensure that patients were cared for at the most appropriate 
level and to reduce the burden on the specialist provider. The community service would 
comprise of a multi-disciplinary team (MDT) of clinicians and health care professionals with 
relevant skills and competencies.  The re-focusing of care would be away from secondary 
services but would be fully supported by senior consultants – it was expected that Level 1 
(Routine) and Level 2 (Enhanced) care should take place within primary care.
This view was also supported by the Integrated Care Vision and Strategy, which highlighted 
the ambition to transform the way patients and citizens accessed local healthcare – with a 
greater volume and breadth tailored, personalized services made available in their own homes 
and/or communities. 
Other important aspects of the new service were the identification and targeting of people 
with diabetes who were at risk of hospital admission or re-admission. This service 
development also had to be in-line with the Strategic Health Authority (SHA) approach to 
diabetes service delivery focusing on independence, choice and control.
Key Financial Benefits: 
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· Reduction in variation in care against 2008-9 Quality and Outcome Framework 
(QOF) baseline
· Increase in patients transferred out of specialist care (level 3) into routine (Level 1) or 
enhanced (Level 2) care
· Quality, Innovation, Productivity and Prevention (QIPP) guidelines – linked to 
financial projections for diabetes care in the community: -
o Central (service based in one PBC area) expected to deliver net savings of: -
Yr 1 £17K,
Yr 2 £78K 
Yr 3 £93K  
o Citywide (roll out of service to all areas) – expected to deliver net savings of: -
Yr 1 £95K 
Yr 2 £111K
Yr 3 £113k 
The PCT suspended tariff and ring-fencing monies spent on diabetic out patients
Service Specification: Identified that the majority of T2DM patients on oral agents, incretin 
mimetics and daily insulin regimens would be managed in primary care. The main aim was to 
assist primary care teams to deliver more complex care, which would require the up skilling 





Consultants would also provide clinical supervision to the specialist team and primary care 
personnel. Initially, the community diabetic service would be implemented in one PBC area 
of the city and a Diabetes Planning and Commissioning Group was established to support the 
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transition process. This group had lay representation via local representatives of Diabetes 
UK. 
Patient education was seen as key enabler within the service re-design, with patient referral to 
structured education courses such as DESMOND recommended. Primary care services 
already offered Expert Patient Programme, health trainers and diabetic support workers. 
Specialist nurses would deliver short-term interventions such as insulin initiation with referral 
back primary care following 3 or 4 contacts, with management plans jointly agree with 




· To improve the quality of care via: -
o Clinical effectiveness; 
o Patient safety 
o Patient satisfaction
· To improve clinical outcomes. 
Main Outcomes: -
· Patient supported via a care planning approach
· The same if not better clinical outcomes as the previous service
· Good patient experience
· An increased number of patient care provided outside the hospital setting
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The service was initiated in a phased way – focusing on one of the PBC groups within the 
city, service roll out to citywide was implemented in March 2012. The Community Diabetes 
Service was launched In April 2009. The specialist team is consultant-led and includes 
community nurses and dieticians. The team provides support and expertise relating to: -
· Self-management
· Diet and Lifestyle
· New Therapies
· Initiation of Insulin Therapy 
The team runs community support clinics to help diabetic patients better understand and 
manage their own condition and live a more independent life. They also provide training for 
practice nurses so they can offer on-going care for diabetic patients. The team attended final 
out-patient appointments to highlight and discuss the new service to aid transition to primary 
care and to allay concerns. 
On-going patient feedback on redesigned services is included as a standard in annual 
evaluation reports (Clinical Commissioning Executive, 2010). Public consultation around 
successive updates of ‘Achieving Balanced Health’ public consultation has confirmed the 
publics’ willingness to use alternatives to hospital where services are available – on-going 
discussion and dialogue is built into the timeline as well as formal Transfer of Undertakings
(Protection of Employment) (TUPE) consultation (Clinical Commissioning Executive, 2010). 
Service Timeline with Achievements 
Year 2009 – 1250 patient follow up appointments for diabetes took place in the community 
instead of hospital (Annual Report 2009/10). 
Year 2010/11 – Diabetes services at hospitals had been re-commissioned using the levels of 
care set out in the long-term conditions strategic framework - with this service focusing on 
Level 3 specialist care. Anyone admitted as an emergency with diabetes was placed directly 
in the care of a consultant diabetes physician. Funding was made available for the national 
THINK GLUCOSE campaign, which included hospital staff training. Continuing liaison 
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between the specialist service and Ambulance Authority – ambulance personnel are to inform 
the Diabetes Specialist Nurses to follow up an emergency call out. 
Year 2012 – Community Diabetes Service rolled out citywide in March – the Clinical 
Director (Diabetes and Endocrinology) described feedback from professionals and patients as 
very positive, with improvement in HbAlc levels. The re-design reflected a more highly 
specialized secondary care service, focusing on diabetes in-patients (16%). Almost 3000 
patients with Type 2 diabetes have been discharged from secondary care – the money saved 
has been re-invested into the multi-disciplinary specialist community team.
Highlighted the belief that tariff based services (particularly where there are different tariffs 
for hospital and community patients) are unhelpful when trying to deliver care across 
boundaries. - the service remains as a block tariff. 
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Appendix 6 Case study 3 exemplar
Patient and Public Involvement in the reorganisation of diabetes services in Case Site 3 
(CS3)  
Culturally sensitive healthcare for the BME community 
 
Introduction to CS3 
CS31 is a large urban town situated in the South of England with a population of around 
200,000.  It is ethnically diverse with a large black and minority ethnic (BME) population 
(around 40.6% of total population2) with significantly higher populations of Pakistani, 
Bangladeshi, Indian and African Caribbean compared to its regional neighbours3. It also has 
comparatively higher than average mixed ethnic and white Irish populations and increasingly 
large minority groups from Eastern European areas, such as Poland.  It is a generally young 
person’s town, having a higher average percentage of people under the age of sixteen than 
within its region4, with a higher than average birth rate but also a rising older age group 
population5.  The Pakistani and Bangladeshi populations are projected to rise by 
approximately fifty per cent between now and 20306  
 
Background to reconfiguration of diabetes services 
Services for diabetes are in the process of being reconfigured to provide more ‘patient 
friendly’ services delivered, in most part, in the community.  Historically there was perceived 
an over reliance on secondary services for diabetes and this was viewed as both inconvenient 
for patients as well as an inefficient use of NHS resources.  The model for delivering diabetes 
services would be through levels of care, from basic and enhanced GP services [level 1 and 
1a} to intermediate community [level 2] and specialist care [level 3].  Patients would be 
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allocated to the appropriate level based on an assessment of risk.  New community integrated 
multidisciplinary teams are being developed to support patients and supplement care 
delivered by GPs, including up-skilling primary care practitioners in diabetes care.  The 
multidisciplinary teams include practitioners from primary, secondary, community and social 
care.  The focus of care will be on prevention, early intervention and support for self-care.  
The main outcomes expected from this reorganisation include a cost saving resulting from a 
reduction in hospital stays and out-patient appointments as well as improved patient self-care 
knowledge and patient satisfaction.  Increased equity of access, particularly for ethnic 
minority patients, is also identified as a key outcome from this reorganisation.  Planning has 
been on-going since early 2010 and there has been a draft business case since July 2011. 
Service specifications have yet to be agreed and it is anticipated that this will not be fully 
operational until April 2014.  
 
The BME community in CS3 
The new service model aimed to address service gaps and unmet needs, including those for 
Black and Minority Ethnic [BME] groups, who were seen to have a lower uptake on some 
diabetes services, such as retinal screening7 as well as having a lack of knowledge and 
awareness of services8  One provider reported that GP referral rates for diabetes services were 
variable for some of the BME community.  Diabetes prevalence in the case study site is 
higher than the national average (6.5% in 20109) though below estimation rates (8.7%) 
indicating that a large number of the population are not yet diagnosed10, with the likely 
possibility that a large number of these would come from the BME community.   
 
National data show that diabetes is six times more common in people of South Asian descent. 
In this case study site the highest rates of diabetes are in wards with a high concentration of 
South Asian communities.  These wards also have the poorest health outcomes in the 
Borough.11   
 
Involving patients and the public in commissioning diabetes services  
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Patient and public involvement in the new diabetes service redesign was tracked for a period 
of eighteen months [from September 2011 to March 2013].  In July 2011 a business case for 
the service redesign was in development and implementation was planned for autumn 2011, 
though they did not get the ‘go ahead’ for implementation until July 201212.   
 
During the redesign there were a variety of methods employed for engaging with patients and 
the public.  The main thrust of engagement appeared to be around assessing needs and 
developing service specifications. Needs assessment involved reference to data from patients’ 
experience of local services, including patient satisfaction measures from GP practice 
surveys13.  This indicated that service users would welcome services closer to home.  
National patient organisations (such as Diabetes UK) were consulted via a Cluster level 
diabetes group14.  On a local level, a diabetes Local Implementation Group [LIG] was set up 
to plan the implementation and help develop local service specifications.  Patient and public 
membership on this group was limited15.  A patient representative was eventually recruited by 
his dietician to sit on the group but did not feel that he had much to offer as much of the 
planning had been agreed and the agenda was often too clinically specialised and technical16.  
Other engagement activities involved diabetes specialist community providers meeting local 
patient groups to inform and educate service users and commissioners meeting with local 
community organisations, specifically those from the BME community, to discuss needs and 
plans. Focus groups and surveys were also carried out with Bengali speaking and other BME 
representatives about specific health needs and experiences.  
There was little evidence of any wider discussions with patients and the public on the new 
services.  Plans were to commence this in some form once the new services were in place, 
with the intention of informing the public and receiving feedback17.   Much of the current 
reconfiguration work has been around staff development, including up-skilling primary care 
providers on their new roles and ways of working.   
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A diabetes service for the local BME community 
As part of the diabetes redesign, local healthcare commissioners and providers have been 
consulting with the BME community about how it could best meet its needs.  A number of 
meetings and focus groups18 have been undertaken with diabetic service users from the 
Bangladeshi community within their local community centre, situated in one of the high 
prevalence of diabetes wards.   
Representatives from this community have indicated that they would welcome diabetic 
services, including advice and guidance on self management, within their community, rather 
than through their GP or general NHS community health centre.  Other main findings of the 
Bangladeshi community with diabetes included: 
· Limited availability of culturally specific health information in own ‘mother tongue’ 
language.   
· Varying experiences of services for diabetes – some dissatisfaction expressed around GP 
access, waiting times and follow up care, many feeling that they are not listened to or 
ignored by their GP.  
· Responders stressed the importance of their local community centre as ‘a hub for 
information about health and well-being’ – particularly for those whose English speaking 
is poor. 
· Participants were keen to become involved in the planning of healthcare services for their 
community but lacked knowledge on how they could do this 
· There was a general lack of knowledge about how to make a complaint about health 
services 
· Some experienced a lack of feedback from health providers when commenting on local 
services or contributing to surveys  
· A preference for receiving diabetes care through a ‘specialist’ practitioner for diabetes 
rather than a GP.  
Further support for the provision of local, culturally sensitive health services was through a 
recent survey undertaken with local residents from the BME community19  where most of 
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those who had never been tested for diabetes said that they would attend for testing and 
lifestyle advice if a clinic was accessible within their local community.   
All those consulted in the focus groups regularly attend a local luncheon club at a community 
centre next door to their local Mosque where they also receive some general advice and 
guidance on healthy living and undertake a number of health related activities.    
The potential to receive specific diabetes and other long term conditions services within this 
or other similar community setting [i.e. close to their Mosque or Temple] as part of the health 
service redesign was being considered by NHS CS3.  The outcomes from the focus groups 
informed some of the initial discussion and planning. From speaking to and observing 
meetings with those responsible for commissioning and providing diabetes services in the 
community, plans were in place in 2012 for the development of an integrated community 
based diabetes [and other long term conditions] service for the BME community.  This was 
likely to be funded and staffed by diabetes specialist nurses working with a Bengali speaking 
support worker and delivered where the community gathered [such as within their own 
community centre or somewhere similar] and some further investment, in the form of funding 
extra diabetes specialist staff to work in the community, had been allocated20.    
Indicators for success 
It was anticipated that this service would lead to:   
· improved access to diabetic services for this group 
· increase in screening for diabetes  
· better knowledge and understanding of diabetes for this community 
 
Update on progress 
The project (to set up the BME service) was planned to commence in September 2012.  This 
was, however, put on hold due to staff capacity [the Bengali speaking support worker left on 
maternity leave and there was no one to replace her].  This delayed its development for one 
year and the plan was to set this up within the local BME community centre by September 
2013. Service specifications were to be developed through further discussions between the 
BME community, clinical providers and commissioners and these were being planned for the 
last quarter of 2012. However NHS re-organisation resulted in the loss of the lead 
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commissioner in December 2012.  The new commissioner is currently in the process of 
reviewing the business plan and it is not clear if this development will be on the agenda as 
initially envisaged as service specs had not been defined and funding had not yet been agreed.  
Recent communication [in March 2013] with one of the community providers suggested that 
they might be now thinking of providing a community ‘drop in service’ where health 
promoting advice and guidance would be offered, rather than the provision of integrated 
health and social care services as originally considered.    
A community hub for providing level two, integrated services for diabetes [and other long 
term conditions]  is also being planned though this will likely be for all LTCs patients21 rather 
than specific BME communities.  
Frustrated by the slow pace and delays/turnaround by the local NHS in developing the service 
the director of the BME community centre is now pursuing alternative funding (BIG Lottery) 
to help develop the centre as a diabetes advice and information centre.  He is also planning to 
build a fitness centre for his community where Bangladeshi and other BME women will be 
more encouraged to undertake health activities as ‘they would be likely to feel more 
comfortable among their own community’22.   
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Appendix 7 Focus group topic guide
Welcome, Thank people for coming.  Introduce self/colleague, organisation and study
Go through Information sheet (with help of interpreter)
· A focus group is a group of people brought together to talk about a particular issue –
in this case it is about health services for people with diabetes in Luton
· We want to get your thoughts and ideas – we want to know about what you really feel 
and think, not what you think you should say. 
· What you say will help the local health service plan better care for people like 
yourselves – we will be writing up a report of this meeting for the people who plan 
health services (but we will not disclose your names or any of your details).
· My job will be to ask the questions and to make sure that we stick to the topic and 
time – it should not be longer than one hour.  My colleague will not be talking but 
will take notes and record the discussion to help us remember how it went. We would 
really appreciate it if you were able to stay until the end but if you need to leave 
beforehand that will be ok – just let me know.
· You can withdraw at any time
Take signed informed consent
Agree Ground Rules (on flipchart paper – for interpreter to interpret if needed)
· Everyone’s views are valuable and should be listened to
· There are no right or wrong answers
· Only one person to speak at a time 
· Anything said in discussion will not be repeated elsewhere ‘what is shared in the 
room, stays in the room’.
Check people are happy for recording
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Start recording
Remind the group what they have been invited to talk about – what they think about 
patients being involved in planning services.  
· Tell me about the services you get
o What works well?
o What doesn’t work so well?
· When things don’t work so well do you know where to go to or who to speak to for 
support?
· As a person who has diabetes (or cares for someone who has diabetes), do you feel 
that you have a say in decisions that are made about services?
o Are you asked for your views and ideas?
o Do you feel your views are listed to?
Who do you think makes decisions about the [diabetes] services that are provided?
o Do you understand what the term ‘commissioning’ means? (Explain)
o Do you know what is currently happening in local commissioning and service 
provision?
o Would you know how to contact commissioners to put your views across?
o Do you know how you can get involved in decision making?
What would commissioners need to do to make services better for you and your 
community?
(prompt:  provide more 
interpreters/information/access)
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o How can they make it happen (suggestions?)
o Is there any more information you would like?
After 50 minutes bring focus group to close. Summary of main points – ask group if they 
agree or if anything forgotten.  Thank people for taking part and answer any questions about 
what happens next in the study.
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Appendix 8 Information for participants of
focus group
London School of Hygiene & Tropical Medicine
(University of London)
Switchboard:        Telex 




SERVICE USER INFORMATION SHEET
Commissioning for Long Term Conditions
You are being invited to take part in this research study. 
Before you decide it is important for you to understand why the research is being done and 
what it will involve.  Please take time to read the following information carefully. Talk to 
others about the study if you wish.
· Part 1 tells you the purpose of this study and what will happen to you if you take part.
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· Part 2 gives you more detailed information about the conduct of the study.
Ask us if there is anything that is not clear or if you would like more information.  Take time 
to decide whether or not you wish to take part.
Thank you for reading this.
Part 1:
What is the purpose of the study?
The purpose of the research is to examine how Primary Care Trusts (PCT) takes into account 
the views of people who have a long term condition and to identify what impact this has on 
the commissioning process and pattern of services. 
Commissioning is the process through which a PCT decides what NHS services are needed 
and should be provided, who should provide the services and how they should be paid for.
The main aim of this study is to find out how service users are involved in the commissioning 
process.
Why have I been invited?
We are inviting you because you are a service user, or care for someone with a long term 
condition, or represent service users with long term conditions within one of three PCT case 
study sites around England. 
Do I have to take part?
Absolutely not. It is up to you to decide whether or not to take part. 
If you decide to take part you are still free to withdraw at any time and without giving a 
reason.  A decision to withdraw at any time, or a decision not to take part, will not affect the 
standard of care you receive.
What will happen to me if I take part? 
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If you agree to take part in the study one of the researchers will contact you. They will 
arrange a convenient time for you to come to a focus group which will be made up of 6-8
people with or representing people with a long term condition. With your permission the 
discussion will be recorded, but only the research team will have access to the recordings and 
they will be deleted at the end of the study. The focus group will take about 90 minutes and 
will seek your views on how service users are involved in deciding which and how long term 
condition services are provided. If you do have to travel for the focus group please give us 
your receipts and you will be reimbursed for your travel expenses. 
At the end of the group we will ask you to complete a quick rating scale about service user 
involvement. We would also like you to fill in the rating scale twice more over the next year 
so that we can see if there are any changes in how service users are involved in 
commissioning. 
What do I have to do?
If you agree to take part in the focus group, simply sign the response form and return to us in 
the pre-paid envelope. We will then contact you to arrange a time and place for the focus 
group. Before the focus group starts the researcher will answer any questions you have. You 
will be asked to sign a consent form giving us permission to conduct the focus group. You 
can leave the focus group at any time.
What are the possible disadvantages and risks of taking part?
There are no disadvantages except the time element required from you. 
You can withdraw from the study at any time.
What are the possible benefits of taking part?
There is unlikely to be any personal benefit from taking part. However, your participation 
may help PCT’s to involve service users more effectively in the commissioning process.  
What happens when the research study finishes?
The findings will be available to you on the project website. A report will be sent to the 
funders of the research and each PCT involved in the study.
What if there is a problem?
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It is unlikely that something may go wrong during the focus group, however if this does 
happen it will be dealt with immediately. The detailed information on this is given in Part 2
Will my taking part in this study be kept confidential?
Yes.  All the information about your participation in this study will be kept confidential.  The 
details are included in Part 2.
For more information about this study please contact:
Telephone: 
Email: 
If the information in Part 1 has interested you and you are considering participation, please 
read the additional information in Part 2 before making any decision.
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Part 2
As this is a focus group, it is very unlikely that anything could go wrong. However if you 
have a concern about any aspect of this study, you should ask to speak with the researchers 
who will do their best to answer your questions. Please contact Lorraine Williams on 020 
7927 2671.
If you are harmed by taking part in this research project there are no special compensation 
arrangements. If you are harmed due to someone’s negligence then you may have grounds for 
a legal action for compensation against the London School of Hygiene and Tropical Medicine
and the University of Hertfordshire but you may have to pay for it. The normal NHS 
complaints mechanism is available to you if you wish to complain about any aspect of the 
way you are approached or treated during the course of this study. Formal complaints should 
be addressed to: 
(Removed for confidentiality)
Should you require independent advice about making a complaint or seeking compensation 
you may wish to contact the: 
(Removed for confidentiality)
Will my taking part in this study be kept confidential?
All information collected in this project will only be accessible by the relevant research staff. 
The information we collect will be kept on secure university computers only accessible to the 
research team with password protection. All the information you provide will be treated 
confidentially. Your comments may be used as quotations within the study findings but will 
be anonymous and you will not be identified. You will also not be identified in any report or 
publication arising from this project. 
Who is organising & funding the study?
The study is being organised by a team of researchers at the London School of Hygiene and 
Tropical Medicine and the University of Hertfordshire.   They are being funded to do the 
study by the National Institute of Health Research.
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Who has reviewed the study?
All research in the NHS is looked at by independent group of people, called a Research 
Ethics Committee, to protect your interests. This study was given a favourable ethical opinion 
for conduct by the Great Ormond Street Hospital/Institute of Child Health Research Ethics 
Committee.
THANK YOU FOR READING THIS INFORMATION SHEET.
YOU MAY KEEP THIS INFORMATION SHEET.
Service user 
Focus Group Response Form
Yes, I am interested in taking part in a focus group and am happy for the 
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Appendix 9 Expert reference panel
TABLE 14 List of EVOC expert reference panel and exemplars reviewed
Exemplar Name of expert Role Perspective
Schools protocol Vivienne Marsh Paediatric Asthma Nurse Specialist at
NHS Dudley
Clinical/children
Bridget Turner Head of Policy, Diabetes UK PPI/diabetes
Lynda Edwards Specialist Community Practitioner
(School Nursing)
Clinical/school nursing
Pat Boyer Ex-head teacher of primary school Teacher in primary education
Sandra Ashby Head teacher of primary school Teacher in primary education
Diabetes service
reorganisation




Bridget Turner Head of Policy, Diabetes UK PPI (diabetes)
Professor Azim Majeed Professor of Primary Care and Head of





David Jones Head of Involvement and Improvement
Diabetes UK
PPI (diabetes)
Don Redding Policy Director, National Voices PPI (general)
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Appendix 10 Report from summative workshop
 
 
       
 
                                                                                                Engagement and Voice  
                                                                                           in Commissioning 
 
Involving patients in commissioning: 
what difference does it make? 
 
Workshop held in London on April 16th 2013  
 
Introduction 
This workshop was organised to present findings and discuss outcomes from a 
national study1 on how patients and the public are involved in local commissioning of 
healthcare services and how organisations, such as clinical commissioning groups 
(CCGs), engage with and enable the service user voice to be heard.  Over forty invited 
participants attended on the day, representing both lay and executive leads for patient 
and public engagement and involvement (PPEI) from a variety of clinical 
1 EVOC (Engagement and Voice in Commissioning) is a 3 year 9 month research project funded by the National Institute of 
Health Research (DH) and led by Professor Stephen Peckham (London School of Hygiene and Tropical Medicine and 
University of Kent) in collaboration with colleagues at the University of Hertfordshire. Commenced in 2009 it is running in 3 
case study sites in England. Further details about the project can be found at 
http://www.netscc.ac.uk/hsdr/projdetails.php?ref=08-1806-261 
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commissioning groups in England, as well as service user representatives and clinical 
commissioners.   
 
Diana Whitworth, chair of the EVOC advisory group, welcomed participants and 
provided an introduction to the workshop.  Dr Patricia Wilson, one of the lead 
researchers for the EVOC project, presented the main outcomes from the research2 
and questions were invited from the audience.  A series of two workshops, focusing 
on aspects of development of PPEI within the new health architecture, were facilitated 
by Douglas Smallwood, PPEI consultant.   
 
Questions for the workshops were: 
 
· What difference is public and patient engagement and involvement making to 
CCGs in:  
o decision making processes? 
o services that are being commissioned? 
o patient experience of services? 
 
· How will public and patient involvement be sustained beyond authorisation? 
o What actions are needed to sustain it? 
o How can sustainability be established and monitored? 
o How can experience be shared between CCGs to help sustain 
involvement? 
 
Lesley Goodburn, Head of Communications and Engagement, Staffordshire 
Commissioning Support Unit, then presented a working model of PPEI3. 
 
2 Presentation circulated separately 
3 Presentation circulated separately  
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This is a brief synopsis of the discussion
What difference is PPEI making to CCGs in their decision-making processes?
Cultural shift
Structures for decision-making were acknowledged as being in place, but their 
adequacy was questioned and there appeared to be little consistency in approach.  The 
need for collaborative working was important but it was unclear if this is happening in 
practice or in plans.  For some, PPIE’s impact on decision-making was viewed as too 
early to be on the agenda.  CCGs have been operational in shadow form for some time 
however PPEI vehicles, such as Healthwatch, are still embryonic.  The emphasis at 
present is more about developing a culture of trust and credibility through listening 
and providing feedback.   
Some informants were sceptical about the CCGs commitment to PPEI in decision-
making, suggesting that it could have the potential to be another ‘tick box’ exercise 
and might not be taken seriously, or even viewed as a ‘hindrance’.  A few lay 
representatives felt that their appointments were tokenistic as they were not given full 
voting rights despite being a member of the CCG Board.  
There was recognition that the rhetoric is changing, but questions were raised on a 
number of concerns, specifically whether this would translate into PPEI in decision-
making and how much priority would be given to PPEI? Variation across CCGs is 
likely.  GPs’ ability to engage with bottom-up initiatives was also questioned.
Suggestions to enable the process were offered. One involved changing the way that 
decisions are made, for example, the use of patient stories or case studies in all 
commissioning meetings, as many CCGs are now beginning to do. 
Recruitment and getting involved 
There was some discussion regarding the importance of ‘new blood’ in relation to 
PPEI recruitment. This approach could bring new ideas to decision-making process. 
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The importance of a charismatic, powerful PPEI representative was highlighted, 
although it was acknowledged that there might be concerns around involvement 
through self-interest.  Having some local credibility was also judged as important.  
PPEI representatives were more likely to be approached if they were already known 
to the organisation.  Their skill was acknowledged – lay members often ask the 
questions that others (e.g. clinicians) do not ask.  There was some discussion on 
whether being a lay representative was a job, or should it be? It was also questioned 
whether the general public knew how to be involved. 
A number of groups, organisations and initiatives were identified as links to potential 
involvement.  This included the Equality Delivery System and the Expert Patient 
Programme. 
Process 
It was observed that the current process for PPEI in decision-making was very limited 
and that CCGs needed to capture a range of different experiences both negative and 
positive. There were also thoughts on how decision-making could be operationalised 
– some noted the difference between single task focused decisions as well as the 
overall process of decision-making in relation to PPEI, both were seen as equally 
important but different. It would require GPs to work differently, ensuring that the 
right people needed to be involved and at the right time. A number of suggestions and 
examples of how involvement could be implemented were offered including: 
· Vertical integration of PPEI throughout care pathways 
· Use of the Equality Delivery System (EDS) to involve community in health 
through the equalities agenda 
Issues around communication processes, advocacy and funding were also highlighted.  
Questions such as how do people know how to air their concerns and in what capacity 
are people being asked to be involved?  Patients as customers have implications for 
shared decision making.   
What difference is PPEI making to the services that are being commissioned? 
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Resources
Although resourcing PPIE was not a recurrent theme from the research data within the 
EVOC project, many informants highlighted the impact of resources on service 
delivery and that CCG agenda had the potential to be dominated by resource issues. 
But it was not clear whether CCG resources were adequate for PPEI as they appeared 
to be targeted at ‘communications’ rather than ‘engagement and involvement’. 
Groups noted that the pressure was to save money; if PPEI could help ‘save money’ 
they would be listened to. However, it was noted that conversations between 
patients/service users and clinicians are different to ‘management’ conversations – it
should be patient focused not resource focused. 
Managing expectations
There was a suggestion for clarity e.g., talk openly about ‘cost effectiveness’ What do 
commissioners say when public demands cannot be met for financial reasons? e.g. out 
of hours service returning to local general practice. Feedback needs to be in plain 
English. There should be clarity in relation to parameters e.g. limited resources. 
Examples of PPEI in service redesign 
· PCT example was given of a Diabetes care pathway – which saw improved 
outcomes in HbAIc, increased ranking of PCT, with the suggestion of 
transferability to CCG, who have a chance to do things differently - ‘wiping the 
slate clean’
· EDS impacted on diabetes services (improving data quality)
· Collective voice improved podiatry and stroke redesign 
PPEI impact
Although there is a lack of research evidence for PPEI impact, it was agreed that it 
will be increasingly important, to ensure sustainability of PPEI, to show how it is 
having an impact on services and that individuals and organisations working in PPEI 
should collect and utilise the evidence where possible.  Evidence exists in the form of 
case studies where PPEI has changed services, in some cases reducing costs.  It was 
also seen as important to capture the patient journey not just focus on 
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complaints/compliments. There was a suggestion that NHS Commissioning Board 
(NHSCB) should hold PPEI intelligence.  
Organisational issues and collaborative working
CCGs need to make links between other factors relating to ill health e.g., money and 
housing. It was noted that Health and Wellbeing Boards acknowledge the social 
environment and there was a potential bridge between budgets and authorities 
(however, no incentive to marry budgets and services). CCGs needed to tackle what 
affects them locally as well as finding an appropriate environment for concerns. 
Accessibility of services was also highlighted with the hub and spoke model of acute 
service not seen as helpful.
The level of authorisation for CCGs was also viewed as significant for some as it 
would affect the ability to commission services and would also impact on the level of 
PPEI. 
There was little evidence on the day of collaborative working  between CCGs and 
CSUs on PPEI.    
What difference is PPEI making to the patient experience of the services? 
Patient story 
Many groups highlighted the importance of the ‘patient story’ - there was discussion 
of its use at CCG Board level with the suggestion that each meeting could start with a 
patient story/experience. It was important to identify both ‘good’ and ‘bad’ practice, 
so as to keep what is working well for patients. This needs a mindset that moves 
beyond tokenism as experiences need to be heard. It is also important to highlight the 
change that has been made as a result of the experience. In order for patient 
experience to make a difference to service – they do not need to be ‘technically 
proficient’ - all voices should be heard. Sharing of experience is also seen as really 
important. It was also seen that capturing the  ‘wider experience’ was required, with a 
balance between single interest groups, voice of carers etc – the experience does not 
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necessarily need to be disease focused - some case studies could be taken from 
Practice Patient Groups (PPGs)
Potential overload 
Groups highlighted that there was a potential for patient and members of the public to 
‘burn out’ (e.g. moving from LINk to Healthwatch) with the risk of disengagement, 
this potentially could be addressed by good active feedback.
How will Public and Patient Involvement be sustained beyond authorisation:  
What actions are needed to sustain it? 
Organisational ethos and commitment 
CCGs needed to be open and transparent, with a commitment to hear what was being 
said, with no boundaries between ‘them and us’. This meant equal partnership and 
developing trust. Again, change in culture was advocated as well as truly valuing 
patient experience, which should be reflected in quality outcomes and improvements. 
It was observed that patients/service users were not ‘numbers’ or ‘stats’ ... ‘we have 
names, views and valuable experiences’.  Questions were raised on whether structures 
had been put in place to sustain PPEI – it was not clear that they had in some quarters.  
An understanding of inevitable change was also viewed as important – how long will 
we have CCGs? The true cost and value of NHS services also needed to be 
understood by all.
Training & expertise 
“PPEI is an art’ was expressed by a number of the workshop participants. Appropriate 
skills need to be developed, as well as guidance through ‘good practice’ examples to 
help CCGs develop PPEI.  The sharing of good ideas was also highlighted as 
valuable. GPs need to know how and why to include PPEI – they often showed good 
intentions but were ‘scared’ to do it.  GPs leading PPEI could turn to Commissioning 
Support Units for help.  Having both lay and clinical PPEI leads on CCG boards was 
suggested as one method of supporting GPs in PPEI.   Recent organisational change 
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has led to a loss of expertise in the workforce.  Sustaining PPEI should therefore 
include some thought to transferring expertise, highlighting a need to leave a PPEI 
legacy for those that come afterwards.  Ensuring good links with the Local 
Authority/Health and Well-Being Boards is fundamental as they usually have good 
expertise in engaging and involving communities.  Access to appropriate training for 
patient and public also required. 
Process and Outcome 
A number of key points and actions were highlighted in relation to sustainability: 
· Mapping provision in the area –
JSNA, PRG
· Leadership (requires CCG 
investment and ownership) - need to 
champion the importance of 
GP/Clinical input and involvement
· Having clinical & non-clinical PPEI 
leads 
· Adequate resources including 
administrative support for PPEI
· A ‘minder’ to ensure commitment & 
implementation 
· Communication Strategy -
Groups/individuals to be kept 
· Identifying potential areas of involvement 
e.g. in service redesign, commissioning cycle
· Clear Terms of Reference  and glossary of 
terms (plain English)
· Ensure sustained engagement by identifying 
a mechanism for refreshing PPEI 
membership such as co-option and time-
limited appointments to 
Boards/Committees/Groups
· Involve local voluntary organisations and 
ensure this continues
· Public consultations are useful
· Learning from other successful models of 
PPEI (e.g. Social Housing)
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informed. How are groups and 
individuals going to be embedded? 
Feedback is essential.
· re/decommissioning, patient journey, 
patient feedback, service 
improvements (this is seen as 
cyclical) 
· Research to evaluate impact of PPEI
· Actions framework/template to focus 
on
· Clinicians asking (proactively) for 
patient/service user feedback
· Good structures and methods to co-
ordinate local commissioning with 
national specialised commissioning   
· Patients to lead patient reference groups -
effective patient groups were most often 
patient, rather than clinician led.
Outcomes
· What difference PPEI input is making
· Dissemination - different times and methods 
used
· Evaluate current position with regular review 
of outcomes and forward strategy e.g., 
positives and negatives, new areas of 
investigation (active work plan)
· Evidence of efficiency e.g., hospital patient 
groups, mental health patient groups.
How can sustainability be established and monitored?
To establish sustainability of PPEI the CCG will need to develop a level of trust and 
confidence with its community.  Being open, honest and transparent is a key factor for 
this, as well as having effective channels for communication built into the structures.  
Establishing PPEI sustainability
· Training is needed in PPEI (for lay and 
executive/employed or ‘staff’ level)
· Having sufficient resources (money, 
personnel)
· Having leaders and champions with 
clout
· Communications – generic - e.g., 
regular slots in local newspaper –
‘getting the message out’
Approaches to monitoring
· Record changes made as a result of PPI 
(as routine) 
· Evaluate outcomes – having measurable 
outputs agreed by patients and public 
· Performance dashboard at CCG Board 
· Equality analysis (legal requirement) 
· Through provider contract with 
‘consequences’ 
· National Commissioning Board to 
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· Sustainability versus tokenism.
· Incentivise CCGs and members –
benefits of getting them involved early 
on.
· Managing politics
· Involvement and awareness of JSNA 
· Local organisations acting together, 
shared interests e.g., 
voluntary/charities/M.Ps,
· Identify specific projects and pathways 
of care in local area with defined project 
plans and outcomes
· Communicating role to each part of PPI 
system to achieve critical mass for 
change
overview
· Annual PPIE report 
· Research – how CCG services look from 
different perspectives - 360 degree 
(national GP survey, hospital survey, 
LINks – compare and contrast)
· Disseminate research outcomes
· JSNA and use of LA – powerful 
monitoring tool
· Healthwatch as monitor (issue of 
capacity?)
· Use of website – results of feedback –
actions taken (you said – we did) 
· CQC inspection of GP practices
· Benchmarking: throughout patient 
pathway and against “most similar 
family” (comparable CCGs)
· Capturing patient experience over 
time/throughout service changes
Respondents added that it was also important to ensure that CCGs had good 
Commissioning Support Units to help with monitoring and that there was good use of 
the media (both negative and positive) including use of social media (Twitter etc). It 
was not necessary, however, to reinvent the wheel – existing monitoring tools should 
be used where possible.
How can experience be shared between CCGs to help sustain involvement?
For some this still felt like a bit of a vacuum, but there was acknowledgement that 
strategies needed to operate both at local and national levels. Would require open and 
honest relationships with an emphasis on ‘share and learn’. It was seen as important to 
develop relationships with other CCGs so experience could be shared, this 
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relationship should open and honest with an emphasis on ‘share and learn’. A number 
of suggestions were made:
Best ways of sharing experiences:
· Through conferences & forums – e.g. NHS 
Clinical Commissioners 
· Via networks:
o PPEI networks such as this 
workshop
o Utilise existing networks such as 
strategic clinical network  
· Use of press and media 
· Adopting an inclusive approach, for 
example incorporating other groups such as 
teenagers/schools 
· Getting the right people in the right room 
who make the decisions and hold the 
budgets 
· Meetings with lay members from different 
CCGs 
· Patient Revolution – sharing positive 
patient experience 
· Via a central database/web portal 
What to share:
· Sharing positive examples – cascade 
experiences out to local organisations 
(sharing could also include ‘bad’ 
experience and practice)
· Sharing cases of good practice 
Other areas to explore: 
· Identify CCGs with similar 
condition/demographic/equality/economic 
profile
· Identify similar CCGs in terms of practices, 
both general and acute
· Benchmarking – Local Area Teams and 
NSF
Some key conclusions from the day
· Key findings from EVOC study validated by respondents
· Clarity around ‘engagement’ and ‘involvement’, as identified in EVOC 
presentation
· There is no consistent approach to patient and public engagement and 
involvement
· Evidence is needed on how different approaches for PPEI impacts on 
outcomes
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· Strong support for approaches such as performance dashboards and patient 
stories
· CCGs and CSUs should be working more collaboratively on PPEI
· There was an identified need for learning and sharing PPEI – including PPEI 
leadership and skills development for patients, clinicians and other personnel 
working to support PPEI  
· The workshop demonstrated the scope for sharing approaches and experiences
Jane Smiddy, Lorraine Williams, Patricia Wilson, Joanne Reay (EVOC Research 
Team) and Douglas Smallwood.  April 2013
List of abbreviations
HbA1c A laboratory test for diabetes showing the average level of 
blood sugar (glucose) over the previous 3 months. 
CCGs Clinical Commissioning Groups





EDS Equality Delivery System
EVOC Engagement and Voice in Commissioning
JSNA Joint Strategic Needs Assessment
LA Local Authority
LAT Local Area Team
M.P. Member of Parliament
NHSCB National Health Service Commissioning Board, now called 
NHS England
APPENDIX 10
NIHR Journals Library www.journalslibrary.nihr.ac.uk
184
NSF National Service Framework
PPEI Patient and Public Engagement and Involvement
PRG Patient Reference Group
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Appendix 11 NHS fact sheet
Commissioning fact sheet for Clinical Commissioning Groups
July 2012
This fact sheet sets out the services to be commissioned by Clinical Commissioning Groups (CCGs) from
April 2013. It also sets out the complementary services to be commissioned by the NHS Commissioning
Board (NHS CB), local authorities and Public Health England (PHE). A number of previous documents have
described commissioning responsibilities, but this fact sheet is intended to be a helpful summary, with
further clarity on certain aspects. It is not a substitute for legislation or guidance or your own legal advice.
In general, you as CCGs will be responsible for commissioning health services to meet all the reasonable
requirements of your patients, with the exception of: certain services commissioned directly by the NHS
CB; health improvement services commissioned by local authorities; and health protection and promotion
services provided by PHE.
You will play a key role in promoting integrated care and, as a member of your local health and wellbeing
board(s), in assessing local needs and strategic priorities. This will mean working collaboratively with
local authorities and the NHSCB. You may decide to pool budgets or have collaborative
commissioning arrangements.
Your commissioning responsibilities (for the areas set out in part 1) will include: planning services, based
on assessing the needs of your local population; securing services that meet those needs; and monitoring
the quality of care provided.
In most cases, you will also be responsible for meeting the cost of the services provided. There will be
some services that you commission for your geographic area (e.g. A&E services) where the costs for an
individual patient may be charged to another CCG (i.e. in an area where the patient is registered or, if
unregistered, where they live). There will be guidance on this in due course, which it is expected will follow
the current ‘responsible commissioner’ arrangements.
Local authorities will take the lead for improving health and coordinating local efforts to protect the
public’s health and wellbeing. They will also provide advice and expertise on how to ensure that the health
services you commission best improve population health and reduce health inequalities. For health
improvement activities transferring to local authorities, such as smoking cessation, sexual health and drug/
alcohol services, you may wish to agree joint commissioning arrangements. You should also consider how
best to work with local authorities to ensure that health improvement activities are an integral part of the
healthcare services that you commission (more detail on local authorities’ commissioning responsibilities
can be found at: www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/documents/digitalasset/
dh_131901.pdf).
A new executive agency, PHE, will take the lead for public health at a national level. It will deliver a
number of national health services and support the development of the public health workforce. The NHS
CB will also commission some public health services nationally as agreed with the Secretary of State.
This fact sheet includes information that is subject to secondary legislation. For example, the list of
specialised and highly specialised services that the Board will be required to commission has not been
finalised; the final list will be included in regulations, which are expected to be laid before Parliament in
the Autumn.
DOI: 10.3310/hsdr02440 HEALTH SERVICES AND DELIVERY RESEARCH 2014 VOL. 2 NO. 44
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Peckham et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
187
Services to be commissioned by CCGs
Unless otherwise indicated (such as for urgent and emergency care), your commissioning responsibility will
be for your local population. Your local population includes registered patients (some of whom may live in
a different area) and unregistered patients usually resident in your area. It does not include members of
the armed forces, or their families if they are registered with Defence Medical Services (DMS) rather than a
NHS GP practice, nor does it include those detained in prison and other custodial settings.
Local authorities will provide public health advice to CCGs on the commissioning of these services.
CCG commissioning Related NHS CB commissioning
Urgent and emergency care (including 111, A&E and
ambulance services) for anyone present in your
geographic area
Out-of-hours primary medical services (for everyone present
in your area), except where this responsibility has been
retained by practices under the GP contract
Urgent care provided under GP contracts
Urgent dental care
Elective hospital care Specialised and highly specialised services
Hospital and community dental services
Public health services for children from pregnancy to aged
5 (Healthy Child Programme 0–5) including health visiting
and family nursing partnership (commissioned on behalf
of Secretary of State)
Antenatal and newborn screening aspects of maternity
services
Health services (excluding emergency care) and public
health services for people in prisons and other custodial
settings
Health services (excluding emergency care services)
for members of the armed forces and their families
(those registered with DMS)
Community health services (such as rehabilitation services,
speech and language therapy, continence services,
wheelchair services, and home oxygen services, but not
public health services such as health visiting and
family nursing)
Other community-based services, including (where
appropriate) services provided by GP practices that go
beyond the scope of the GP contract
Rehabilitation services
Maternity and newborn services (excluding neonatal
intensive care)
Children’s healthcare services (mental and physical health)
Services for people with learning disabilities
Mental health services (including psychological therapies) Mental health interventions provided under
GP contract
Some specialised mental health services
Secure psychiatric services
NHS continuing health care Operation of Independent Review Panels
Infertility services Infertility services for the armed forces and some infertility
services for veterans in receipt of compensation under the
Armed Forces
Compensation Scheme on grounds of infertility
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Services to be commissioned by the NHS CB
NHS CB commissioning Related CCG commissioning
Essential and additional primary medical services through
GP contract and nationally commissioned enhanced services
Out-of-hours primary medical services (where practices have
retained the responsibility for providing OOH services)
Out-of-hours primary medical services (where practices have
opted out of providing OOH services under the GP contract)
Community-based services that go beyond scope of GP
contract (akin to current Local Enhanced Services) Resources
attached to current Local Enhanced Services (LES) (except
for public health LES) are proposed to be included in
CCG funding
Pharmaceutical services provided by community pharmacy
services, dispensing doctors and appliance contractors
Meeting the costs of prescriptions written by member
practices (but not the associated dispensing costs)
Primary ophthalmic services, NHS sight tests and
optical vouchers
Any other community-based eye care services and
secondary ophthalmic services
All dental services, including primary, community and
hospital services and including urgent and emergency
dental care
Health services (excluding emergency care) and public
health services for people in prisons and other custodial
settings (adult prisons, young offender institutions, juvenile
prisons, secure children’s homes, secure training centres,
immigration removal centres, police custody suites)
Emergency care, including 111, A&E and ambulance
services, for prisoners and detainees present in your
geographic area
Health services for adults and young offenders serving
community sentences and those on probation
Health services for initial accommodation for asylum seekers
Health services for members of the armed forces and their
families (those registered with DMS)
Prosthetics services for veterans
(Primary care for members of the armed forces will be
commissioned by the Ministry of Defence)
Health services for veterans or reservists (when not
mobilised), for whom normal commissioning responsibilities
apply
Emergency care, including A&E and ambulance services,
for serving armed forces and families registered with DMS
practices present in your geographic area
Specialised and highly specialised services Related services along patient pathways
Public health services to be commissioned by the NHS CB
Public health services for children from pregnancy to age 5 (Healthy Child Programme 0–5), including health visiting,
family nurse partnership, responsibility for Child Health Information Systems
(Responsibility for children’s public health 0–5 due to transfer to local authorities in 2015)
Immunisation programmes
National screening programmes
Public health care for people in prison and other places of detention
Sexual assault referral services
Further detail on the arrangements for commissioning these services will be confirmed in Autumn 2012.
DOI: 10.3310/hsdr02440 HEALTH SERVICES AND DELIVERY RESEARCH 2014 VOL. 2 NO. 44
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Peckham et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
189
Public health services to be provided or commissioned by local authorities
In addition to the functions set out below, local authorities will be responsible for providing population
health advice, information and expertise to CCGs to support them in commissioning health services that
improve population health and reduce inequalities.
Local authorities will also need to ensure plans are in place to protect the health of their population and










Healthy Child Programme for
school-age children, including
school nursing
Treatment services for children,




(pregnancy to five years old),
including health visiting and
family nurse partnership
Immunisation programmes
Sexual health Contraception over and above
GP contract




















mental illness prevention and
suicide prevention














Local programmes to prevent




Advice as part of other
health-care contacts
NHS treatment of overweight
and obese patients




Drug misuse Drug misuse services,
prevention and treatment




Alcohol misuse Alcohol misuse services,
prevention and treatment
Alcohol health workers in a
variety of health-care settings
Brief interventions in
primary care




Brief interventions in secondary
care and maternity care
Brief interventions in
primary care
Nutrition Any locally-led initiatives Nutrition as part of treatment













Support in primary care for
















to reduce and prevent birth
defects (with PHE)















and oral health improvement,
including water fluoridation
(subject to consultation)












Some of the above services will be mandated for local authorities and the commissioning of other services
will be discretionary. More information is available at: www.dh.gov.uk/prod_consum_dh/groups/
dh_digitalassets/documents/digitalasset/dh_ 131901.pdf.
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for local authorities and
NHS CB
Social marketing and behaviour
change campaigns including
campaigns to prompt early
diagnosis via awareness
of symptoms
Promoting early diagnosis as
part of community health
services and outpatient services
Promoting early diagnosis as
part of primary care
Infectious disease Current functions of the Health
Protection Agency (HPA) in
this area




role for local authorities)
Treatment of infectious disease
Co-operation with PHE and
local authorities on outbreak
control and related activity
Co-operation with PHE and
local authorities on outbreak












resilience remains part of the
core business for the NHS





on health improvement and
health protection (with local
authorities), including many





Agency for Substance Misuse’s
National Drug Treatment
Monitoring System




NHS data collection and
information reporting systems
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Appendix 13 Documentary analysis






l Teaching hospital HR
committee reference to equality
and human rights annual
report by 1 January 2012
l Teaching hospitals annual
report and accounts
2010–11
l Teaching hospitals forward
plan strategy 2012, 2013,
2014
l Annual report on patient
experience 2010–11
presented 24 October 2011
CCG related
(PPI/PPE focus)
l Item 7 Patient and Public
Involvement Action Plan
15 November 2011
l Item 7 Patient and Public
Involvement Action Plan




l Observed CCG meeting
notes 15 November 2011
l Paper on PPI DES
4 July 2011
l Shadow CCG Structure
l CCG Board Infrastructure
l QIPP Leadership Board
subcommittee TOR
August 2011
l Draft TOR Clinical
Executive Committee
l Shadow CCG Board
Structure – visual
l Notes for Shadow
CCG Board Meeting
19 July 2011+
l Shadow GP-led commissioning
consortium paper System
Reform and Transition update
17 February 2011
l GP commissioning transition
plans 2011–12
l CS3 Sustainable Community
Strategy
l CS3 – shadow GP consortium
paper




l CCG board meeting
6 September 2011
review of governance
arrangements and TORs (2)
l CCG clinical reference GRP
progress report January 2012
l CCG clinical reference
GRP progress report
January 2012 (2)









1 November 2011 held
in public
l CCG committee
1 November 2011 held
in public (2)
l CCG committee
12 January 2012 held
in public
l CCG committee
12 January 2012 held
in public (2)
l CCG committee operating
model for CCG locality
working 8 December 2011
l CCG COMPACT agreement
2 February 2012
l Developing CCGs in CS1 – a
guide September 2011
l PPE PID paper
l Publicity leaflet – How Health
Care is changing
l Field notes GP
Commissioning PPE event
27 and 28 January 2011
l Locality Stakeholder Forum
25 August 2011
l Consortia structure – (H)
Management structure
l Agenda Item 10ii CS1 GPCB –
Transition Plan –
10 January 2012
l Agenda Item 10iii CS1 GPCB –
JSNA – 10 January 2012
l Agenda Item 10iv CS1 GPCB –
PPE PID – 10 January 2012
l Agenda Item 10iv CS1 GPCB –
PPE PID – 10 January 2012
l Agenda Item 10v CS1 GPCB –
Integrated Plan – 10
January 2012
l Agenda Item 16 CS1 GPCB –
Primary Care –
10 January 2012
l Agenda Item 17 CS1 GPCB –
LTC – 10 January 2012
l Agenda Item 7 CS1 GPCB –
Equality Delivery –
10 January 2012
l Agenda Item 9iii CS1 GPCB –
Provider Performance –
10 January 2012
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l CCG integrated commissioning





l CCG Portfolios for Clinical
Commissioning Group (CCG)
5 April 2012
l CCG prospectus and strategy
September 2011
l CCG prospectus January 2012
l CCG Review of governance
arrangements 1 March 2012
l CCG TOR October 2011 to
March 2013
l Developing 2012 clinical
commissioning prospectus
12 January 2012
l Draft 2012–13 business plan
for CCG – 5 April 2012
l Equality objectives
5 April 2012
l Introduction of NHS health
checks CCG 5 April 2012
l Right first time programme
update 1 March 2012
l Right first time programme
update 5 April 2012
l Minutes CS1st (E) GPCB –
06 December 2011 (3)
l RCN summary primary care
and community services in EoE
l Agenda Item 10ii CS1
GPCB – Transition Plan –
10 January 2012
l Agenda Item 10iii CS1 GPCB –
JSNA – 10 January 2012
l Agenda Item 10v CS1
GPCB – Integrated Plan –
10 January 2012
l Agenda Item 11 CS1
GPCB – Planned Care –
10 January 2012
l Agenda Item 11i CS1
GPCB – CRS –
10 January 2012
l Agenda Item 12 CS1
GPCB – Urgent Care –
10 January 2012
l Agenda Item 13 CS1 GPCB –
Medicines Management –
10 January 2012
l Agenda Item 14 CS1 GPCB –
Children & Maternity –
10 January 2012
l Agenda Item 15 CS1 GPCB –
Mental Health & LD –
10 January 2012
l Agenda Item 16 CS1
GPCB – Primary Care –
10 January 2012
l Agenda Item 17 CS1 GPCB –
LTC – 10 January 2012
l Agenda Item 5 CS1 GPCB –
Joint Commissioning
ECC – 10 January 2012
l Agenda Item 5 CS1 GPCB –
Joint Commissioning ECC –
10 01 12
l Agenda Item 6 CS1 GPCB – IT
Upgrade Programme –
10 January 2012
l Agenda Item 7 CS1
GPCB – Equality Delivery –
10 January 2012
l Agenda Item 8 CS1 GPCB –
Rationalisation of Estates –
10 January 2012
l Agenda Item 9i CS1 GPCB –
Finance – 10 January 2012
l Agenda Item 9ii CS1 GPCB –
Performance Report –
10 January 2012
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l Attitudes To Healthcare
Survey




l A tale of 2 cities CS2
project 2009
l Achieving balanced health 3
CS2 2009–10/2013–14
l Achieving balanced health in
CS2 April 2011
l Basket of health inequalities
and indicators 2009
l Changes in the new structure
for CS2 excerpt achieving
balanced health
l Commissioning for Quality
annual report 2010–11,
August 2011
l Equality diversity human
rights strategy 2009 2012
September 2009
l Fairer CS2 healthy lives health
inequalities action plan
2010–13, 2010
l Health & social care Quality
account 2010–11 May 2011
l Health & well-being joint
strategic needs ass feb10
l Health Profile 2011 CS2
l LAA – final-report July 2011
l Past present future public
health report September 2011
l Public health in CS2 May 2011
l Shaips2 survey 2000
l CS2 health & exercise
survey 2004
l CS2 health & illness
prevalence survey 2002
l CS2 Index of multiple
deprivation 2010
l CS2 Index of multiple
deprivation 2010
chge analysisMch2011.xls
l CS2 meta data tables available
l CS2 PCT annual report 2010
11 June 2011
l Standing up for CS2
Corporate Plan 2011–14,
December 2011
l World Class Commissioning
Report 2010
l Cardiovascular dis W CS1
health profile
l CS1 (U) Health Profile2011
l CS1 (EF) Health Profile2011
l CS1 (H) Health Profile2011
l PH Outcomes Evidence Base
October 2011
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l Equalities Delivery System
NEDT EDC EDS Objectives
and Outcomes v7 230211[1]
l NEDT EDC EDS presentation
April 2011 v1
l EDS Draft Guidance
March 2011
l EDS Q&A 2 Feb 2011
l NEDC EDC EDS Factsheet
April 2011 v1[1]
General PPI l CS2 PCT PPI strategy
September 2007
l CS2 PPI annual report 2008
l CS2 PPI strategy
l Patient experience
strategy 2009–12
l PEBL in CS1






l Local Health Services
Top League
l Luton and (B) Cluster paper
l GP commissioning transition
plans 2011–12
HWBB






l Notes from meeting of joint
health overview and scrutiny
committee (1)
l Notes from meeting of joint
health overview and scrutiny
committee 2010
l Notes of meeting
November 2011
l Notes from meeting of joint




l Joint Strategic Needs
Assessment 2008 (2)




l GP-List January 11





GPCC in CS2 June 2011
HWBB
l Establishment of H&WE Board
2 February 2012
l Establishment of shadow
H&WE Board 12
January 2012
l CS2 first health & wellbeing
partnership board
15 February 2011
l CS2s health & wellbeing joint
strategic needs assessment
February 1
l GP commissioning board TOR
December 2010
l CS1 PRG evaluation report
HWBB
l DRAFT EVIDENCE BASE FOR
THE CS1 HEALTH &
WELLBEING STRATEGY[1]




l West CS1 CCG JSNA Profile
20 January 2012
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LA l CS3 Sustainable
Community Strategy
l CS3 LAA
l Refreshed CS3 LAA
l Link workplan 2010–2011 l What’s going on within social
care in CS1 January 2012
l ECC GP briefing January 2012
l Health Select Committee
Hearing from ECC
8 November 2011
l 1318947727 bqMB (E)
introductory briefing for GPs










l TPCSS PPE Report
l TPCSS PPE Report (2)
l Transforming Primary And
Community Services Strategy
2010–2015 (1)
l Transforming Primary And
Community Services Strategy
2010–2015 1 (2)
l Community health champions
l Transforming community
services 1 February 2011
l CQIN 2009
LTCs general l Long Term Conditions
Update Report
l Long Term Conditions
Update Report (2)
l Long Term Conditions
Update Report.1pdf









l Brief Explanation Of
Community Diabetes Services






l Referral Pathway Into
Community Diabetes Services
l Your CS3 service directory
for adults
Neuro
l 25 January 2011
l 31 March 2011
l Agenda 20 1 12
l Agenda 25 5 11
l Agenda 27 9 11
l Agenda 28 7 11





l Diabetes community health
Profile updated March 2012
l Presentation on diabetes in
CS2 2010
l Diabetes in CS2
September 2010
l Diabetes Insulin Management
Service Spec draft 2008
l Diabetes Resource Pack
September 2009
Neuro
l Epilepsy in adults
protocol 2010
l Parkinson’s disease protocol
2009
RA
l Hip and knee pathway
Diabetes
l CS1 Diabetes Guidance
for Schools




l PD nurses – guide
for commissioners
l E0E neurology profile




DOI: 10.3310/hsdr02440 HEALTH SERVICES AND DELIVERY RESEARCH 2014 VOL. 2 NO. 44
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Peckham et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
199




l Minutes 28 July 2011









l 423 Network Bulletin
16 December 2010
l 423 Network Bulletin
No 2 6 January[1]
l 423 Network Bulletin
No 3 27 January[1]
l 423 Network Bulletin
No 4 25 February[1]
l 423 Network Bulletin
No 5 21 March[1]
l 423 Network Bulletin
No 6 28 April[1]
PCT/cluster l Notes from first meeting
with CS3
l Action points from
prevention and education
group LTCs Jane 2012
l Five Year Strategic
Plan Refresh1





l Item 7 Patient and Public
Involvement Action Plan
l Item 7 Patient and Public
Involvement Action Plan
l Item 8 A Strategy for Public
and Patient Involvement
l CS3 Cluster paper
l CS3 Annual Report 2011
l CS3 Shadow GP
consortium paper
l CS3 Strategic Plan 2009
l CS3 Strategic Plan 2009 (2)
l CS3 Annual Report 2010
l CS3 Annual Report 2010 (2)
l Notes from first meeting with
CS3 (2)
l Notes from prevention and
education meeting
l Notes on GP commissioning
in CS3
l Operating Plan 2010–11
l Operating Plan 2010–11 (2)
l World Class Commissioning
Panel Report On CS3
l World Class Commissioning
Panel Report On CS3 (2)




l CS2 5.3 of Clinical Audit and
Effectiveness Annual
Report 2010–11
l Evaluating the engagement of
seldom heard groups in
commissioning health services
October 2009
l Minutes final meeting
Advisory forum
22 March 2011
l CS2 board meeting
commissioning patient
experience March 2011
l S Yorks & B NHS
recommendations for
adoption of cluster priorities
for implementation of any
qualified provider Oct 2011
l 2012–01–12 Transition
2nd phase N CS1 cluster
l Assurance Framework
March 2012
l Assurance Framework v3
31 January 2012
l Audit Committee TOR
January 2012
l Equality Assurance report v3




l Handover doc for N CS1
February 2012
l Handover doc for N CS1
February 2012 (2)
l Implementing the NHS White
Paper 14 May 2011
l Integrated Plan 2012–13 to
2014–15 31 January1202
l List papers cluster bd
March 2012
l Minutes 31 January 2012
l NE PCT Cluster Transition Plan
Sept 2011








meeting letter] 28 November
2011 inc. PPE (2)
l PPE strategy 31 January 2012
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l Quality report PPE from page
12. March 2012
l Quality and Governance TOR
January 2012
l Single Executive Board TOR
January 2012
l Transition 2nd phase
January 2012
l Transition 2nd phase January
2012 (2)
l Transition Board Report
update 27 March 2012
l W CS1 ANNUAL
REPORT 2010–11
l W CS1 strategic
plan 2009–14
l W CS1 strategy for health
care 2008 to 2012
QIPP
l System integrated QIPP &
reform plan
l W CS1 integrated plan QIPP
reform plan 2011
l QIPP PPE
l NE cluster board-list of
meetings/papers
l Handover doc for NE cluster
bd Feb 2012
l Integrated Plan 2012–13 to
2014–15 31.01.12
l NE cluster bd
minutes 31.01.12
l NE PCT Cluster Transition Plan
2011–13 v2 Jan 2012




letter 28.11.11 inc PPE page 3
l Report to cluster bd-PPE
strategy 31.01.12
l Public Patient Engagement
and Experience Strategy
transition 2012–13 Jan 12
l NHS NE Cluster Board-Audit
Committee TOR Jan 2012
l Quality and Governance TOR
Jan 2012
l Single Executive Board TOR
Jan 2012
CRS, community rehabilitation services; ECC, Essex County Council; EoE, East of England; GPCB, general practitioner
commissioning board; GRP, group; H&WE, Hertfordshire and West Essex; IT, information technology; JHSOC, Joint Health
Overview and Scrutiny Committee; LA, local authority; LAA, local area agreement; MNDPSP, Motor Neuron Disease
progressive supranuclear palsy; NEDT EDC EDS, National Equality and Diversity Team, Equality and Diversity Committee,
Equality and Diversity Strategy; PD, Parkinson’s disease; PEPL, Patient Experience and Public Engagement Blogging;
PHB, Public Health Board; PID, project initiation document; PwLTNC, patients with long-term neurological conditions;
Q&A, question and answer; RCN, Royal College of Nursing; TOR, terms of reference; TPCSS, Transforming Primary and
Community Services Strategy.
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TABLE 16 National documents (PPE/LTCs) for analysis
Focus of documents Documents
CCG l CCG authorisation letter April 2012
l Working with LINks and local Healthwatch
l CCG Authorisation slides
l Community development 2013 improving population health
l Engagement for commissioning success
l Get smart about engagement series introduction
l Listening- learning and responding
l Practices and patient engagement
l Working with lay members and patient representatives
l Working with lay members and patient representatives (2)
Children’s l Children health services 191211
Commissioning for LTCs l 1303812108 kQBz patient – public involvement – GP commissioning su[1]
l cfpswrldclssscmweb
l Corp chronic disease nhs[1]
l CRough%20guide%20A5%20v5d
l ENGAGING WITH LOCAL PEOPLE[1]
l Giving GPs budgets for commissioning report final[1]
l Health reform in England commissioning framework annex
l Lambeth PCT PPI toolkit[1]
l Managing Diabetes 1 200707300356
l NAVCA 2011 Beginners guide to commissioning
l NHS operating framework 07–08
l OD%20report%20-%20Lewisham
l our health our care our say
l PCT commissioning survey report FINAL for web
l Priorities for commissioners [1]
l RA guidance
l Supporting people with ltc to self care
l Ten steps to pbc (improvement foundation)
l The Kings Fund Nuffield Trust Integrated Care Patients Populations Paper [1]
Engagement strategies
HWBB l Health-and wellbeing-boards-the-kings-fund-april-2012
Health service research l alliancehpsr reader
Healthwatch l alliancehpsr reader
Integrated care l What patients want from integration national voices paper
National Voices l What patients want from integration national voices paper
CCG PPI/PPE Pathfinder l 1314802480 LvHK big changes, small steps
l 1314802480 LvHK big changes, small steps (2)
l 1314802480 MNdF what does a “patient engaged organisation” look li
l 1314802480 MNdF what does a “patient engaged organisation” look li (2)
l 1314802554 bgFn summary report for discovery interviews for patien
l 1314802554 bgFn summary report for discovery interviews for patien (2)
l 1314802554 pMMm summary report of health and wellbeing in north be
l 1314802554 pMMm summary report of health and wellbeing in north be (2)
l 1314802554 rlMP a practice-based approach to ppe in southend estua
l 1314802554 rlMP a practice-based approach to ppe in southend estua (2)
l Buckinghamshire PPI Pilot – What keeps you well Citizens J
l Buckinghamshire PPI Pilot – What keeps you well Citizens Jury v3
l Buckinghamshire%20PPI%20Pilot%20-%20What%20keeps%20you%20well%20%
20Citizens%20Jury%20v3%20%282%29
l Citizens Jury progress report – Bucks – 10Jun11
l Community Voices and starter guide March 2
l Consortia%20PPE%20Projects External%20Stakeholders incl%20pilots%20-feb6th
l Coventry%20project
l CRough guide A5 v5d
l CRough guide A5 v5d 1
l Halton%20and%20St%20Helens
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TABLE 16 National documents (PPE/LTCs) for analysis (continued )
Focus of documents Documents
l Horizon Health Path finder PPI report Diabetes 1314802554 bgFn summary report for




l Pathfinder – information for gps
l Pathfinder,%20Early%20thinking%20on%20Public%20Engagement
l Patient and public engagement and involvement – April 2011





l West Sussex pathfinder – Coastal Fed PRP structure Feb 11V 1
l West Sussex pathfinder – Coastal Fed PRP structure Feb 11 V3
l West Sussex pathfinder – Roles and responsibilities of the
l West Sussex pathfinder – Roles and responsibilities of the Coastal West Sussex
Federation Public Reference Panel V1
Patient representative role l link-representative-ccg-role-description
l link-representative-hwbb-role-description
PPI/PPE l East of England PPI pilots summary.[1]
l Engaging patients & public national report
l Engaging patients & public practice briefing
l LINks-PCTs-Survey-February2010-PDF
l NHS Confederation discussion paper October 2011 PPE
l NHS Future forum PPI report
l PCT commissioning survey report FINAL for web
l Role of LINks in quality accounts DH
l Scoping study of PPI in NHS Trusts in England
QIPP LTC l December 2011 1
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